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SS 1.03
Potential complications at CT colonography in 
asymptomatic and symptomatic patients: national 
survey of Italy
M. Ciolina1, F. Iafrate1, G. Iussich2, D. Regge2, M. Iannitti1,  
P. Baldassari1, A. Pichi1, A. Laghi3;  1Rome/IT, 2Candiolo/IT, 
3Latina/IT
Purpose: The purpose of this study was to retrospectively evaluate the 
incidence of complication related to CTC performed in both symptomatic and 
asymptomatic patients undergoing CTC during the period ranging from 2000 
and 2010.
Material and Methods: With a national survey, an e-mail questionnaire about 
serious adverse events of CT colonography was sent to all Italian Public Health 
Centers performing a daily CTC service. Technical parameters related to 
complications and kind of treatment needed for adverse events were also 
investigated. Collected data were analyzed and raw frequencies were 
determined.
Results: All centers (13/13) interviewed, answered positively to the survey. 
Among 13 centers, 40.121 CTC were performed. No deaths were reported. 39 
(0.097%) patients experienced a complication during the procedure: 32 
vasovagal self-limiting attack episodes (0.079%) and 7 bowel perforations 
(0.017%). In 4 (57%) cases, the site of perforation was within the rectum, in 3 
(43%) cases within the sigmoid colon. No case of perforation within transverse, 
ascending colon and caecum. Three of perforated patients had to undergo 
surgery, while four patients had a conservative treatment. 4/7 cases of 
perforation had a conventional colonoscopy in the past seven days prior to 
CTC or on the same day of the exam.
Conclusion: In summary, we found a low rate of colonic perforations (0.017) 
that were associated with CT colonography. The rate of occurrence of luminal 
perforation, however, was more than four times lower than equivalent rates 
published for colonoscopy.
SS 1.04
National survey of colonic imaging in the UK
A. Lowe, A.D. Culverwell, S. Punekar, D. Prasad,  
S. Stephenson, C. Jackson, C. Kay; Bradford/UK
Purpose: The purpose of this study was to evaluate current provision of 
colonic imaging in the UK NHS, to quantify radiologist and radiographer 
experience and training, and to document current CTC technique and future 
plans for delivering colonic imaging services.
Material and Methods: Postal questionnaires were sent to GI lead radiologists 
and radiology managers at UK hospitals between April 2011 and November 
2011. Comparison is made to a previous national survey in 2004.
Results: Responses were obtained from 86 UK hospitals. There has been a 
signiﬁcant increase in the percentage of centres and volume of CTC being 
performed since 2004. Most reporters are GI sub-specialists, trained on formal 
courses, but 40% are non-specialist and 18% have not been formally trained. 
60% of centres double read at least some of the examinations. 94% use 
automated insufﬂation, 96% buscopan, 72% oral tagging. 54% use full 
purgation for all cases. 46% use iv contrast for all cases. 16% of centres have 
radiographers performing ﬁrst read. Increasing demand is being managed by 
creating more CT capacity by extended working into evenings and weekends 
and training more radiologists and radiographers to read CTC.
Conclusion: Role out of CTC into UK radiology departments since 2004 has 
been extensive and responsible. Technique is good with experienced, specialist 
radiologists providing the majority of ﬁnal reports. In less experienced centres, 
double reading is frequently utilised. Issues remain around low volume in 
centres and individuals and lack of formal training in a minority.
SS 1.05
How do patients and doctors weight the relative 
importance of false-positive and false-negative 
diagnoses of cancer by CT colonography: discrete 
choice experiment
D. Boone1, S. Halligan1, N. Bell1, S. Zhu2, S. Mallett3, C. von 
Wagner1, S.A. Taylor1, D. Altman3, R. Lilford2;  1London/UK, 
2Birmingham/UK, 3Oxford/UK
Purpose: Receiver operator curve (ROC) analysis of radiological tests applies 
equal penalties for false-negative and false-positive diagnosis. We determined 
whether patients and doctors also weight these errors equally.
Material and Methods: 72 patients and 50 doctors completed a discrete 
choice experiment of 20 individual questions, presented graphically on a 
laptop. Each question posed 2 alternative radiological tests; CT colonography 
versus a “new” hypothetical scan that correctly diagnosed one additional 
11:00 - 12:30 Pentland
Scientiﬁc Session 1
CT Colonography 1 - Implementation
SS 1.01
CTC: a comparative analysis of the actual costs with 
current reimbursement rates provided by the National 
Health Service
R. Scandiffio, A. Mantarro, L. Faggioni, P. Bemi, P. Vagli,  
I. Cavallini, E. Neri, C. Bartolozzi; Pisa/IT
Purpose: The purpose of this study was to evaluate the economical impact of 
CTC on the National Healthcare System (NHS) by comparison of the CTC 
actual costs with the allocated reimbursement rates.
Material and Methods: We estimated the actual costs of human resources, 
equipments and consumables (medical devices and drugs) employed to 
perform one CTC examination in our Unit. The costs of human resources were 
calculated assuming an average CTC execution and reporting time of 30 and 
15 minutes, respectively. Radiological equipments encompass: PROTOCO~2~L 
Colon Insufﬂator; 64-row CT scanner LightSpeed-VCT; Advantage Workstation 
GE-Healthcare. Medical staff included: one radiologist, one radiographer and 
one nurse. Medical devices comprised: enema bag, administration set with 
small catheter and retention cuff CO~2~ delivery system for colonic insufﬂation, 
2 pairs of gloves, 2.5-mL syringe, needle cannula, push-ﬁstula bandage, 
patient’s gown, shorts and sheets. Drugs included: 50 mL diatrizoate 
meglumine+diatrizoate sodium solution (Gastrograﬁn®); 250 mL water for 
injection; lidocaine hydrochloride (Neﬂuan®); 20 mg hyoscine butylbromide 
(Buscopan®); 4 L carbon dioxide.
Results: The actual costs for each category are as follows (Euros): medical 
staff, 74.19; radiological equipments, 72.20; medical devices, 38.88; drugs, 
12.09. The sum of these items yields an overall cost of 197.40 Euros/
examination. By comparison, current NHS reimbursement amounts to 184.00 
Euros, resulting in a hospital debt of 13.40 Euros/examination.
Conclusion: Current NHS reimbursement is unable to fully support the actual 
cost of CTC examinations, with consequent excessive expenditure of hospital 
resources.
SS 1.02
CT colonography versus colonoscopy or barium enema 
for diagnosis of symptomatic colorectal cancer: 
economic analysis from a multicentre randomised 
controlled trial
S. Halligan1, G.L. Yao2, K. Wooldrage1, S. Zhu2, W. Atkin1, R. 
Lilford2, T. Siggar Investigators1;  1London/UK, 2Birmingham/UK
Purpose: The purpose of this study was to determine the cost-effectiveness 
of CT colonography (CTC) for diagnosis of symptomatic colorectal cancer 
using real-world data obtained from 5384 patients participating in a multicentre 
pragmatic randomised controlled trial (RCT).
Material and Methods: Cancer detection rates were determined via two 
RCTs: barium enema (2527 patients) versus CTC (1047) and colonoscopy 
(1277) versus CTC (533). Resource costs for diagnostic procedures, the 
proportion of patients referred for subsequent investigations/treatment, and all 
associated downstream costs (further diagnostic procedures, surgery, 
outpatient visits, treatment costs, hospital stay, etc.) were calculated on an 
individual-patient basis. Cost per additional cancer detected was calculated 
via intention-to-treat with bootstrapping for incremental cost-effectiveness.
Results: Total mean and procedure costs were as follows: enema 444GBP 
(procedure cost 169GBP) versus CTC 512 (215); colonoscopy 651 (270) versus 
CTC 512 (215). The additional cost per colorectal cancer detected was 
21,333GBP for CTC versus enema (3 additional cancers per 1000 patients). 
Cancer detection was similar for CTC versus colonoscopy, so cost per 
additional cancer for colonoscopy was >100,000GBP. For CTC, the mean cost 
per additional primary extracolonic cancer was 1965GBP.
Conclusion: CTC is more cost-effective than barium enema. CTC is marginally 
cheaper than colonoscopy but with similar cancer detection rates; choice of 
procedure will depend on other factors, including safety, acceptability and 
detection of extracolonic tumors. Notably, CTC becomes cost-effective at the 
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SS 1.08
Perforation rate in CT colonography: a systematic 
review from literature
D. Bellini, M. Rengo, D. Caruso, F. Vecchietti, M. Osimani,  
A. Laghi; Latina/IT
Purpose: The purpose of this study was to assess the perforation rate in CT 
colonography and to evaluate methodological aspects and patients’ 
characteristics related to colonic perforation.
Material and Methods: Methods for analysis and inclusion criteria were based 
on PRISMA recomandations for systematic reviews and meta-analyses. 
MEDLINE, Cochrane, Sumsearch2 and Web of Science databases, from 
inception to September 2011, were searched for studies that reported 
perforation rate in Virtual Colonography. The evaluation of eligibility and the 
selection of articles were performed independently by two radiologists. From 
each primary study, reviewers abstracted the year of publication, the country 
where the study was performed, whether it was a single or multicenter study, 
number of patients, number of patients underwent CTC for screening and 
because symptomatic, whether manual or Automatic colon distention was 
performed, number of patients perforated, center experience. Moreover, for 
each one of perforated patients, clinical data were extracted.
Results: 188 articles were identiﬁed through database searching and after 
screening process, 15 articles fulﬁlled eligibility criteria and were selected for 
qualitative synthesis. The number of patients enrolled per study ranged from 
262 to 21923, with a median of 9617. In 57700 CTC performed (44% for 
screening, 50% because symptomatic), 21 patients (mean age 75) have been 
perforated with a perforation rate of 0.0298. Only 3 patients perforated 
underwent CTC for screening.
Conclusion: While considered safer than optical colonoscopy, CT 
colonography is not without risk, especially in symptomatic patients.
SS 1.09
Withdrawn by the authors
SS 1.10
Role of CT colonography in preoperative evaluation 
prior to laparoscopic surgery for complicated 
diverticular disease
R. Rizzati1, S. Tartari1, G. Anania2, M. Bassi1, M. Princivalle1, 
R. Righi1, G. Benea1;  1Lagosanto/IT, 2Ferrara/IT
Purpose: The purpose of this study was to investigate the clinical value of CT 
colonography (CTC) in the diagnosis of complicated diverticular disease in 
order to properly plan the laparoscopic surgery.
Material and Methods: From January 2009 until November 2010, 49 patients 
scheduled for surgery for complicated diverticulitis, known or suspected, 
underwent CTC. All patients were previously evaluated with optical colonoscopy 
(OC). Sensitivity in lesion location and detection was compared between OC 
and CTC and discrepancies analyzed. Accuracy of CTC in complicated 
diverticulitis evaluation was determined.
Results: A total of 49 patients with complicated diverticulitis were classiﬁed by 
CTC. OC was incomplete in 37/49 (26%) cases. Based on CTC assessment, 
10 cases of complicated diverticulitis were managed medically; 30 patients 
underwent laparoscopic surgery for complicated diverticular disease. In 14 
patients, CTC ﬁndings suggested an open surgery treatment due to adhesions, 
abscesses or ﬁstulas. In diagnosis of complicated diverticular disease, CTC 
showed 100% agreement regarding location and extent of the lesion and 90% 
sensitivity for complications. Furthermore, CTC detected 34 extracolonic 
ﬁndings, 12 of whom had major clinical relevance.
Conclusion: CTC provides more detailed and precise depiction of complicated 
diverticular disease compared to OC, allowing an appropriate and accurate 
management of patient.
colorectal cancer or polyp (i.e. a lesser false-negative rate), raising sensitivity 
by 10% (from 85% to 95%) but at the expense of additional false-positive 
diagnoses. The number of false-positives per additional cancer diagnosis was 
varied for each question. The clinical consequences of false-positive diagnoses 
were explained prior to the test. Participants indicated their preferred test for 
each question. Responses were collated and the “tipping-point” calculated for 
each group overall.
Results: For 10% increase in cancer sensitivity, patients tolerated a mean 
47% (95%CI 39%-56%) increase in false-positives, equating to 2350 per 
additional cancer detected. Doctors tolerated an additional 14% (95%CI 9%-
21%), which equated to 700 per cancer. For an 10% additional polyp 
detections, patients tolerated an additional 33% rise in false-positives 
compared to 17% for doctors.
Conclusion: Patients (especially) and doctors regard false-negative diagnosis 
of colorectal cancer (and polyps) as overwhelmingly more important than 
false-positive diagnoses. Statistical analysis of radiological tests must take 
this discrepancy into account if they are to truly reﬂect diagnostic beneﬁt.
SS 1.06
Use of computed tomographic colonography (CTC) in 
patients older than 75 years
D.A. Tiferes, A. Habr-Gama, J.G. Rodrigues, R.O. Perez,  
I. Proscurshim, R. Blasbalg, R.P. Caldana; São Paulo/BR
Purpose: The purpose of this study was to demonstrate the use of CTC in 
patients older than 75 years.
Material and Methods: Retrospective analysis of 116 consecutive CTC 
examinations performed in patients older than 75 years was undertaken. 
Performance and outcome measures including colonoscopy referral, prevalence 
of lesions  10mm, signiﬁcant extracolonic ﬁndings and complication rates were 
obtained by using a CTC database and review of medical records.
Results: 35 males and 81 females, with ages ranging from 75 to 95 years 
(mean 81.2 years), underwent CTC for colorectal cancer screening (27.6%), 
due to incomplete colonoscopies (33.6%) and for evaluation of gastrointestinal 
symptoms (38.8%). Adequate technique (insufﬂation and bowel preparation) 
was obtained in 93.2% (645 of 696) of the colonic segments evaluated. There 
were no complications. Colonoscopy was indicated in 19% (22 of 116) of 
patients, using a 10 mm lesion size as threshold for referral. Sixteen of these 
patients underwent colonoscopy and/or surgery, with 15 patients harboring 
lesions  10 mm (11 invasive cancers and 4 advanced adenomas). The overall 
per-patient CTC positive predictive value was 93.8% (15 of 16). Signiﬁcant 
extracolonic ﬁndings were seen in 12.9% (15 of 116) of patients, mostly 
consisting of aortoiliac aneurysms (n=6).
Conclusion: CTC is a safe and effective modality for colorectal evaluation in 
patients older than 75 years. Based on CTC results, optical colonoscopy may 
be ultimately avoided in over 80% of those patients.
SS 1.07
CTC in symptomatic patients: are we keeping negative 
colonoscopies to a minimum?
S.F. Kerr, D.J.M. Tolan, M. Sheridan; Leeds/UK
Purpose: In many institutions, CTC has supplanted colonoscopy as ﬁrst-line 
investigation for colonic neoplasia in symptomatic patients with comorbidity. 
However, published outcomes of CTC performance outside research trials are 
lacking. We reviewed our CTC experience in symptomatic patients with the 
primary objective of establishing positive predictive value (PPV) for 
benchmarking clinical practice during early service development.
Material and Methods: All CTC examinations performed over a two-year 
period from May 2007 (i.e. 2-year minimum clinical follow up) were reviewed. 
For those reporting a signiﬁcant colonic abnormality (i.e. polyp 6mm; cancer; 
or indeterminate thickening), endoscopy and pathology reports were reviewed. 
CTC was performed with standard technique including intravenous contrast.
Results: Of 1852 consecutive CTC examinations (median age 78), 337 
reported a signiﬁcant colonic abnormality. 70 had undergone previous 
incomplete colonoscopy and were excluded from further analysis. 215 had 
subsequent colonoscopy and/or surgery; corresponding lesions were 
conﬁrmed in 167 and excluded in 32. Excluding 16 patients with inadequate 
subsequent visualisation of the appropriate colonic segment, per-patient PPV 
of CTC was 83.9%. Seven patients were ultimately diagnosed with inﬂammatory 
(rather than neoplastic) lesions; categorising these as “false positive” reduces 
PPV to 80.4%. In total, 251 polyps 6mm and cancers were reported on CTC 
in 194 patients proceeding to colonoscopy and/or surgery; per-lesion PPV was 
85.7%.
Conclusion: PPV of CTC for signiﬁcant colonic abnormalities is high and the 
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Material and Methods: 46 liver tumours [hepatocellular carcinoma (22), 
metastases (24)], with a mean tumour size of 30mm, in 37 patients with an 
average age of 67 years were treated by multi-station percutaneous MWA over 
14 months. Post-ablation dual-phase CT was performed on average at 23 
days post-treatment and technical success assessed. Subsequent follow-up 
CTs have been performed. Data were collected prospectively.
Results: 40 of 46 tumours (87%) were successfully treated by MWA. Sub-total 
treatment occurred initially in eight tumours in seven patients. Sub-total 
treatments were anticipated in one patient with two tumours in whom the 
procedure was abandoned due to general anaesthesia difﬁculties. Of six 
unexpected sub-total treatments, three tumours underwent completion MWA, 
and one completion trans-arterial chemoembolization. Average length of 
imaging follow-up was 116 days (maximum 449 days). From tumours with 
complete ablations, there has been only one late local recurrence, detected at 
132 days post-ablation. Five patients died of progressive disease, at an 
average of 245 days post-ablation.
Conclusion: Complete MWA was achieved in 40 of 46 (87%) tumours with an 
average size of 30 mm. Early experience has led to a modiﬁed, multi-stationed 
approach with a trend to primary complete treatments later in this cohort.
SS 2.04
Biodegradable oesophageal stents: indications and 
complications in the management of malignant 
oesophageal tumours
D. Mullan, P. Kellati, H. Sheikh, H. Laasch; Manchester/UK
Purpose: Oesophageal stents are well established in the management of 
malignant oesophageal tumours and traditionally require covered, retrievable, 
metal stents to avoid complicated mucosal embedment. Radiotherapy should 
not be given with a metal stent in situ, requiring stent retrieval and nasogastric/
gastrostomy insertion. Biodegradable oesophageal stents are a recent product 
indicated primarily for benign strictures. We report the novel use of non-
covered biodegradable stents in the management of malignant strictures, 
allowing concurrent radiotherapy with stent in situ. We discuss indications, 
implications and complications.
Material and Methods: Patients with oesophageal malignancy suitable for 
radical radiotherapy were referred for biodegradable stent insertion at a 
regional oncology centre. Prospective auditing allowed retrospective statistical 
review of clinical data including symptoms, demographics, outcomes, 
complications and survival. All cases were performed under ﬂuoroscopic 
guidance by a consultant radiologist.
Results: 18 stents were inserted in 17 patients between 17/4/2009 and 9/8/2011. 
All were placed immediately prior to radiotherapy. Two stents blocked with food/
mucosal hyperplasia, one requiring gastrostomy and one preferring NG insertion 
due to stent associated pain. 1 patient complained of pain alone, endoscopy 
showing mucosal hyperplasia. 1 stent slipped requiring reinsertion.
Conclusion: Biodegradable stents inserted for potentially curable malignancy 
confer the signiﬁcant advantage of permitting concurrent radiotherapy whilst 
obtaining luminal expansion. This permits a psychologically signiﬁcant oral diet 
and avoids the need for gastrostomy/nasogastric tube insertion. They do, however, 
seem prone to speciﬁc complications, such as pain and mucosal hyperplasia.
SS 2.05
Right-sided Wallﬂex stenting in patients with malignant 
colonic obstruction: a single-centre prospective study
I. Walton, B. Fox, P. Williams; Plymouth/UK
Purpose: Self-expanding metallic stents (SEMS) have been used to relieve 
malignant colonic obstruction as palliation or as an interim procedure to 
surgical resection. There is a paucity of data related to colonic stent insertion 
in the proximal colon. We present the world’s largest single-centre 10-year 
prospective data to assess the outcomes in stented patients with right-sided 
lesions.
Material and Methods: A total of 40 consecutive patients (45% women; mean 
age 76) were treated for right-side obstruction due to primary or recurrent 
colon cancer with SEMS: 2 as an interim to surgery and 38 for palliation. A 
Wallﬂex stent was used in all patients and inserted under combined endoscopic 
and ﬂuoroscopic guidance.
Results: Right-sided colonic stent deployment was attempted in all 40 patients 
with 41 stents. SEMS was successfully deployed in 34 cases (85%) with two 
complete obstructions, one failure deployment, and an inaccessible obstructing 
lesion in three cases. There were no procedural complications (perforation, 
migration). Clinical success was achieved in 30 of 34 cases (88%). Long-term 
complications included: a migration of a successfully deployed stent, and 
three re-obstructions due to faecal blockage or tumour ingrowth. The remaining 
patients had normal bowel movements for the period of follow-up or until 
expiration.




CT-perfusion technique, with evaluation of quantitative 
perfusion map, as an early predictor for tumour 
response to transarterial chemoembolization in patients 
with HCC lesions
P.A. Bonaffini, D. Ippolito, C. Talei Franzesi, C. Capraro,  
R. Corso, S. Sironi; Monza/IT
Purpose: The purpose of this study was to prospectively investigate the role 
of CT-perfusion (CT-p) technique in evaluation of perfusion changes in HCCs 
before and after transarterial chemoembolization (TACE) therapy.
Material and Methods: Twenty-seven patients with cirrhotic liver disease and 
histologically proved HCC were prospectively enrolled in our study. CT-p study 
was performed on 16 multidetector CT (Brilliance 16, Philips, NL), dose 
exposure was 120 Kv, 80 mAs. In all cases, bolus injection of 50 ml of non-
ionic contrast agent (350 mgI/ml) at a ﬂow rate of 6 ml/sec was performed and 
forty dynamic scans were acquired at a ﬁxed table position. A dedicated 
perfusion software which generated a quantitative map of arterial and portal 
perfusion by means of colour scale was employed. The following perfusion 
parameters were assessed before and after TACE: hepatic perfusion (HP), 
arterial perfusion (AP), blood volume (BV), hepatic perfusion index (HPI).
Results: A complete HCC ﬁlling by lipiodol was found in 18 cases with 
following perfusion parameters: HP 32.7±15.1 ml/sec/100gr; AP 38.4±8.8 ml/
min; BV 17.6±9.5 ml/100mg; HPI 96.2 ±7.5%. Corresponding value calculated 
in patients without residual tumor were: HP 13.6±6.3; AP 13.1±7; BV 6.8±4.8; 
HPI 13.6±9.2. A signiﬁcant difference (p<0.001) was found for all parameters 
between residual viable tumor tissue (p<0.001) compared to successfully 
treated lesion, due to the presence of residual arterial vascular structure in 
viable portion of treated HCC.
Conclusion: On the basis of the small patient population, this feasibility study 
shows that quantitative analysis of perfusion could provide an in vivo early 
biomarker for predicting treatment response in patients with HCC lesions.
SS 2.02
Survival after radiofrequency ablation and salvage 
transplantation in patients with hepatocellular 
carcinoma and Child-Pugh A cirrhosis
O. Seror, G. N’Kontchou, M. Beaugrand, J.C. Trinchet,  
Y. Ajavon, N. Sellier; Bondy/FR
Purpose: In patients with hepatocellular carcinoma (HCC) in Milan criteria, liver 
transplantation (LT) may be the best therapeutic option. However, the shortage 
of grafts, leads to attempt liver resection (LR) or radiofrequency ablation (RFA) as 
a ﬁrst-line treatment for patients with Child-Pugh A cirrhosis.
Material and Methods: We report results, obtained between 2000 and 2007 
from a single center, involving 67 patients (mean age: 58 years) eligible for LT, 
who were treated with RFA, followed by LT if there was recurrence or liver 
failure.
Results: RFA achieved complete ablation in 96% of nodules. No mortality 
occurred. During a post-RFA median follow-up of 48 months, 38 patients 
experienced recurrence, corresponding to a 5-year recurrence rate of 58%. Of 
these, 14 patients did not receive a transplant, because they fell outside the 
Milan criteria, 21 were transplanted, and 3 were treated by RFA after refusing 
LT. Binodularity (95% CI HR=2, 1.0–4.0; p=0.049) was the unique risk factor for 
recurrence. By the study’s end-point, 24 patients had undergone LT. No HCC 
recurrence occurred after LT. Among the 43 non-transplant patients, 12 died 
due to HCC progression, and 27 were alive without detectable viable tumor. 
The probability rates for 5-year overall and tumor-free survival were 74% and 
69%, respectively.
Conclusion: First-line RFA followed by salvage LT allows comparable survival 
ﬁgures with a ﬁrst-line LT, whist limiting the number of grafts.
SS 2.03
Microwave ablation of liver tumours at 2.45 GHz with a 
1.8 mm applicator: radiological outcomes
P.A. Patel, I.D.C. Wilson, C.N. Hacking, B. Stedman,  
D.J. Breen; Southampton/UK
Purpose: Little published data exist on outcomes following microwave ablation 
(MWA) at 2.45 GHz in human liver tumours. We have analysed our performance 
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SS 2.08
Comparison of percutaneous portal vein embolization, 
portal vein ligation and portal vein occlusion combined 
with ipsilateral hepatic artery cannula implantation prior 
to major liver resection
P. Pajor, O. Hahn, I. Dudas, A. Zsirka, T. Winternitz,  
P.K. Kupcsulik; Budapest/HU
Purpose: The purpose of this study was to evaluate the results of percutaneous 
portal vein embolisation (PVE), portal vein ligation (PVL) and portal vein ligation 
combined with hepatic artery cannula implantation into the ipsilateral hepatic 
artery (PVL+can) prior to extended hepatectomy.
Material and Methods: Between 2004 and 2012, hundred and twenty patients 
presenting with multiple or large liver metastases or large hepatocellular 
carcinoma were included. The estimated residual liver volume (FLR) of these 
patients after the planned extended hepatectomy was less than 30% (normal 
liver), or 40% (cirrhotic liver). To increase the FLR, portal vein occlusion 
techniques (39 PVE, 81 PVL alone, or PVL+can) were performed. They were 
evaluated with MDCT including volume assessment, before and 8 weeks after 
these procedures.
Results: 96/120 patients became resectable (PVE, PVL, PVL+can, 74.3%, 
80%, 88.5%). FLR increase 8 weeks after PVE, PVL or PVL+can was 17.6%, 
16.5%, 19%, the complication rate of the various portal occlusion techniques 
were 4.5%, 3.6%, 11,5%, respectively. At least 4 segments were resected 
during hepatectomy. Overall, postoperative morbidity and mortality rates were 
13% and 2.5%, respectively. Complication and mortality rates did not differ 
signiﬁcantly in the 3 groups.
Conclusion: Patients with previously unresectable liver tumors can beneﬁt 
from resection after all kinds of portal occlusion techniques. Although 
complication rate of portal occlusion combined with hepatic artery canulla 
implantation is higher, more patients become resectable due to higher increase 
rate of FLR in this group.
SS 2.09
Dynamic evaluation and quantiﬁcation of 
microvascularization during degradable starch 
microspheres transarterial chemoembolisation (DSM-
TACE) of HCC lesions: a feasibility study
P. Wiggermann, W.A. Wohlgemuth, A.G. Schreyer, M. Loss, 
C. Stroszczynski, E. Jung; Regensburg/DE
Purpose: The purpose of this study was to evaluate the time-dependent 
changes of microvascularization in HCC lesions during DSM-TACE using 
contrast enhanced ultrasound (CEUS).
Material and Methods: A total of 64 CEUS examinations were performed (1-5 
MHz, convex probe) in 8 selected patients who underwent DSM-TACE of HCC 
lesions. I.v. application of ultrasound contrast media was performed before 
and 24 h post-embolization. In addition, i.a. contrast application was performed 
via the angiographic catheter right before and after the embolization and 
during a follow-up time of 2 h every 30 min. The capillary perfusion was 
analyzed using a dedicated perfusion software.
Results: A reduced microvascularization was seen right after DSM-TACE in all 
cases. The reduction of PEAK, RBV (regional blood volume) and RBF (regional 
blood ﬂow) compared to pre-embolization values was highly signiﬁcant 
(p<0.001). During follow up, a stepwise revascularization of the lesions was 
documented: 90 min post embolization perfusion parameters were not 
signiﬁcantly different from pre-embolization values.
Conclusion: In this feasibility study, capillary perfusion quantiﬁcation of HCC 
lesions after DSM-TACE could be demonstrated using CEUS. It was possible 
to quantify for the ﬁrst time the transient embolizing effect of DSM-TACE.
SS 2.10
Multi-centre survey of radiologically inserted 
gastrostomy feeding tube in the UK
A. Lowe1, H.U. Laasch2, S. Stephenson1, C. Butterﬁeld1,  
M. Goodwin2, C. Kay1;  1Bradford/UK, 2Manchester/UK
Purpose: The purpose of this study was to evaluate variance in current UK 
practice and clinical outcomes for direct percutaneous radiologically inserted 
gastrostomy (RIG).
Material and Methods: A prospective UK multi-centre survey of RIG was 
performed between October 2008 and August 2010.
Results: Data from 684 patients were provided by 45 radiologists working at 
17 UK centres. 263 cases (40%) were performed with loop-retained catheter, 
and 346 (53%) with balloon-retained devises. 60% of all patients experienced 
pain in the ﬁrst 24 hours but settled in the majority thereafter. Early 
complications, deﬁned as occurring in the ﬁrst 24 hours, included: minor 
Conclusion: Management of proximal malignant colonic obstruction with the 
Wallﬂex device is safe and effective. Technical and clinical success is 
encouraging, with outcomes comparable to distal colonic stenting.
SS 2.06
Selective radioembolization with 90y microspheres for 
liver secondary lesions: our experience
R. D’Angelo, F. Fiore, L. Aloj, C. Arrichiello, S. Lastoria,  
V. Albino, F. Izzo; Naples/IT
Purpose: The purpose of this study was to assess the safety and effectiveness 
of intra-arterial Y90 SIR sphere treatment in patients with liver metastasis.
Material and Methods: Between 2005 and 2011, radioembolization was 
performed in 83 patients with non-surgical liver metastases in progression 
after chemiotherapy: 52 with colorectal tumor; 19 with breast cancer; 4 with 
melanoma; 2 with NET; 2 with pancreas tumor; 2 with gastric tumor; 2 with 
ovarian tumor. The administered dose was calculated with Body Surface Area 
Method (BSA). All patients underwent PET/TC before and after treatment. PET-
Y90 was performed to check the microspheres distribution. Work up included 
also embolization of gastroduodenal artery and other arteries using micro-
coils. Shunting study was performed with TC 99MAA after positioning of 
3French microcatheter.
Results: The mean administered dose was 1.55 GBq. The partial/complete 
response was achieved in 27 patients; in 42 was obtained stability and 
progressive disease in 24 patients. No signiﬁcant side-effects of treatment 
were observed; 37 patients developed fever and can last up to a week. 43 
patients also experienced abdominal pain controlled by oral analgesia. 
Prophylaxis treatment was used for 1 month after with PPI.
Conclusion: Our experience suggests that radioembolization is effective and 
safe for local treatment of non-surgical hepatic metastasis in progression after 
systemic chemotherapy.
SS 2.07
Role of transarterial chemoembolization as bridging 
strategy in T2 HCC patients on the waiting list
I. Bargellini, E. Bozzi, G. Lorenzoni, P. De Simone, R. Cioni, 
F. Filipponi, C. Bartolozzi; Pisa/IT
Purpose: The purpose of this study was to retrospectively evaluate long-term 
outcomes of T2 stage HCC patients who underwent orthotopic liver 
transplantation (OLT) after transarterial chemoembolization (TACE), compared 
to patients transplanted without bridging therapy.
Material and Methods: The study included 168 cirrhotic patients (147 male, 
mean age 55.8 years) with T2 HCC, who underwent OLT from 1996 to 2010. In 
patients treated by TACE, latest CT examination prior to OLT was reviewed to 
assess tumor response according to mRECIST. Patients were divided into 
three groups: (A) no bridging therapy; (B) complete response (CR) after TACE; 
(C) partial response, stable or progressive disease after TACE. Overall (OS), 
recurrence-free (RFS) and disease-free (DFS) survivals were calculated by 
Kaplan-Meier analysis and compared by log-rank test.
Results: Fifty-six patients were in group A, 60 patients in group B and 52 
patients in group C; preprocedural data were comparable among groups. Five-
year OS, RFS and DFS were 75.2%, 92.7% and 73.2%, respectively. Survivals 
were signiﬁcantly higher in group B compared to group C and comparable 
between group A and B. Of interest, in tumors > 3cm, RFS and DFS censored 
for periprocedural deaths (n=7) were higher in group B compared to group A 
(p=0.05).
Conclusion: In T2 transplanted patients, CR after pre-operative TACE 
represents a favorable prognostic indicator. TACE may be beneﬁcial for T2 
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Results: The mean value of Dmax obtained by surgical specimen was 50 mm 
(range 30-60) versus 63 mm (range 46-92) of Dmax measured through MDCT. 
If the Dmax values were stratiﬁed in three groups (group 1 smaller than 40 mm, 
group 2 between 40 and 80 mm, group 3 bigger than 80 mm), a correlation 
with MDCT results of 25%, 62% and 71%, respectively, was found.
Conclusion: MDCT is an accurate technique to obtain an appropriate 
preoperative deﬁnition of Dmax, within the limits of tumor bigger than 40 mm. 
The revaluation of each case with Dmax smaller than 40 mm will supply 
additional information about the discrepancy (retraction of the stomach 
following immersion into formalin, diffusion in the submucosal layer).
SS 3.03
Evaluation of nine CT-signs in surgically proven internal 
hernia after gastric bypass, initially missed on CT
J. De Cock, D. Vanbeckevoort, L. Van Muylder, M. Lannoo, 
D. Bielen; Leuven/BE
Purpose: Retrospective evaluation of nine CT-signs of internal herniation after 
laparoscopic gastric bypass in 13 patients with surgically proven internal 
hernia where the diagnosis initially was missed.
Material and Methods: We retrospectively evaluated the CT-scans of 13 
patients who had complaints of long-lasting vague abdominal pain after 
undergoing a laparoscopic gastric bypass procedure. None of the patients 
were initially diagnosed with internal herniation. Surgical exploration revealed 
internal herniation in all 13 patients. We reevaluated the images using nine CT-
signs: swirled appearance of mesenteric fat or vessels, mushroom shape of 
the hernia, mesenteric inﬁltration, the presence of reactive lymph nodes, 
tubular distal mesenteric fat surrounded by bowel loops, small-bowel dilatation, 
clustered loops of small bowel, small bowel other than duodenum posterior to 
the mesenteric artery and right-sided location of the enterostomy.
Results: Presence of the signs: Mesenteric swirl and mesenteric inﬁltration 
were 100%. Mushroom shaped hernia and reactive lymph nodes were 77%. 
Clustered loops of small bowel were 46%. Small-bowel dilatation was 38%. 
Displaced enterostomy was 31%. Tubular distal mesenteric fat surrounded by 
bowel loops was 23%. Small bowel other than duodenum posterior to the 
mesenteric artery was 15%.
Conclusion: When a patient suffers from vague long-lasting abdominal 
complaints after gastric bypass, thorough investigation of the nine CT-signs 
presented above is mandatory in diagnosing internal herniation on an 
abdominal CT-scan.
SS 3.04
Post-operative ileus, abnormal bowel and overall 
radiologist impression are independent predictors for 
clinical anastomotic leak on CT
K. Adams, D. Bosanac, A. Hansman, P. Peddu, S. Ryan,  
S. Papagrigoriadis; London/UK
Purpose: The purpose of this study was to investigate individual radiological 
features as predictive factors for anastomotic leak detection in CT scans 
following colorectal resections.
Material and Methods: Patients were identiﬁed from a prospective database 
from 2005 to 2011 with surgically conﬁrmed post-operative anastomotic leaks. 
The control group (matched in 2:1 ratio) was selected from patients who were 
scanned with a suspicion of leak, but improved without operation. Four 
gastrointestinal radiologists reviewed anonymised CT scans, blinded to clinical 
outcome. Radiologists assessed for the overall impression of anastomotic 
leak, presence of leak features, and conﬁdence level in their results.
Results: 17 patients with conﬁrmed anastomotic leaks and 36 control patients 
were enrolled. No signiﬁcant difference was observed in the sensitivity/
speciﬁcity between the radiologists in correct leak detection, with overall 
correct diagnosis in 81.4%. A leak prediction model was constructed with 
multivariate binomial logistic regression with outcome classiﬁed as clinical 
leak. Leak, abnormal bowel wall and ileus were signiﬁcant predictors (all 
p<0.05). The prediction model produced an overall sensitivity 85.2%, speciﬁcity 
80.2% and ROC curve area of 87.3% (see graph). A correct leak prediction 
was associated with a signiﬁcantly higher conﬁdence level: 7.09/10 when 
incorrect versus 8.50/10 when correct (p=0.02).
Conclusion: Diagnostic accuracy was signiﬁcantly higher when radiologists 
had a higher level of conﬁdence in their diagnosis. Individual CT features have 
been used to create a risk prediction model for leak detection that improves 
diagnostic accuracy above overall radiological impression alone.
bleeding (1%), wound infection (3%), peritonism (2%) and tube misplacement 
(1%). Late complications, occurring between day 2 and day 30, included: mild 
pain (30%), persisting peritonism (2%) and 30-day mortality of 1% (5/665). 
93% of cases were performed using gastropexy. Gastropexy decreased post-
procedural pain (p<0.001), but gastropexy-related complications occurred in 
5%. Post-procedure pain increased signiﬁcantly as tube size increased 
(p<0.001). The use of balloon retention feeding tubes was associated with 
more pain than the use of loop retention devices (p<0.001).
Conclusion: RIG is a relatively safe procedure with a mortality of 1%, with or 
without gastropexy. Pain is the commonest complication. The use of 
gastropexy, smaller tube sizes and loop retention catheters signiﬁcantly 
reduced the incidence of pain. There was a gastropexy-related complication 
rate in 5% of patients. Neither pre-procedural antibiotics nor anti-MRSA 
prophylaxis affected the rate of wound infection.




Software-assisted evaluation of gastric motility in MRI 
improves the assessment of functional parameters
S. Bickelhaupt1, J.M. Froehlich1, R. Cattin2, S. Raible2,  
H. Bouquet3, U. Bill3, M.A. Patak1;  1Zurich/CH, 2Biel/CH, 
3Bern/CH
Purpose: Functional MRI of gastric motility is of high clinical relevance, e.g. for 
gastric-emptying disorders, but time-consuming due to the manual 
measurement. A newly developed software (Motasso) has proven valid for 
semi-automatic measurement of small-bowel motility. The aim of this study 
was to evaluate the feasibility of Motasso for the assessment of gastric motility 
by comparing it to manual measurements.
Material and Methods: 10 patients (5 male/5 female; mean 41 years) were 
included in this study. MRI (1.5-T, Siemens-Sonata) was performed after 
standardized preparation (3% Mannitol over 1 h). 2D (dynamic-T2-2D-
FIESTA;TR253.8/TE1.89/FOV400/10mm slice) motility acquisitions covering the 
entire abdomen were performed in apnea. Image analysis for assessment of 
gastric motility was performed both manually and with the software in the 
proximal/distal corpus. The main characteristics (amplitude/frequency/diameter) 
describing gastric motility were compared using (paired) Student’s t-test.
Results: 10 single regions-of-interest (5 in the proximal/5 in the distal corpus) 
were measured by hand and with Motasso. All motility curves qualitatively 
matched each other (10/10; 100%). No signiﬁcant difference (p>0.05) was 
found for amplitudes (mean: 18.17 mm, manual: 17.78 mm, Motasso), 
contraction frequency (5.1/min, 4.7/min) and mean lumen diameters (34.12 
mm, 33.13 mm). Mean duration for single measurement was signiﬁcantly 
(p<0.001) lower with Motasso (6.40 min, manual: 1.40 min, Motasso). Mean 
manual wave propagation was 0.68 mm/sec.
Conclusion: Motasso proves to be feasible for fast and accurate measurement 
of gastric motility in both the proximal and distal corpus. No signiﬁcant 
differences between manual measurements and the software could be 
observed. Motasso can help to reduce the time needed for assessment of 
relevant characteristics in gastric motility and thus ease the clinical practice of 
gastric motility analyses.
SS 3.02
Accuracy of MDCT in preoperative deﬁnition of 
maximum tumor diameter in patients with gastric 
cancer
S. Guerrini, M.A. Mazzei, N. Salvini, P. Mercuri, N. Ciofﬁ 
Squitieri, C. Vindigni, D. Marrelli, L. Volterrani;  Siena/IT
Purpose: The maximum tumor diameter (Dmax) is a prognostic factor in 
patients with gastric cancer, considering its dependance on the depth of 
invasion. The aim of our work has been to evaluate the accuracy of MDCT in 
the preoperative deﬁnition of Dmax in patients with gastric cancer, assuming 
surgical specimen measurements as gold standard, in order to obtain a pre-
surgery prognostic evaluation.
Material and Methods: Pre-surgery CT examinations of 47 patients (mean 
age 53.5, range 48-71) with diagnosis of gastric cancer were evaluated 
retrospectively and in a blind fashion by a radiologist with expertise in the 
oncologic ﬁeld. The Dmax measured was obtained through 2D multiplanar 
curved reconstruction (ADW 4.6 GE Healthcare). The results were compared 
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(n=25), then combined with 45 non-digitating examinations (total=100), 
anonymised, and reviewed by two experienced GI radiologists (blinded). 
Certainty of digitation, LIG presence/absence, and perceived effects of 
digitation were recorded. A statistician was involved during methods/results.
Results: Qualitative data: 92% referrers visualised LIG in representative 
studies, 69% and 62% felt study appreciation and patient consultation would 
improve. Prospective study results: Signiﬁcant overall interobserver agreement 
(Kappa 0.84) in conﬁdence whether digitation occurred or not (false positive 
1%). LIG use: Both readers detected all digitation and that LIG were worn 
(sensitivity/speciﬁcity 100%); in 97% readers were conﬁdent about digitation 
effects. NG use: Digitation was detected with certainty in 66% and effects of 
digitation were felt apparent in 18% (poor interobserver; Kappa 0.11). Certainty 
of digitation and its effects signiﬁcantly improved (p<0.01 and <0.001, paired 
t-tests) with LIG compared to NG.
Conclusion: Clinicians value improved digitation visualisation in study 
appreciation and patient consultation and LIG use signiﬁcantly improves 
visualisation of digitation and its effects during evacuation proctography 
compared to NG.
SS 3.08
Incidental focal colonic FDG uptake: correlation with 
colonoscopic ﬁndings
R.R. Nensey1, G. Bhatnagar1, H.S. Sidhu1, S.J. Higgins2,  
T. Sulkin3;  1Plymouth/UK, 2Torquay/UK, 3Treliske/UK
Purpose: The purpose of this study was to assess the incidence of focal FDG 
uptake in the colon in patients not known to have colorectal carcinoma and to 
determine the signiﬁcance of these PET positive scans on follow-up 
endoscopy.
Material and Methods: A retrospective data collection of the PET CT scans 
performed on patients at Royal Cornwall hospital was reviewed. The study 
included data of 306 scans performed over 15 months between October 2008 
and December 2009. Patients with known bowel pathology were excluded 
from the study.
Results: Incidental FDG uptake within the colon was seen in 15 of the 306 patients. 
Endoscopy was subsequently performed on 9 of these cases, demonstrating an 
anomaly in the form of polyp or tumour. A further 2 incidental polyps were identiﬁed 
on endoscopy which did not indicate corresponding increased FDG uptake on the 
PET scans. Malignant tumours were identiﬁed on 3 of these PET positive patients; 
the sites being the rectum, sigmoid colon and caecum. The positive predictive 
value of PET for colonic disease from our study is 100%.
Conclusion: The positive predictive value of PET is 100% in detecting colonic 
pathology. It is vital to systematically review the bowel on nuclear medicine 
scans and if positive, follow up of such cases must be performed with 
endoscopy and biopsy for early detection and appropriate management of 
colonic pathology.
SS 3.09
Small and large bowel MRI: can additional diffusion-
weighted MR imaging improve diagnostic conﬁdence?
S. Kinner, S. Blex, M. Forsting, T.C. Lauenstein; Essen/DE
Purpose: MR enterography and colonography are well accepted techniques 
for the depiction of inﬂammatory and tumor diseases. Diagnostic conﬁdence 
in some cases can be limited, especially in the presence of motion/breathing 
artifacts or suboptimal bowel distension. Diffusion-weighted imaging (DWI) is 
an emerging technique for abdominal MRI. Therefore, we aimed to evaluate if 
additional DWI for bowel MRI can improve diagnostic conﬁdence.
Material and Methods: 18 patients underwent bowel MR because of 
suspected or known IBD (n=9), tumor disease (n=6), unspeciﬁc abdominal 
pain (n=2) and suspected graft-versus-host disease (n=1). MRI was performed 
on a 1.5 T (Magnetom Avanto, Siemens). In addition to T2w and contrast-
enhanced T1w data, DWI sequences in axial and coronal plane were collected 
(b = 50, 500, 1000). The diagnostic conﬁdence for lesion detection with and 
without DWI was evaluated by two experienced radiologists using a 4-point 
Likert scale (1: certainly no lesion(s), 2: probably no lesion(s), 3: probably 
lesion(s), 4: certainly lesion(s)).
Results: In 3 of 18 patients (17%), the diagnostic accuracy was improved by 
DWI. In two patients, readers changed diagnosis from “probable present 
lesion(s)” to “certain present lesion(s)”. In one patient, a cecal tumor was 
diagnosed only on the basis of DWI. This diagnosis was subsequently 
conﬁrmed by endoscopy.
Conclusion: DWI of the bowel can provide additional information to the reader 
and should be performed routinely with every gastrointestinal MRI as it can 
improve diagnostic conﬁdence.
SS 3.05
A diagnostic accuracy meta-analysis of endoanal 
ultrasound (EAUS) and magnetic resonance imaging 
(MRI) for Perianal Fistula Assessment
M.R.S. Siddiqui1, H. Ashraﬁan2, P. Tozer1, N. Daulatzai1,  
D. Burling1, A. Hart1, T. Athanasiou2, R.K. Phillips1;  1Harrow/UK, 
2London/UK
Purpose: We present a systematic review of published literature comparing 
endoanal ultrasound with magnetic resonance imaging for the assessment of 
idiopathic and Crohn’s perianal ﬁstulas.
Material and Methods: Electronic databases were searched from January 
1970 to October 2010 for published studies in any language.
Results: Six studies comparing endoanal ultrasound and magnetic resonance 
imaging for perianal ﬁstulas were analysed. There were 293 ﬁstulas in the 
ultrasound group and 291 in the magnetic resonance group. The combined 
sensitivity and speciﬁcity of magnetic resonance for overall ﬁstulas detected 
were 0.90 (95% CI: 0.75-0.96) and 0.66 (95% CI: 0.48-0.80). There was 
signiﬁcant heterogeneity between studies reporting on MRI (Q=52.39, df=5, 
p=0.000, I2=90%). This compares to a sensitivity and speciﬁcity for endoanal 
ultrasound of 0.88 (95% CI: 0.77-0.95) and 0.45 (95% CI: 0.24-0.67), 
respectively. There was signiﬁcant heterogeneity between studies (Q=49.28, 
df=5, p=0.000, I2=90%).
Conclusion: From the available literature, the summarised performance 
characteristics for MRI may be interpreted as better than those for EAUS, but 
the signiﬁcant between-study heterogeneity precludes any ﬁrm conclusions 
being made for clinical practice. Future trials with improved study design 
(including prospective data collection and consideration of veriﬁcation bias) 
may help to further clarify the role of MRI in the assessment and treatment 
response monitoring of perianal ﬁstulas (particularly in patients with Crohn’s 
disease).
SS 3.06
Clinical impact of defecographic images in patients with 
rectoanal intussusception  as a disorder of obstructed 
defecation
H.J. Jeon1, U.C. Park2, H.S. Park1, Y.J. Kim1, S.I. Jung1,  
S.W. Park1;  1Seoul/KR, 2ChungJu/KR
Purpose: Rectoanal intussusception (RAI) is a telescoping of the rectal wall 
during defecation. This study was designed to characterize a defecographic 
images and to evaluate clinical usefulness in a group of patients with RAI.
Material and Methods: Anorectal physiologic studies were performed in 555 
patients with chronic constipation. Studies included defecography (n=315), anal 
manometry (n=237), anal EMG/PNTML (n=133) and colonic transit time study 
with KUB ﬁlm (n=85). With the use of pre-treatment proctographic images, 
circumferential RAI was deﬁned as ﬁrst degree when detectable below the 
anorectal ring on straining, as second degree when it reached the dentate line 
and as third degree when it reached the anal verge. We analysed a correlation 
between the symptoms as obstructed defecation and the degree of RAI.
Results: 138 patients (43.8 percent) were found to have RAI. The defecographic 
images revealed 96 cases of RAI (70%) having associated anorectal pathology. 
RAI was of ﬁrst degree in 101 (73%), of second degree in 21 (15%) and of third 
degree in 16 patients (12%). The mean size of the intussusception was 2.5 cm 
(range 1.0-5.5 cm). RAI patients with mechanically obstructing intussusceptum 
evacuated slower and less completely than those with non-obstructing 
intussusceptum on evacuation proctography (P < 0.001). Patients with second 
and third degree RAI showed a signiﬁcantly higher frequency of obstructed 
defecation than in patients with ﬁrst degree RAI (P < 0.01).
Conclusion: Present series with sub-classifying intussusception morphology 
provided the important diagnostic ramiﬁcation and clinical therapeutic proﬁles 
in RAI patients with functionally obstructed defecation.
SS 3.07
Novel method for improving digitation characterisation 
during evacuating protography
H.S. Sidhu, G. Bhatnagar, S.A. Jackson, B. Fox; Plymouth/UK
Purpose: Some pelvic ﬂoor dysfunction patients digitate to facilitate 
evacuation; their ability to see digitation effects may improve their 
understanding/consultation. This study compares the use of newer lead-
impregnated gloves (LIG) to traditionally used normal/latex gloves (NG) during 
evacuating proctography in detecting digitation and perceived certainty of its 
effects.
Material and Methods: Qualitative questionnaire to referrers was performed 
assessing the importance of digitation visualisation. Prospective randomised 
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Material and Methods: Retrospective review of radiology database revealed 
36 patients with Whipple procedure who also had preoperative MRI with DWI. 
Two reviewers blindly and independently assessed the DWI images. Four 
weeks later, they reviewed the remaining MRI sequences for size of mass, 
double duct sign (DD), pancreatic duct cut off (CO), and perivascular soft 
tissue cufﬁng (VC). Univariate and multivariate analyses were performed, using 
surgical pathology as gold standard.
Results: There was no difference in age or gender between the cancer (group 
A, n=13) and chronic pancreatitis (group B, n=23) groups. On univariate 
analysis, the only ﬁnding that differentiated the two groups was size of mass. 
On logistic regression, no conventional or DWI parameter was found to be 
differentiate the two groups. There was no signiﬁcant lowering of ADC in both 
mass-like chronic pancreatitis and cancer, compared to rest of pancreas. 
Findings such as DD, CO and VC, which are typically associated with cancer, 
were not useful in differentiating the two groups.
Conclusion: Conventional MRI and DWI are not useful in separating cancer 
from chronic inﬂammation. Neither entity causes substantial lowering of ADC.
SS 4.03
Initial evaluation of a new high-resolution diffusion-
weighted MR sequence (ZoomEPI) for dedicated 
imaging of the pancreas
N. Schramm1, W. Horger2, M.F. Reiser1, C.J. Zech1;  
1Munich/DE, 2Erlangen/DE
Purpose: The purpose of this study was to initially evaluate a new high-
resolution DWI sequence (ZoomEPI) with a small ﬁeld-of-view for dedicated 
pancreas imaging.
Material and Methods: In 30 patients who underwent an abdominal MR 
examination on a 1.5T MR-system due to a clinical indication, a ZoomEPI 
sequence (Siemens, Erlangen, Germany) was acquired. In this sequence, a 
modiﬁed excitation pulse based on bipolar planar gradient trajectories aims to 
reduce the echo train length. Two reviewers compared the ZoomEPI sequence 
to the standard single-shot EPI DWI sequence in consensus. Image quality 
and disturbance of aliasing artifacts were assessed utilizing a four-point scale 
(1: excellent, no artifacts; 2: good, few artifacts; 3: moderate, still diagnostic, 
4: non-diagnostic, heavy artifacts). Apparent diffusion coefﬁcient (ADC) maps 
were generated (b50, b800). For statistics, a t-test was applied.
Results: The image quality of ZoomEPI was signiﬁcantly better than that of 
standard DWI with a mean score of 1.97 vs. 2.36 (p<0.01). The ZoomEPI was 
judged from excellent to non-diagnostic in 13/30 (43.3%), 12/30 (40%), 4/30 
(13.3%) and 1/30 (3.3%) patients, respectively. Standard DWI was rated from 
excellent to non-diagnostic in 4/30 (13.3%), 16/30 (53.3%), 7/30 (23.3%) and 
3/30 (10%) patients, respectively. Despite the small FOV, aliasing was not 
noted in the ZoomEPI.
Conclusion: ZoomEPI imaging of the pancreas is feasible without disturbing 
aliasing artifacts. Due to its higher image quality compared to the standard 
DWI sequence, it has the potential to further improve DWI of the pancreas.
SS 4.04
Comparison of diffusion-weighted MR imaging and [68]
Ga-DOTATATE PET/CT in detecting neuroendocrine 
tumors of the pancreas
C. Schmid-Tannwald, C. Schmid-Tannwald, R. Neumann,  
A. Haug, N. Schramm, G.P. Schmidt, M.F. Reiser, C. Rist; 
Munich/DE
Purpose: The purpose of this study was to compare diffusion-weighted MRI 
and DOTATATE-PET/CT in detecting pancreatic neuroendocrine tumors 
(NET).
Material and Methods: 19 patients with pancreatic NET were retrospectively 
included who underwent MRI including DWI and DOTATATE-PET/CT within 6 
weeks. Two blinded readers compared T2-weighted (T2w), T2w+DW-MRI, 
T2w+contrast-enhanced T1-weighted (CE-T1w) MR and PET/CT for NET 
detection and conﬁdence level. Sensitivity and conﬁdence level of each review 
session were compared. ADC of tumor and normal pancreatic tissue was 
compared.
Results: 9/25 (36%) and 15/25 (60%) NET were detected on T2w and T2w+DW-
MRI by both observers, respectively. Observer 1 and 2 detected 15/25 (60%) 
and 16/25 (64%) NET on their review of T2w+CE-T1w, respectively, and all 25 
NET (100%) were detected on PET/CT by both observers. Detection rate and 
conﬁdence level improved signiﬁcantly by combined interpretation of T2w and 
DW-MRI or CE-T1w (p<0.05). There was no signiﬁcant difference between NET 
detection rate of T2w+DW-MRI and T2w+CE-T1w (p>0.05). Detection rate and 
conﬁdence level of PET/CT were signiﬁcantly higher than MRI (p<0.04). Mean 
ADC of NET (1.02+/-0.26 x 10-3 mm²/s) was signiﬁcantly lower than mean ADC 
of normal pancreatic tissue (1.47 +/- 0.39 x 10-3 mm²/s).
SS 3.10
Value of CT colonography as preliminary study prior to 
laparoscopic surgery in patients with colon 
malignancies
S. Tartari1, R. Rizzati1, G. Anania1, M. Bassi1, L. Scagliarini2, 
G. Benea1;  1Lagosanto/IT, 2Ferrara/IT
Purpose: The purpose of this study was to assess the clinical value of CT 
colonography (CTC) in the diagnosis and staging of colorectal cancer (CRC) in 
preoperative evaluation for laparoscopic surgery.
Material and Methods: From January 2009 until November 2011, 113 patients 
scheduled for surgery for CRC underwent CTC. All patients were previously 
evaluated with optical colonoscopy (OC). Sensitivity in lesion location and 
detection was compared between OC and CTC and discrepancies analyzed. 
Accuracy of CTC in CRC staging was determined.
Results: A total of 113 CRC were found by CTC. OC was incomplete in 37/113 
(26%) cases. There were 17 cases of discrepancy of lesion location correctly 
identiﬁed by CTC and 7 polypoid (6-9 mm) lesions detected by CTC and 
missed by OC. Based on CTC ﬁndings, 103 patients with CRC were managed 
laparoscopically and 10 patients underwent conventional open surgery. 
Sensitivity of CTC in TNM preoperative staging of patients with CRC resulted 
to be respectively 100%, 86% and 100%. Furthermore, CTC detected 34 
extracolonic ﬁndings, 12 of whom had major clinical relevance.
Conclusion: CTC is a useful method for diagnosing CRC. It allows to determine 
local cancer progression and yields to detect synchronous lesions in the large 
bowel also in endoscopically inaccessible regions. Compared to OC, CTC is 
more accurate in lesion location, making the laparoscopic surgical planning 
more precise and safer.




Diffusion-weighted MRI in the characterization of 
pancreatic ﬂuid collections
H. Rodrigues Duarte1, M. Arvanitakis2, M. Delhaye2,  
M.A. Bali2, C. Matos2;  1Porto/PT, 2Brussels/BE
Purpose: The purpose of this study was to measure the accuracy of diffusion-
weighted MRI (DW-MRI) in the diagnosis of infected pancreatic ﬂuid collections 
(PFCs).
Material and Methods: Between January 2010 and November 2011, all 
patients with post-pancreatitis PFCs requiring transmural EUS-guided 
drainage were prospectively included. Exclusion criteria were previous 
drainage or surgery. Before the endoscopic procedure, patients underwent 
high b-value DW-MRI with ADC measurements. Infection was suspected in 
cases of high signal of PFC in DW-MRI and low ADC. After drainage, ﬂuid was 
sent for bacteriological cultures and considered infected if these were positive 
(gold standard). Continuous values were expressed in median and range and 
comparisons were performed using non-parametric tests.
Results: 26 patients were included in the study. The underlying disease was acute 
(n=15, 58%) or chronic pancreatitis (n=11, 42%). Sensitivity, speciﬁcity, accuracy, 
negative and positive predictive values of DW-MRI for predicting PFC infection 
were, respectively, 55.5% (5/9), 94% (16/17), 80% (21/26), 80% (16/20) and 83% 
(5/6). Some of these values increased if we considered only patients without previous 
antibiotics (n=17) (respectively, 75%, 92%, 88%, 92% and 75%). Median ADC was 
signiﬁcantly lower in infected PFCs (2.8 vs 1.1 x 10[-3]mm[2]/sec, p=0.045).
Conclusion: DW-MRI may provide additional information concerning PFC 
assessment before drainage. Results show high speciﬁcity and negative 
predictive values, which can help in excluding PFC infection and determining 
time of drainage.
SS 4.02
Does diffusion-weighted imaging help in the 
differentiation of mass-like chronic pancreatitis and 
pancreatic cancer?
K. Sandrasegaran, B. Tahir, M. Tann, T. Howard; 
Indianapolis, IN/US
Purpose: Many patients with mass-like chronic pancreatitis, particularly in the 
pancreatic head, undergo radical surgery, since it is not possible to 
preoperatively differentiate this entity from ductal adenocarcinoma. We wanted 
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Material and Methods: Among the 130 diagnosed with PAI were included 37 
patients with focal forms. Image analysis included parenchymal enlargement, 
signal intensity abnormalities, enhancement, main pancreatic duct (MPD) 
diameter and MPD focal narrowing, length of narrow stricture of the PD, 
presence of upstream dilatation from the stricture, multiple stenosis and 
dilatation of side branches. After secretin administration, the presence of the 
“duct penetrating” sign was evaluated as a problem-solving tool in the 
differential diagnosis between focal AIP and ductal adenocarcinoma. Median 
follow-up was 23.9 (range 4.1-126.7) months.
Results: At diagnosis, involvement of main pancreatic duct in the focal form of 
AIP showed a single stenosis in 27 (72.9%) patients, multiple stenosis in 10 
(27.1%). The mean diameter of the length of the narrow stricture of the MPD 
was 13.5 mm, whereas the mean value of the upstream dilatation from the 
stricture was 3.9 mm. The alteration in signal intensity of pancreatic parenchyma 
was localized in the head in 18/37 (48.6%) patients, 10/37 (27.02%) in the 
body and 9/37 (24.3%) in the tail. Dilatation of side branches was observed in 
17/37 (45.9%) patients.
Conclusion: After steroid treatment, there was a reduction in the size of 
pancreatic parenchyma in 16/37 (43.2%) patients, normalization of signal 
intensity abnormalities in 12/37 (32.4%) and recurrence of disease in 5/37 
(13.5%). 4 (10.8%) patients underwent resective surgery conﬁrming the 
histopathological diagnosis of AIP.
SS 4.08
MRCP evaluation of focal and diffuse forms of 
autoimmune pancreatitis
F. Castelli, V. Di Paola, R. Negrelli, R. Manfredi, R. Pozzi 
Mucelli; Verona/IT
Purpose: The purpose of this study was to evaluate focal and diffuse forms of 
autoimmune pancreatitis (AIP) and description of the main characteristics at 
diagnosis and follow-up through MR and MRCP.
Material and Methods: We included in the study 130 patients with histological 
diagnosis of AIP who underwent MRCP before and after steroid therapy. The 
analysis considered: pancreatic volume, localization of the lesion, abnormal 
signal intensity, enhancement of the parenchyma in the post-contrastographic 
phase, presence of stenosis of the main pancreatic duct (MPD), dilatation of 
the secondary pancreatic ducts (SPD).
Results: MRI showed a diffuse volumetric increase of the pancreas in 50/92 
(54%) patients and a focal volumetric increase in 42/92 (46%). We observed 
changes in signal intensity represented by hypointensity on T1 imaging in 
65/92 (70.6%) patients and hyperintensity on T2 imaging in 32/92 (35%); 51/92 
(55.5%) patients showed parenchymal hypo-vascularization and 34/92 (37%) 
retention of medium of contrast in the late phase. There was a stenosis of MPD 
in 64/92 (69.5%) cases and a dilation of SPD in 36/92 (39%) patients. After 
therapy, 39/92 patients (42.4%) showed restitutio ad integrum, 49/92 (53.3%) 
parenchymal atrophy, while 4/92 (4.3%) patients underwent surgery. After 
secretin administration, the presence of the “duct penetrating-sign” was 
observed in 33/92 (36%) patients.
Conclusion: MRCP is useful in the diagnosis, monitoring of the response to 
therapy and evaluation of the different forms of AIP and of degree of ductal 
involvement.
SS 4.09
Multifocal branch-duct intraductal papillary mucinous 
neoplasms of the pancreas: MR imaging pattern and 
evolution over time
F. Castelli, V. Di Paola, D. Bosetti, R. Manfredi, R. Pozzi 
Mucelli; Verona/IT
Purpose: The purpose of this study was to follow the evolution over time of 
multifocal intraductal papillary mucinous neoplasms (BD-IPMN) of the side 
branches by MRI.
Material and Methods: We evaluated 155 patients with multifocal BD-IPMN 
examined with MR/MRCP. Inclusion criteria: 2 BD-IPMN involving any site of 
the parenchyma; communication with the main pancreatic duct (MPD) and 
previous investigations by MRI/MRCP after at least six months. Median follow-
up was 25.8 (range 12-217) months. Exclusion criteria: <12 months of follow-
up (n=33) and patients without follow-up (n=14). The population is thus of 108 
patients. Quantitative analyses were number of dilated side branches; 
maximum diameter of the largest branch duct in the head and body-tail; 
maximum diameter of MPD in the head and body-tail, annual change of the 
largest lesion. Qualitative analyses were the presence of malformations/
anatomical variants of the pancreatic ductal system; site of the lesions (head-
uncinate process, body-tail, ubiquitous, bridge morphology); intraluminal 
dependent defects; mural nodules.
Conclusion: DW-MRI is a valuable adjunct to T2w and comparable to CE-T1w 
in detection of pancreatic NET and ADC measurements provide a quantitative 
differentiation between NET and normal pancreatic tissue. DOTATATE-PET/CT 
seems to improve signiﬁcantly the detection of pancreatic NET compared to 
MRI.
SS 4.05
Cystic pancreatic lesions: evaluation by diffusion-
weighted 3T MR imaging with b-multiple SE-EPI
F. Donati, P. Boraschi, R. Gigoni, F. Falaschi, C. Bartolozzi; 
Pisa/IT
Purpose: The purpose of this study was to evaluate the usefulness of diffusion-
weighted 3T MR imaging with b-multiple SE-EPI in providing an objective 
value for the differentiation of cystic pancreatic lesions.
Material and Methods: Fifty-two patients with cystic pancreatic lesions and 
ten normal subjects underwent MR imaging at 3T (GE-DISCOVERY-MR750; 
GE-Healthcare). After the acquisition of axial T1w/T2w sequences and coronal 
MRCP, diffusion-weighted MR imaging was performed using an axial 
respiratory-triggered spin-echo echo-planar sequence with multiple b-values 
(150, 500, 1000, 1500 sec/mm2) in all diffusion directions. ADC value was 
calculated using a dedicated software ﬁtting the curve obtained from the 
corresponding ADC for each b value. Fitted ADC values were calculated by 
two observers in conference for each cystic pancreatic lesion and for normal 
pancreatic parenchyma. Imaging results were correlated with surgery, ERCP, 
and/or imaging follow-up.
Results: Final diagnoses included intraductal papillary mucinous tumor (IPMT, 
n=35), serous cystadenoma (n=10), and mucinous cystadenoma (n=7). Fitted ADC 
value was 1.33x10-3 mm2/sec for normal pancreatic parenchyma, 3.11x10-3 mm2/
sec for IPMT, 2.50x10-3 mm2/sec for serous cystadenoma, 2.97x10-3 mm2/sec for 
mucinous cystadenoma. Fitted ADC values were signiﬁcantly higher in mucinous 
neoplasms than in serous cystadenomas (p-less-than-0.05).
Conclusion: Our results suggest that diffusion-weighted 3T MR imaging with 
b-multiple SE-EPI may be helpful to differentiate mucinous from serous cystic 
pancreatic lesions. Further investigations in larger series of patients are 
necessary to conﬁrm our preliminary data.
SS 4.06
The utility of secretin-enhanced MRCP in diagnosing 
chronic pancreatitis
K. Sandrasegaran, B. Tahir, M. Tann, T. Howard, F. Akisik; 
Indianapolis, IN/US
Purpose: The purpose of this study was to assess the additional value of 
secretin-enhanced MRCP over conventional MRCP in diagnosing ductal 
abnormalities in chronic pancreatitis.
Material and Methods: Retrospective review found 140 patients with SMRCP 
and ERCP correlation within 3 months of each other. All studies were anonymized 
and the secretin-enhanced MRCP (group A) was separated from conventional 2D 
and 3D MRCP and T2-weighted images (group B). Groups A and B for each 
patient were assigned different and randomized case numbers. An experienced 
MRI radiologist graded image sets for no chronic pancreatitis using the Cambridge 
classiﬁcation, and for the certainty of diagnosis (1= deﬁnitely certain, 2 = 
moderately certain, 3 = unsure). ERCP ﬁndings were taken as gold standard.
Results: In diagnosing the presence of chronic pancreatitis, the sensitivity 
(95% CI) was signiﬁcantly higher in group A [62.8% (46.7-77.0) compared to B 
[47.7% (32.5-63.3), p<0.01]. The speciﬁcity (95% CI) was also signiﬁcantly 
higher in group A compared to B [94.7 (88.0-98.3) vs. 87.3% (78.8-93.2), 
p<0.01]. The percentage of deﬁnitely certain diagnosis was higher in group A 
compared to group B (14%, p=0.03). In differentiating mild chronic pancreatitis 
(side branch disease only) from normal, the area-under-ROC curve (95% CI) 
was higher for group A compared to group B [0.71 (0.61-0.79) vs. 0.54 (0.44-
0.64), p<0.01].
Conclusion: The use of secretin signiﬁcantly improves the accuracy and 
conﬁdence of diagnosing chronic pancreatitis, especially mild chronic 
pancreatitis.
SS 4.07
Stenosis of the main pancreatic duct in focal form of 
autoimmune pancreatitis: imaging ﬁndings on MR-
MRCP and dynamic secretin-enhanced MRCP
F. Castelli, R. Negrelli, V. Di Paola, R. Manfredi, R. Pozzi 
Mucelli; Verona/IT
Purpose: The purpose of this study was to evaluate the MR-MRCP imaging of 
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SS 5.02
Histopathological inﬂuences on the efﬁcacy of dynamic 
gadoxetate disodium-enhanced magnetic MRI in 
staging liver ﬁbrosis
D.S. Feier1, R. Nolz2, J. Maresch2, C. Balassy2, R. Badea1,  
A. Ba-Ssalamah2;  1Cluj-Napoca/RO, 2Vienna/AT
Purpose: The purpose of this study was to evaluate the inﬂuence of histological 
parameters on the efﬁcacy of dynamic gadoxetate disodium-enhanced (Gd-
EOB-EDTA) MRI in staging liver ﬁbrosis (LF) in patients with diffuse chronic 
liver diseases (CLD).
Material and Methods: Between January 2009 and November 2011, we 
analyzed retrospectively 80 consecutive patients (mean age 54.86 years, 
58.7% males) with histologically proven LF, who underwent dynamic contrast-
enhanced 3 Tesla MRI (CE-MRI) with Gd-EOB-EDTA. The patients were divided 
according to Metavir scoring system: F0 (n=17), F1 (n=10), F2 (n=12), F3 
(n=11), F4 (n=26). The CE-MRI images were obtained blinded to histology 
before contrast injection and in the arterial (25 s), portal (70 s) and hepatocyte 
phase (20 min). Signal intensity of the liver in all phases was deﬁned using 
region-of-interest measurements and relative enhancement (RE) was 
calculated.
Results: RE correlated strongly with ﬁbrosis (r=-0.65, p<0.0001), moderately 
with necro-inﬂammatory activity (r=-0.41, p=0.002) and iron load (r=-0.21, 
p=0.05) but not with steatosis (r=-0.12, p=0.32). In multivariate analysis, only 
ﬁbrosis independently inﬂuenced the values of RE (p<0.0001). The predicted 
RE cut-off values were: 1.30 for F1 (AUROC=0.97, Se=100%, Sp=91%, 
PPV=76.9%, NPV=100%), 1.27 for F2 (AUROC=0.96, Se=81%, SP=98%, 
PPV=95.6%, NPV=91.2%), 1.12 for F3 (AUROC=0.98, Se=92.3%, Sp=97.5%, 
PPV=97.2%, NPV=93%) and 0.93 for F=4 (AUROC=0.93, Se=91%, Sp=88%, 
PPV=100%, NPV=83%). Discordance between RE and ﬁbrosis stage was 
observed in 22 (27.9%) patients.
Conclusion: CE-MRI is accurate in staging LF in CLD patients. Steatosis, 
inﬂammation and iron load have no inﬂuence on the RE.
SS 5.03
Qualitative evaluation of liver ﬁbrosis using gadoxetate 
disodium-enhanced MRI in patients with diffuse liver 
diseases
D.S. Feier1, R. Nolz2, J. Maresch2, C. Balassy2, R. Badea1,  
A. Ba-Ssalamah2;  1Cluj-Napoca/RO, 2Vienna/AT
Purpose: The purpose of this study was to assess if gadoxetate disodium-
enhanced MRI (Gd-EOB-EDTA CE-MRI) using quality scores is able to predict 
advanced liver ﬁbrosis (LF) in patients with chronic liver diseases (CLD).
Material and Methods: We analyzed retrospectively 95 consecutive patients 
(mean age 54.18 years, 62.1% males) with histologically proven LF, who 
underwent dynamic 3 T CE-MRI with Gd-EOB-EDTA. A single expert 
pathologist assessed LF according to Metavir system. F0-2 (n=45, 47.4%) was 
considered insigniﬁcant LF and F3-4 (n=50, 52.6%) as advanced LF. The CE-
MRI images were obtained blinded to histology before contrast injection and in 
hepatocyte phase (20 min). We assessed three new scores: enhancement 
homogenity (EnH, 1=homogenous, 0=inhomogenous), enhancement quality 
score (EnQS) and excretion quality score (ExQS, 0=none, 1=poor, 2=sufﬁcient, 
3=good, 4=excellent).
Results: LF correlated strongly with EnQ score (r=-70, p<0.0001), moderately 
with ExQ score (r=-0.41, p<0.0001) and EnH (r=0.35, p=0.0008). Independently, 
advanced LF can be predicted by a EnQS <=3 with an AUROC=0.90 [Se=93.8% 
(83.1-98.7), Sp=73.3% (58.1-85.4), PPV=79.6%, NPV=91.5%], by ExQS<=2 
with an AUROC=0.72 [Se=36.73% (23.4-51.7), Sp=97.78% (88.2-99.9), 
PPV=94.8%, NPV=58.2%] and by EnH with an AUROC=0.67 [Se=40.82% (27-
55.8), Sp=93.33% (81.7-98.6), PPV=87.2%, NPV=58.7%]. Together, the three 
scores are able to predict advanced LF with an AUROC=0.92 [Se=79.59% 
(65.7-89.8), Sp=93.33% (81.7-98.6), +LR=11.33, -LR=0.26, PPV=92.6%, 
NPV=77.4%]. The interobserver agreement and reliability was very good for all 
three scores: EnQS (k=0.84, ICC=0.91), ExQS (k=0.91, ICC=0.91), EnH (k=0.80, 
ICC=0.87).
Conclusion: The degree of liver parenchymal enhancement and the extent of 
biliary excretion of Gd-EOB-EDTA CE-MRI imaging are reliable predictors of 
LF in CLD patients.
Results: At diagnosis, the mean value of cystic lesions of the side branches 
was 7.09. The mean diameter of the cystic lesions was 13.7 mm. The mean 
diameter of the MPD was 3.6. At follow-up, the mean number of cystic lesions 
of the branch-duct was 7.76 (p<0.05). The mean diameter of the cystic lesions 
was 13.9 (p<0.05). The mean diameter of the MPD was 3.7. Intraluminal ﬁlling 
defects in the side branches were seen in 18/108 (16.6%) patients; mural 
nodules in 3/108 (2.7%) patients.
Conclusion: Multifocal BD-IPMN shows a very slow growth and evolution 
over time.
SS 4.10
Determination of pancreatic cancer extent using CT and 
MRI: implications for neoadjuvant treatment planning
O. Zakharova, G.G. Karmazanovsky; Moscow/RU
Purpose: A R0 resection is dependent on accurate preoperative staging. 
There is still no consensus on the single best diagnostic modality. The inverse 
relationship of tumor size and prognosis has been noted in many studies; 80-
85% of patients are treated palliatively or neoadjuvantly. The high rate of 
duodenal invasion suggests a risk of duodenal undercoverage with highly 
conformal radiotherapy.
Material and Methods: To analyze the accuracy of CT and MRI in determining 
PC extent, we performed a retrospective analysis of CT and MRI scans and 
pathohistological reports of 174 cases of PC after pancreatoduodenectomies 
(2006-2011). We compared tumor size measurements of PC evaluated on CT 
and MRI with those in the pathological reports.
Results: Our study demonstrated sensitivity, speciﬁcity, and accuracy of 
contrast enhanced MDCT of 86%, 75%, and 83.3%, respectively, with a PPV 
of 96% and NPV of 100%. The sensitivity, speciﬁcity, and accuracy of MRI 
reaches approximately 75%, 50%, and 74.3%, respectively, with a PPV of 
98.1% and NPV of 94.4%. In 124 patients (71.3%), tumor size reported by 
pathologist surpassed one claimed by CT and MRI studies (p<0.001).
Conclusion: The values of sensitivity, speciﬁcity and accuracy in PC detection 
speak in favor of MDCT as the single best diagnostic modality. Surgeons and 
oncologists need to keep in mind that MDCT and MRI have a tendency to 
underestimate the size of PC. This has important implications for neoadjuvant 
treatment planning.
11:00 - 12:30 Moorfoot
Scientiﬁc Session 5
Liver 1: Diffuse disease
SS 5.01
Evaluation of spleen stiffness with acoustic radiation 
force impulse: a comparison with  histology in the 
assessment of liver ﬁbrosis
P. Cabassa, F. Sogaro, L. Sottocornola, M. Ravanelli,  
A. Rossini, R. Maroldi; Brescia/IT
Purpose: The purpose of this study was to evaluate the spleen stiffness in 
patients affected by chronic hepatopathy by means of acoustic radiation force 
impulse (ARFI) and to match the results with the ﬁbrosis grade, assessed by 
liver biopsy.
Material and Methods: 51 consecutive patients affected by chronic 
hepatopathy (mainly HCV) underwent ARFI of the spleen and liver biopsy. 
According to Knodell’s index, 25 patients were classiﬁed F1, 14 F3 and 12 F4. 
33 healthy volunteers represented the control group. All the studies were 
performed by two radiologists. Every study included a median of 5 ARFI 
measurement. Mean ARFI velocities (in m/s) were statistically compared. 
Diagnostic performance of ARFI in assessing different grades of liver ﬁbrosis 
was assessed by ROC analysis. Inter- and intra-observer variability was also 
calculated using Bland-Altman plot.
Results: Spleen ARFI values were signiﬁcantly different among healthy 
volunteers and F1-F4 patients (p<0.001), F1 versus F3-F4 patients (p<0.001) 
and F1-F3 versus F4 patients (p<0.001). There was no signiﬁcant difference 
among healthy volunteers and F1 patients. ROC analysis showed a good 
performance of ARFI in differentiating mild (F1) from severe (F3-F4) ﬁbrosis 
(AUROC 0.8). The differentiation between F3 and F4 ﬁbrosis resulted to be 
difﬁcult. Inter- and intra-observer agreement was good.
Conclusion: The stiffness of the spleen is increased in case of ﬁbrosis. ARFI 
can differentiate mild (F1) from severe (F3-F4) ﬁbrosis. ARFI of the spleen can 
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from manually drawn ROIs in the liver. ROIs were automatically coregistered 
onto the repeated scans. Reproducibility indices (RI) were calculated by Bland-
Altman analysis (deﬁned as 1.96.SD of paired differences/mean value).
Results: Mean elasticity was 2.33±0.76 kPa (patients) and 1.65±0.15 kPa 
(volunteers). Mean viscosity was 2.28±0.59 Pa.s (patients) and 1.76±0.22 
(volunteers). RI did not differ signiﬁcantly between patients and volunteers. 
Mean RI of elasticity for all participants was 8.2%, 18.5% and 24.0% for ISR, 
WDR and BWR, respectively. For viscosity, RIs were 17.7%, 28.6% and 
27.9%.
Conclusion: Elasticity showed better reproducibility than viscosity. The 
between-weeks reproducibility analysis shows that a change in liver tissue 
elasticity of more than 20% indicates a signiﬁcant change, implying disease 
progression or regression.
SS 5.07
Comparison of MR elastography and US elastography in 
assessment of hepatic ﬁbrosis
J. Yoon, J.M. Lee, J.K. Han, B.I. Choi; Seoul/KR
Purpose: The purpose of this study was to compare liver stiffness values in 
patients who underwent liver ﬁbrosis using MR and US elastography, and to 
evaluate diagnostic performance between two examinations.
Material and Methods: For 5 months from 2011 Aug, 39 patients underwent 
MRE/USE and liver operation (n=37) or percutaneous biopsy (n=2). Hepatic 
ﬁbrosis was graded by using Metavir score [F0-1 (n=21), F3 (n=4) and F4 
(n=14)]. 6 mean liver stiffness values were averaged at USE. Mean liver stiffness 
value at MRE was an averaged value on 4 consecutive MRE images. For the 
assessment of concordance between USE/MRE, regression model was used 
and Pearson correlation coefﬁcient was obtained. ROC analysis was performed 
between groups to assess diagnostic performance.
Results: At MRE, mean liver stiffness values in F0-1, F3, F4 were 1.76, 4.16 
and 5.99, respectively. At USE, mean liver stiffness values were 4.74, 13.0, 
44.9, respectively. Two exams showed moderate correlation (p=0.69), R2 was 
0.61 (p<0.001). Correlation coefﬁcients between two exams and Metavir score 
were 0.83 (MRE) and 0.81 (USE). As for differentiation of group F0-1 and F2-4, 
both showed 100% sensitivity and 95.2% speciﬁcity (MRE: Az >2.17, USE: Az 
>6.84). According to F0-3 versus F4 differentiation, MRE showed 100% 
sensitivity and 80% speciﬁcity (Az>2.2) and USE showed 92.9% sensitivity 
and 92% speciﬁcity (Az>10.16).
Conclusion: MR/US elastography were concordant in hepatic ﬁbrosis 
evaluation. Mean liver stiffness values at both exams showed good correlation 
with Metavir score.
SS 5.08
The role of abdominal MR susceptibility-weighted 
imaging in diagnosing advanced liver ﬁbrosis in patients 
with chronic liver diseases: a feasibility study
C. Balassy1, D.S. Feier2, G. Reiter1, B. Kiefer3, Y. Dai4,  
S. Witoszynskyj1, A. Ba-Ssalamah1;  1Vienna/AT,  
2Cluj-Napoca/RO, 3Erlangen/DE, 4Shanghai/CN
Purpose: The purpose of this study was to assess the diagnostic value of 
susceptibility-weighted imaging (SWI) in detecting advanced liver ﬁbrosis (LF) 
in patients with chronic liver diseases (CLD).
Material and Methods: Thirty-seven consecutive patients (mean age 55 
years, 58.7% males) with histologically proven LF, who underwent abdominal 
SWI on a 3 Tesla MR scanner between January and November 2011, were 
analyzed retrospectively. A single expert pathologist assessed LF according to 
the Metavir system. F0-2 (n=20, 54.1%) was considered no-to-moderate 
ﬁbrosis and F3-4 (n=17, 45.9%) as advanced ﬁbrosis. The SWI measurements 
were evaluated with readers blinded to histology and clinical data. Normalized 
liver-to-muscle signal intensity ratios (LMR) were deﬁned using region-of-
interest measurements on SWI images.
Results: Log-transformed LMR values correlated strongly with LF (r=-0.75, 
p<0.0001), and moderately with necro-inﬂammatory activity (r=-0.45, p=0.004) 
and iron load (r=-0.33, p=0.04), but not with steatosis (r=0.2, p=0.23). In 
multiple regression analysis, LF and iron load independently inﬂuenced LMR 
values (p<0.0001). Together, LF and iron load explained 62% of the variance in 
LMR values (R[2]=0.62, p<0.001). The two parameters explained 58% of the 
amount of R[2], with LF as the largest contributor. The area under ROC curve 
for the diagnosis of advanced LF (F3-4) was 0.86 [sensitivity=66.7% (38.4-
88.2), speciﬁcity=90.0% (70.8-98.9), +LR=7.33, -LR=0.37, PPV=33.8%, 
NPV=80.0%].
Conclusion: SWI is a promising non-invasive tool to detect advanced LF in 
CLD patients. LF is the main predictor of LMR, but iron load has an inﬂuence 
on these values.
SS 5.04
Performance of liver stiffness measurement by Acoustic 
Radiation Force Impulse (ARFI) for the diagnosis of liver 
ﬁbrosis
V. Cartier, J. Boursier, J. Lebigot, O. Adib, I. Fouchard,  
S. Michalak, C. Aube; Angers/FR
Purpose: The purpose of this study was to evaluate the performance of ARFI 
for the diagnosis of liver ﬁbrosis.
Material and Methods: 98 patients were prospectively included. For each 
patient, 10 shear wave velocity measurements (m/s) were performed with ARFI 
in the right lobe, 10 in the left lobe, using an Acusson S2000 ultrasound 
system. The ﬁbrosis stage was assessed by liver biopsy according to the 
Metavir F scoring. Cut-offs and diagnostic accuracies were calculated for 
different diagnostic targets of ﬁbrosis and for the different sites of 
measurement.
Results: The population was constituted of 58% of men and the mean age 
was 54±13 years. The etiology of the liver disease was: alcohol (n=14), virus 
(n=26), dysmetabolic (n=43), other (n=15). The Metavir score was: F0/1: n=46, 
F2: n=24, F3: n=19, and F4: n=9. 30 valid measurements were obtained for all 
the patients. The cut-off and the diagnosis accuracy for F2 ﬁbrosis were: 
1.80m/s and 67.3% in the right lobe, 1.75m/s and 73.5% in the left lobe; for 
F3 ﬁbrosis: 1.94m/s and 77.6% in the right lobe, 2.08m/s and 80.6% in the 
left lobe; and for F4 ﬁbrosis: 2.17m/s and 84.7% in the right lobe, 2.30m/s and 
79.6% in the left lobe.
Conclusion: ARFI has a high feasibility and good performances for the non-
invasive diagnosis of liver ﬁbrosis. Systematic use of ARFI during any 
abdominal ultrasound examination could be useful to detect patients with 
undiagnosed ﬁbrosis.
SS 5.05
Is measurement of liver elasticity and liver iron content 
of value to identify high-risk patients with Gaucher 
disease?
A.E. Bohte1, L. Van Dussen1, E.M. Akkerman1, A.J. Nederveen1, 
R. Sinkus2, M. Maas1, J.M. Aerts1, C.E.M. Hollak1,  
P.L.M. Jansen1, J. Stoker1;  1Amsterdam/NL, 2Paris/FR
Purpose: Long-term liver-related complications of Gaucher disease (GD) 
include ﬁbrosis and increased risk to develop hepatocellular carcinoma (HCC). 
Splenectomy is a known risk factor for the development of liver pathology in 
GD. Moreover, accumulation of iron in Gaucher cells in the liver has been 
described. No adequate diagnostic tools exist to identify at-risk GD patients. 
We evaluated the potential usefulness of iron measurement, MR elastography 
(MRE) and Fibroscan of the liver in patients with GD.
Material and Methods: Twenty participants were included (16 male; mean 
age 48, range 24-70): 6 splenectomized GD patients (high-risk) and 7 non-
splenectomized GD patients (low-risk) who were matched for age and gender 
with 7 healthy controls. All underwent liver iron concentration (LIC) measurement 
at 1.5T (Gandon, T2*), MRE at 3T and Fibroscan. For MRE, an SE-EPI sequence 
(TR/TE=420/40 ms; acquisition time 70s) was used. Groups were compared 
with non-parametric tests.
Results: Mean MRE values were 2.5 kPa (range 2.37-2.64) for high-risk GD 
and 1.67 kPa (range 1.31-2.12) for low-risk GD (p=0.006). Mean Fibroscan 
stiffness values were 8.1 kPa (range 3.5-10.5) for high-risk GD and 5.2 kPa 
(range 3.4-7.2) for low-risk GD (p=0.045). Low-risk GD did not differ signiﬁcantly 
from controls for MRE and Fibroscan. LIC did not differ signiﬁcantly between 
the groups.
Conclusion: MRE and Fibroscan can be used to monitor liver elasticity in 
patients with GD. We found no apparent role for LIC measurements.
SS 5.06
Reproducibility of magnetic resonance elastography of 
the liver at 3T
A.E. Bohte1, A.J. Nederveen1, P.F.C. Groot1, A. De Niet1, R. 
Sinkus2, P.L.M. Jansen1, J. Stoker1;  1Amsterdam/NL, 2Paris/FR
Purpose: To measure the reproducibility of MR elastography of the liver.
Material and Methods: 15 healthy volunteers and 13 patients with viral 
hepatitis B/C and liver ﬁbrosis (17 male; mean age 34±12 years) were scanned 
four times at 3T: twice while in the same position (intrascan reproducibility, 
ISR), once after repositioning (within-day reproducibility, WDR), and once 2-4 
weeks later (between-weeks reproducibility, BWR). Mechanical waves were 
applied to the chest with a coil-driven vibrating (50 Hz) piston. An SE-EPI 
sequence was used from which axial elasticity and viscosity maps were 
generated (TR/TE=420/40 ms; 7 slices, voxel size 4x4x4mm; acquisition time 
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SS 5.09
Value of 1H MRS and chemical shift MR imaging in 
quantitative analysis and follow-up of fatty liver
F. Yuan, B. Song; Chengdu/CN
Purpose: The purpose of this study was to investigate the value of [1]H 
magnetic resonance spectroscopy (MRS) and chemical shift MR imaging 
techniques in quantifying fat content and monitoring treatment effects for fatty 
liver at follow-up examinations on 3.0 T MR system.
Material and Methods: 26 patients with conﬁrmed fatty liver disease were 
examined with proton MRS and chemical shift-based fat suppression MR 
sequences (Dixon and triple-echo Dixon) on 3.0 T MR at baseline and 3, 6 
months after treatment, respectively. Fat index (FI) of Dixon and the fat index 
star (FI*) of triple-echo Dixon, the relative lipid content 1 (RLC1) and relative 
lipid content 2 (RLC2) of MRS were calculated. Fatty liver index (FLI) was 
referred to the standard which was calculated from triglycerides (TG), gamma-
glutamyl-transferase (GGT), waist circumference and body mass index (BMI). 
Statistical analysis was performed for the correlation between MR measured 
values and FLI.
Results: Signiﬁcant positive correlation was demonstrated between MR 
imaging techniques measured values (FI, FI*, RLC1,RLC2) and FLI. There was 
statistical difference between FI, RLC1, RLC2 and FLI at baseline and 3, 6 
months after treatment, respectively (p<0.05), while the statistical difference 
was found between FI* and FLI only at baseline and 6 months after treatment 
(p<0.05).
Conclusion: [1]H MRS and chemical shift-based fat suppression MR 
techniques can not only quantitatively measure liver fat content, but also 
dynamically evaluate the therapeutic effects. Dixon technique is more stable, 
while proton MRS is more accurate.
SS 5.10
Early detection of liver steatosis by magnetic resonance 
imaging in rats infused with glucose and lipids and 
correlation to insulin levels
G. D’Assignies1, C. Kauffmann2, G. Soulez2, B. Van Beers1, 
V. Vilgrain1, V. Poitou2, A. Tang2;  1Clichy/FR, 2Montreal, QC/CA
Purpose: The purpose of this study was to investigate the accuracy of 1.5 T 
MR imaging, 1H-MR spectroscopy and histological techniques to detect liver 
steatosis in three rat phenotypes assigned to an experimental glucolipotoxic 
model or a control group, and to correlate fat fraction assessed by MR 
techniques with insulin plasma level.
Material and Methods: Thirty-two rats [thirteen 2-mo-old (young) Wistar (YW), 
six 6-mo-old (old) Wistar (OW) and thirteen Goto-Kakizaki (GK)] fed a standard 
diet were assigned to a 72-h intravenous infusion of glucose and Intralipid fat 
emulsion or a saline infusion. Plasma insulin levels were measured. Steatosis 
was quantiﬁed with multiecho MRI, 1H-MRS and histology as fat fractions 
(FF).
Results: A signiﬁcant correlation was found between multipoint Dixon MRI-FF 
and 1H-MRS-FF (r = 0.81, P < 0.01) and a weaker correlation was found 
between histology and 1H-MRS fat fractions (r = 0.60, P < 0.01). MRS and MRI 
accurately distinguished YW and GK rats receiving the glucose + Intralipid 
infusion from those receiving the saline control, whereas histology did not. A 
signiﬁcant correlation was found between MRI-FF or 1H-MRS-FF and insulin 
plasma level (r = 0.63, p < 0.01; r = 0.57, P < 0.01).
Conclusion: MRI and 1H-MRS may be more sensitive to measure early-onset 
liver steatosis than histopathology in an experimental glucolipotoxic rat model. 
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SS 6.03
Value of 3T MRI in evaluating the mucosal involvement 
in Crohn’s disease
R. Scandiffio, E. Neri, L. Faggioni, C. Bartolozzi; Pisa/IT
Purpose: The purpose of this study was to determine the diagnostic accuracy 
of 3T MRI in detecting mucosal involvement in Crohn’s disease.
Material and Methods: Twenty-seven patients with known or suspected 
Crohn’s disease underwent 3T small bowel MRI. All patients were evaluated 
after oral assumption of water solution. Acquisition protocol included Fast 
Imaging Employing Steady State Acquisition (FIESTA), Single-Shot FSE and 
contrast-enhanced dynamic study with Liver Acquisition with Volume 
Acquisition (LAVA). Aphtoid ulcers, pseudopolyps, fold thickening and 
distortion were the target of mucosal evaluation. Endoscopic examination and 
histopathological examination in patients who undergone surgery were 
considered as gold standard. Statistical signiﬁcance was calculated with the 
Fisher exact test; sensibility and speciﬁcity of the MRI examination have been 
also calculated.
Results: Mucosal abnormalities were identiﬁed in 11 patients (42%); 2 
examinations (8%) resulted as false negative (p=0.00002). All patients with 
mucosal abnormalities detected by MRI examination had active/severe 
disease. Sensitivity and speciﬁcity of MRI were 100% and 85%, respectively.
Conclusion: This preliminary experience shows an high diagnostic accuracy 
of 3T MRI in detecting mucosal abnormalities in Crohn’s diseases; this 
represents an added value of MRI in the clinical assessment of the severity of 
the disease.
SS 6.04
Software-supported evaluation of small-bowel motility 
in MRI for faster and more reliable diagnoses
S. Bickelhaupt1, J.M. Froehlich1, R. Cattin2, S. Raible2,  
H. Bouquet3, U. Bill3, F. Merz3, M.A. Patak1;  1Zurich/CH,  
2Biel/CH, 3Bern/CH
Purpose: Functional analyses of small-bowel motility by MRI have been 
performed by hand, which is potentially subjective and time-consuming. A 
newly developed software (Motasso) permits semi-automatic measurement of 
small-bowel diameter over time, thus displaying motility. The aim was to 
validate the software prototype comparing it to manual measurements.
Material and Methods: 45 patients (18 male/27 female; mean 48 years) were 
included. MRI (1.5-T, Siemens-Sonata) was performed after standardized 
preparation. 2D (dynamic-T2-2D-FIESTA) motility acquisitions covering the 
entire small bowel were performed in apnea (27 s). Image analysis for 
assessment of small-bowel motility was performed both manually and with the 
software. The time consumption and main curve characteristics were compared 
using Student’s t-test, the level of scattering of individual measurements using 
Bland-Altman.
Results: 91 single regions of interest were analysed three times by hand and 
three times with Motasso, each measurement done by another expert. Overall 
92% of the motility curves qualitatively matched each other. No signiﬁcant 
intraindividual difference (p>0.05) was found for peristaltic frequencies (mean: 
4.14/min, manual: 4.22/min, Motasso). Amplitudes (5.14 mm, 5.57mm) and 
mean lumen diameters (17.39mm, 14.68mm) slightly but signiﬁcantly differed 
due to systematic differences in the deﬁnition of the bowel wall. Mean duration 
for single analysis was signiﬁcantly (p<0.01) lower with Motasso (6.25 min, 
manual 1.30min, Motasso). The scattering differed signiﬁcantly (p<0.01) 
between the methods.
Conclusion: The use of Motasso proves highly reliable, fast and accurate 
measurement of small bowel motility. Curve characteristics and peristaltic 
motility frequencies of manual and software-supported analyses did not differ 
signiﬁcantly, while the measurement precision and the time needed for 
measurement differed signiﬁcantly in favor of Motasso.
SS 6.05
Does quantiﬁed small bowel motility supplement the 
ability of conventional anatomical MRI markers to 
predict Crohn’s disease activity?
A. Menys, F. Odille, M. Rodriguez-Justo, I. Proctor, M. 
Novelli, S. Punwani, D. Atkinson, S. Halligan, S.A. Taylor; 
London/UK
Purpose: The purpose of this study was to investigate the beneﬁt of adding 
quantiﬁed small bowel motility to a validated MRI model of Crohn’s disease 
activity.
Material and Methods: 23 Crohn’s patients (mean age 35, 15 female) 
underwent MR enterography (Axial and coronal TrueFISP, HASTE, post-
gadolinium VIBE images and coronal TrueFISP cine motility) and endoscopic 
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Small bowel MRI in Crohn’s disease
SS 6.01
Quantiﬁcation of small bowel motility in stricturing 
Crohn’s disease using dynamic MRI
A. Menys, E. Helbren, J. Makanyanga, N. Bell, S. Halligan, 
D. Atkinson, S.A. Taylor; London/UK
Purpose: The purpose of this study was to quantify small bowel motility within 
and upstream of Crohn’s disease-related strictures.
Material and Methods: A previously validated non-rigid registration-based 
software algorithm was used to quantify small bowel wall motion acquired 
during coronal FISP sequence (20 second breath hold, TR-4ms, TE-1.7ms, 
slice thickness 10 mm, 1 slice/0.8 sec) in 34 Crohn’s patients with stricturing 
disease (14 female, mean age 36) undergoing MR enterography. Linear ROIs 
were placed within the stricture (S), immediately upstream (pre-stricture-PS) 
and in normal bowel (N). ROIs were automatically propagated through the time 
series by the software and motility quantiﬁed, expressed as a Jacobian derived 
motility metric. Motility between locations was compared by paired Wilcoxon-
Rank test. The PS bowel was divided into dilated and non-dilated groups 
(dilated = >50% increase in luminal diameter compared to normal bowel) and 
motility compared using Wilcoxon’s rank-sum test.
Results: Mean motility within PS, S and N segments was 0.32, 0.16 and 0.38, 
respectively. There were signiﬁcant differences between PS and S (p=0.0003), 
S and N (p=3.6e[-7]), but not N and PS (p=0.06). However, dilated PS had 
signiﬁcantly reduced motility (mean=0.28) compared to non-dilated PS bowel 
(mean=0.44, p=0.01).
Conclusion: Small bowel motility is reduced in Crohn’s strictures as would be 
expected. However, dilated segments of pre-stricture bowel also show 
abnormal reduced motility possibly representing a failure of small bowel 
propulsion and contributing to patient symptoms.
SS 6.02
Correlation between global small-bowel motility in MRI 
and local disease activity in patients with Crohn’s 
disease
S. Bickelhaupt1, J.M. Froehlich1, R. Cattin2, S. Raible2, U. Bill3, 
H. Bouquet3, M.A. Patak1;  1Zurich/CH, 2Biel/CH, 3Bern/CH
Purpose: Crohn’s disease (CD) is an inﬂammatory bowel disease (IBD) 
characterized by local severe inﬂammation. Previous studies revealed reduced 
small-bowel motility in affected tissue measured at the terminal ileum. The aim 
was to evaluate the inﬂuence of local disease activity on global small-bowel 
motility in patients with CD based on histopathology.
Material and Methods: 15 healthy individuals (11 male, 4 female; mean 44 
years) and 15 patients with histopathologically proven active CD (10 female, 4 
male; mean 37 years) were included in this IRB-approved retrospective study. 
MRI (1.5 T, Siemens Sonata) was performed after a 1 h preparation of 1000 cc 
mannitol solution (3%). Cine T2-2D-FIESTA (TR 283.3/TE 1.89/FOV400/10 mm 
slice) motility acquisitions were performed in apnea. Image analysis for 
assessment of gastric motility was performed using a dedicated MR motility 
assessment software (Motasso) in 3 randomly chosen areas of the small-bowel 
outside the known CD-affected hot spots. The main characteristics (frequency, 
amplitude, diameter) were compared using Student’s t-test and one-way 
ANOVA.
Results: 3 randomly chosen regions of interest were analyzed with Motasso in 
each participant. Patients with active-46913 revealed both signiﬁcantly 
(p<0.01) reduced contraction-frequency (active-CD: 2.86/min;healthy: 4.53) 
and contraction-amplitude (6.71mm;10.14mm) compared to healthy 
individuals. Mean bowel-lumen diameter was only slightly, but signiﬁcantly 
(p=0.04) larger in patients with active-CD (16.91mm) compared to healthy 
participants (14.79mm).
Conclusion: Small-bowel motility in patients with active-CD seems to be 
globally inﬂuenced by the local activity of the disease. Both contraction-
frequency and contraction-amplitude were signiﬁcantly reduced compared to 
healthy individuals, while the mean lumen-diameter was slightly increased. 
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Conclusion: MR enterography provides an excellent correlation regarding the 
disease behavior (Vienna and Montreal classiﬁcation) for patients with Crohn’s 
disease. This represents an extremely important prerequisite for therapeutical 
planning concerning surgery or pharmaceutical therapy.
SS 6.08
Magnetic resonance imaging is correlated to faecal 
calprotectin level in the evaluation of small bowel and 
colonic Crohn’s disease
D. Pendse, J. Makanyanga, E. Atkins, A. Menys, S. Bloom, 
S. McCartney, S. Punwani, S. Halligan, S.A. Taylor; London/UK
Purpose: Crohn’s disease management requires knowledge of overall disease 
burden. A new MRI score of Crohn’s disease activity was tested against 
reference standards of global activity: Harvey Bradshaw index (HBI) and faecal 
calprotectin.
Material and Methods: 34 patients (15 male), median age 33 (range 17-78), 
with known or suspected Crohn’s disease underwent MR enterography [axial/
coronal HASTE, TrueFisp and post gadolinium coronal VIBE/THRIVE at 1.5 T 
(n=24) or 3 T (n=10)]. On the same day, HBI questionnaire and faecal 
calprotectin were measured. Two observers qualitatively graded bowel wall 
thickness, mural T2 signal, mesenteric oedema, T1 enhancement and colonic 
haustral loss from 0 (normal) to 3 (most abnormal) for the jejunum, proximal 
ileum, terminal ileum and colon (6 segments). Each individual small bowel and 
colonic segmental score was multiplied according to the length of disease in 
that segment (0-5 cm x1, 6-15 cm x1.5, and 16 cm x2). For each of 
lymphadenopathy, comb sign, abscesses and ﬁstula, a score of 5 was added 
if present. The relationship between MRI score, calprotectin and HBI was 
evaluated using Kendall’s rank correlation.
Results: The mean MRI activity score was 15 (range 0-61.5) and was 
signiﬁcantly correlated with calprotectin, Kendall’s tau b=0.42, p=0.0009, but 
not with HBI, Kendall’s tau b=0.006, p=1.
Conclusion: Global Crohn’s disease activity measured using a qualitative MRI 
score is correlated to the faecal calprotectin level. MRI is useful for the global 
assessment of Crohn’s disease activity.
SS 6.09
Correlating faecal calprotectin with small bowel MRI: a 
retrospective analysis
G. Bhatnagar, H.S. Sidhu, K. Woolson, C. Edwards, M. Puckett; 
Torbay/UK
Purpose: There is no gold standard test for comprehensive assessment of 
Crohn’s disease (CD). Small bowel MRI (SBMR) and faecal calprotectin (FC) 
are emerging tools. Understanding the relationship of these two tests will 
enhance our ability to stage disease activity in CD.
Material and Methods: Patients attending Torbay Hospital with SBMR and FC 
samples within 35 days of each other were retrospectively assessed. SBMR 
were analysed using several criteria that were individually compared to FC.
Results: The study included 16 patients (5 normal, 11 abnormal FC). All 
patients with elevated FC had abnormal SBMR (p=0.05). More than half the 
patients with normal FC had abnormal SBMR (p=0.05). Statistical analysis by 
Fischer’s exact test for count data of speciﬁc SBMR ﬁndings such as number 
of abnormal segments, wall thickness of abnormal segments and enhancement 
of abnormal segments amongst others did not demonstrate any signiﬁcant 
relationship.
Conclusion: SBMR in patients with abnormal FC is always abnormal. This 
may prove to be a cost-effective ﬁnding in restaging CD by obviating the need 
for repeat SBMR in cases of deranged FC. SBMR may be abnormal in cases 
of normal FC. This ﬁnding suggests that SBMR is a more sensitive test of 
disease activity in CD and may represent the new gold standard. Some 
limitations of this retrospective analysis such as inconsistent temporal 
correlation between FC and SBMR as well as small sample size are 
recognised.
SS 6.10
Assessment of small bowel inﬂammation, stenosis and 
complications in patients with Crohn’s disease on 
anti-TNF treatment using serial MRI scans
J.A.W. Tielbeek, M. Löwenberg, C.Y. Ponsioen, G. D’Haens, 
J. Stoker; Amsterdam/NL
Purpose: The purpose of this study was to assess the evolution of small bowel 
disease activity and complications in Crohn’s disease patients treated with 
anti-TNF agents using serial MRI scans.
terminal ileal (TI) biopsy within 4 weeks (mean 5 days). TI motility (Motil) was 
quantiﬁed using validated software which measures bowel wall displacement 
based on non-rigid registration, expressed as the mean jacobian standard 
deviation. Two observers in consensus applied a validated MRI score of activity 
to the TI based on grading (0-3) mural thickness, T2 signal, contrast 
enhancement, and perimural oedema (scores totalled, tMRI). TI biopsies were 
assigned an acute inﬂammatory score (eAIS, 0-6) based on the presence of 
ulceration and neutrophil inﬁltration. On statistical advice, univariate analysis 
assessed the association between eAIS and both tMRI and Motil independently. 
A multivariate analysis with backward selection assessed the beneﬁt of adding 
Motil to the tMRI model’s ability to predict eAIS.
Results: There was a signiﬁcant association between tMRI and eAIS (Reg 
Coeff=0.28, p=0.002) and negative association between Motil and eAIS (Reg 
Coeff=-0.49, p=0.02). However, there was no signiﬁcant advantage in eAIS 
prediction by adding Motil to the tMRI model (p=0.6).
Conclusion: Small bowel motility is negatively associated with Crohn’s disease 
activity, but may not add to existing anatomical MRI biomarkers.
SS 6.06
Software-assisted MRI assessment of gastric motility in 
patients with active Crohn’s disease
S. Bickelhaupt1, J.M. Froehlich1, R. Cattin2, S. Raible2,  
H. Bouquet3, U. Bill3, M.A. Patak1;  1Zurich/CH, 2Biel/CH, 
3Bern/CH
Purpose: Humoral mediators released during inﬂammation in Crohn’s disease 
(CD) may inﬂuence gastrointestinal motility beyond the affected areas. This 
could affect the functionality of other gastrointestinal organs, e.g. the stomach. 
Thus, the aim was to evaluate the systemic inﬂuence of local disease activity 
on gastric motility in MRI in patients with histopathologically proven active-
CD.
Material and Methods: 10 individuals (6 healthy and 4 with histologically 
proven active-CD, 6 female/4 male, mean age 40y) were included in this IRB-
approved, retrospective study. MRI (1.5-T, Siemens Sonata) was performed 
after a 1-h preparation of 1000 cc Mannitol solution (3%). Cine T2-2D-FIESTA 
(TR 283.3/TE 1.89/FOV 400/10 mm) motility acquisitions were performed in 
apnea. Gastric motility analyzed in the corpus image analysis for gastric 
motility was performed using a dedicated MR motility assessment software 
(Motasso). The main characteristics (frequency, amplitude, diameter, 
propagation) were compared using Student’s t-test.
Results: Overall contraction frequency was not signiﬁcantly (p>0.05) reduced 
in patients with active-CD (1.7/min) compared to healthy individuals (1.9/min). 
Yet, further comparison revealed several signiﬁcant (p<0.05) differences in the 
motility characteristics with a reduced wave propagation speed (healthy: 2.36 
mm/sec; active-CD: 0.25 mm/sec), contraction amplitude (22.74 mm; 13.84 
mm) and mean diameter (36.38 mm; 17.45 mm) in patients with histologically 
proven active-CD.
Conclusion: Gastric motility patterns were signiﬁcantly altered in patients with 
active-CD. Contraction waves propagated signiﬁcantly slower and with lower 
amplitudes in patients with active-CD compared to healthy individuals, though 
the gastric contraction frequency was not signiﬁcantly reduced. This might 
reﬂect the inﬂuence of inﬂammatory mediators on gastric motility.
SS 6.07
Correlation of MRI with surgery regarding disease 
behavior (Vienna classiﬁcation) in patients with Crohn’s 
disease
G. Schill, L.M. Dendl, C. Stroszczynski, A.G. Schreyer; 
Regensburg/DE
Purpose: The purpose of this study was to correlate the radiological 
assessment of Crohn’s disease (CD) based on magnetic resonance 
enterography (MRE) with the surgical and histological assessment using the 
Vienna and Montreal classiﬁcation score.
Material and Methods: We retrospectively assessed the MRE in 76 
consecutive patients with known CD who had a MRE and surgery with a 2 
weeks time period. Based on MRE, the diagnosis of abscess, ﬁstula, 
conglomerate tumor, and stenosis was documented. For surgery and histology, 
the surgeon who performed the procedure as well as a pathologist did the 
Vienna and Montreal scoring regarding the subgroups B1 (non-stricturating, 
non-penetrating), B2 (stricturating) and B3 (penetrating).
Results: We found an excellent correlation (k=0.937) regarding the correct 
scoring assessment for disease behavior (B score). We found the highest 
sensitivity (96 %) for stenosis assessment and the highest speciﬁcity (95%) for 
ﬁstulas. We calculated the highest positive predictive value for conglomerate 
tumors (95%) and the highest negative predictive value (98%) for abscesses. 
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Results: We found a kappa value on 0.73 (95% CI: 0.61-0.87) for the sub-
classiﬁcation between the two methods. The kappa value in classifying early 
versus advanced T3 rectal tumours was 0.91 (95% CI: 0.81-1.00). There were 
no differences in mean maximal tumour outgrowth measured on TRUS, 5.3 
mm (95% CI: 4.1-6.7 mm) and on MRI, 6.4 mm (95% CI: 4.9-7.9 mm).
Conclusion: There is a good agreement between TRUS and MRI in the 
pretreatment sub-classiﬁcation of T3 tumours and a very good agreement in 
classifying tumors as early and advanced. TRUS can be used to predict 
advanced rectal cancers and thus be helpful if chemoradiation is considered in 
patients with contraindications to MRI.
SS 7.03
Rectal tumour volume delineation using T2-weighted 
and diffusion-weighted MRI: implications of observer 
agreement for radiotherapy planning
F. Regini, R. Cardoso De Melo, N. Grifﬁn, J. Parikh,  
G. Charles-Edwards, G. Rottenberg, M. Leslie, A. Gaya,  
V. Goh; London/UK
Purpose: The purpose of this study was to determine if observer agreement 
for tumor volume delineation is better for DW-MRI than T2W MRI.
Material and Methods: 27 consecutive patients (15 male, 12 female, mean 
age 66.9, range 27.1-88.8 years) underwent 1.5 T MRI (Siemens) prior to 
chemoradiation (45 Gy in 25 fractions; oral capecitabine 850 mg/m[2]), 
including T2W (TR=6600 ms, TE=90 ms, NEX=2, ST=6 mm) and DW-MRI 
(TR=3000 ms, TE=77 ms, NEX=4, ST=6 mm, b=0-100-800 s/mm[2]) axial 
sequences. 3D tumor volume (cm[3]) was measured by VOI analysis by two 
independent readers for the T2W and b800 DWI axial images (OsiriX 3.9). T2 
and DW-MRI tumor volumes were compared using Mann-Whitney test. 
Observer agreement was assessed using Bland-Altman statistics. Signiﬁcance 
was at 5%.
Results: Artefacts precluded DWI analysis in 1 patient. In the remaining 26 
patients evaluated, median (range) in cm[3] for the T2W and DWI (b=800) 
volumes was 47.24 (7.57-267.68) and 47. 22 (3.68-251.00), respectively, for 
Reader One and 44.67 (11.63-249.36) and 43.79 (6.70-291.54) for Reader Two. 
T2 volumes were slightly larger but not signiﬁcantly different from DWI volumes: 
median 43.77 versus 42.44, P=0.92 for Reader One; median 42.25 versus 
40.09, P=0.68 for Reader Two. Mean difference (95% limits of agreement) for 
T2 and DWI was -0.89 (-29.95 to +28.16) and +2.57 (-23.04 to +28.19), 
respectively, indicating slightly better inter-observer agreement for DWI.
Conclusion: Slightly better inter-observer agreement for volume delineation 
was noted for high b-value DWI, related to better conspicuity.
SS 7.04
Wall deformity in preoperative distinction between T1-T2 
and T3-T4 staging of colorectal cancer
N. Flor, M. Mezzanzanica, P. Rigamonti, M. Peri, F. Sardanelli, 
G. Cornalba; Milan/IT
Purpose: To predict colorectal cancer (CRC) T stage using preoperative 
contrast-enhanced computed tomography colonography (CE-CTC).
Material and Methods: Sixty-nine patients with 75 CRC underwent CE-CTC. 
Two readers evaluated on 3D views three different types of wall deformity (WD) 
due to the CRC: < 25% of the lumen; between 25% and 50% (apple core); and 
50%. Each category was associated with a T stage: < 25%, T1; between 
25% and 50%, T2; 50%, T3 or T4. Standard of reference: pathology. This 
study was approved by IRB.
Results: Pathology: T1 (n = 5), T2 (n = 12), T3 (n = 45),T4a (n = 8) and T4b (n = 
5). The detection rate of CRC was 100% (75/75). Mean CRC’s largest diameter 
was 49 ± 20 mm (range 10-110), 19 mm for T1, 40 mm for T2, 52 mm for T3 
and 64 mm for T4. The bowel preparation and colon distension were adequate 
in 62/69 (90%) and 67/69 patients (97%), respectively. Intra- and interobserver 
reproducibility for WD was almost perfect (k = 1 and k = 0.88, respectively). 
Sensitivity of WD for T stage 3 was 0.96 (56/58, 95% CI 0.88-0.96), speciﬁcity 
0.71 (12/17, 95% CI 0.44-0.90), PPV 0.92 (56/61, 95% CI 0.82-0.97), NPV 0.86 
(12/14, 95% CI 0.57-0.98) and accuracy 0.91 (68/75, 95% CI 0.82-0-96). 
Twenty out of 69 patients had at least one synchronous polyp 6 mm.
Conclusion: The presence of WD 50% (apple core type) is highly predictive 
of stage T3 or higher.
Material and Methods: We performed a retrospective study of patients with 
Crohn’s disease who had undergone serial MRI scans (T1- and T2-weighted 
sequences) while receiving anti-TNF treatment. Patients were grouped as 
clinical responders or non-responders. Stricturing lesions were evaluated 
using simpliﬁed scoring systems of inﬂammation (Steward et al.) and stenosis 
(Fornasa et al.). Complications were scored evaluating penetrating lesions, 
abscesses and/or ﬁstulas.
Results: Forty-two MRI scans were evaluated in 13 clinical non-responders 
and 8 responders. In all patients, median inﬂammation scores decrease from 
10 (range 6–15) on initial MRI to 8 (range 1–13) on follow-up MRI (p=0.168). In 
the responder group, 86% had reduced inﬂammation on follow-up MRI 
(p=0.0571). In this group, the ﬁrst MRI detected complicated disease in 25% 
of the patients which resolved at follow-up MRI. Severity of stenosis was 
signiﬁcantly reduced between serial MRI scans (p=0.0148). In the non-
responder group, only 23% showed decreased inﬂammatory scores (non-
signiﬁcant). Severity of stenosis, stricturing and penetrating lesions was 
unchanged as indicated by serial MRI scans.
Conclusion: A reduction in both small bowel inﬂammation and inﬂammatory 
stenosis on serial MRI scans correlates with clinical responses to anti-TNF 
treatment. MRI can be used as a complementary approach to measure 
transmural healing in order to improve the clinical management in Crohn’s 
disease patients.




DCE-MRI correlates with tumor: free resection margins 
in recurrent rectal cancer
M. Gollub1, K. Cao2, D. Gultekin1, D. Kuk1, M. Gonen1,  
M. Sohn1, L. Schwartz1, P. Paty1;  1New York, NY/US, 
2Beijing/CN
Purpose: The purpose of this study was to explore whether pre-operative 
DCE-MRI correlates to clinical outcome variables in patients who undergo 
surgical treatment for recurrent rectal carcinoma.
Material and Methods: A retrospective study of DCE-MRI in patients with 
recurrent rectal cancer was performed after obtaining an IRB waiver. We queried 
PACS from 1998 until 2008, to allow 3-year follow up. Using patient medical 
records, we determined which exams were done for recurrent disease. We 
explored the correlation between K[trans], Kep, Ve and AUC 90 and 180 seconds 
with time to re-recurrence [TTR], overall survival [OS] and margin status. The 
surgeons were blinded to DCE ﬁndings. Univariate Cox PH models were used 
for TTR and OS, while univariate logistic regression was used for margin status.
Results: One-hundred sixty-eight patients underwent MRI for recurrence. 
Major exclusions included: treatment prior to MRI, n=38; second recurrence, 
n=30 and medical treatment only, n=28. Among the remaining 47 patients, 27 
went directly to surgery. Fourteen of these had positive margins. K[trans] (OR 
0.03: CI: 0.001, 0.826, p=0.0382) and Kep (OR 0.19: CI: 0.039, 0.938, p= 
0.0415) were inversely correlated with positive margins. In 20 patients 
undergoing neoadjuvant treatment, a correlation between AUC 90 and TTR 
was noted (HR 1.191, CI: 1.003, 1.413, p=0.0456).
Conclusion: A direct correlation was found between K[trans], Kep and clear 
resection margins. Such information might be helpful for treatment 
individualization.
SS 7.02
Agreement between transrectal ultrasound and MRI in 
prediction of depth of extramural tumor spread in rectal 
tumours
S.R. Rafaelsen, C. Vagn-Hansen, T. Sørensen, J. Pløen,  
A. Jakobsen; Vejle/DK
Purpose: The purpose of this study was to evaluate the agreement between 
transrectal ultrasound (TRUS) and MRI in sub-classiﬁcation of T3 tumours.
Material and Methods: From January 2010 to December 2011, 68 consecutive 
patients with T3 tumours were included in this study. The mean age of the 
patients was 67.5 years (range: 33-91 years). The tumours were all >T2 on 
TRUS. The sub-classiﬁcation was deﬁned as T3a with a penetration of the 
rectal wall from 0 to 1 mm, T3b 1-5 mm, T3c 6-15 mm, T3d >15 mm: early T3 
as T3ab and advanced tumours as T3cd (>5 mm). The TRUS ﬁndings were 
blinded to two experienced radiologist who did the interpretation of the MRI 
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Results: A total of 34 patients were pN0, and 19 pN+. Gadofosveset-MRI 
correctly staged 42 patients (sensitivity 84%,speciﬁcity 76%, PPV 67%, NPV 
90%); 3 pN+ patients were understaged, 8 pN0 were overstaged. FN ﬁndings 
were due to: N+ node obscured by adjacent vessel (n = 1); microscopic tumour 
cells too small to detect with MRI (n = 2). FP ﬁndings were due to: interpretation 
errors that could be corrected by the expert reader (n = 3), decreased 
gadofosveset uptake in presacral/peri-vascular nodes (n = 4) and absence of 
gadofosveset-uptake eci (n = 1).
Conclusion: The previously reported high accuracy was sustained in this 
second cohort and was reproducible by non-expert radiologists. Understanding 
the pitfalls is crucial for clinical implementation. Pitfalls mainly occur due to 
readers’ inexperience and insufﬁcient uptake of gadofosveset in nodes located 
between vessels (in the upper mesorectum).
SS 7.08
Are p53 and c-erb-B2 expression useful as adjuvant 
tools in staging gastric adenocarcinoma by MDCT and 
MRI?
R. Mateus Marques, J. Dias, L. Fernandes, P. Mendonça,  
P. Santos, J. Esteves, L. Costa, F. Pina, M. Oliveira,  
J. Guedes Da Silva, A. Caldeira Fradique; Lisbon/PT
Purpose: P53 and c-erb-B2 have been proposed as indicators of poor prognosis 
in gastric adenocarcinoma (GA), while MDCT and MRI may understage the 
disease. The purpose of this study is to evaluate a relationship between the 
expression of these cellular markers and differences between staging by imaging 
and according to pathological studies or clinical progression.
Material and Methods: Between January 2009 and December 2011, 64 
patients with GA underwent p53 and c-erb-B2 measurements by biopsy or 
surgery. P53 expression was divided into three levels and c-erb-B2 values 
were divided between negative and positive. Results were compared by 
logistical regression and Chi-square statistics with differences between clinical 
(CIS) or nodal (NIS) staging by imaging and clinical or nodal staging (CS and 
CNS) obtained by surgery or clinical progression.
Results: The results of P53 levels were low in 38 patients, moderate in 10 
patients and high in 15 patients. C-erb-B2 was negative in 49 patients and 
positive in 10 patients. Differences in staging were 50% (CIS/CS) and 56.2% 
(NIS/CNS). Chi-square statistics revealed a p value of .481 and 0.705, 
respectively, for differences between CIS/CS ( lower level of p value, 153 
obtained for high p53 expression) and NIS/CNS. Cellular markers measurements 
correctly increased CIS in 6.9% and NIS in 3.5%.
Conclusion: P53 and c-erb-B2 measurements increased CIS and NIS with 
MDCT or MRI, but such improvement was not statistically signiﬁcant, so their 
use as adjuvant tools needs further evaluation.
SS 7.09
Withdrawn by the authors
SS 7.10
Value of 3D FSE-Cube sequence at 3T MRI in pre-
operative local staging of rectal cancer
R. Scandiffio, E. Neri, L. Faggioni, A. Mantarro, R. Balestri, 
C. Bartolozzi;  Pisa/IT
Purpose: To compare a standard T2w imaging based on 2D acquisitions with 
3D FSE-Cube sequence in the local staging of rectal cancer at 3T MRI.
Material and Methods: Eleven patients with rectal cancer were prospectively 
evaluated at 3T MRI. Sagittal, coronal, axial and oblique 2D T2w FSE images 
were obtained. An additional 3D T2 FSE-Cube sequence was performed after 
the 2D sequences. Each 3D data set was processed with multiplanar and 
curved planar reconstructions. Two experienced radiologists, using respectively 
2D or 3D sequences, evaluated T and N parameters, with speciﬁc attention to 
measurement of the distance between the lesion and puborectal muscle and 
mesorectal fascia, and lesion extension. Linear Cohen k values were calculated 
to quantify agreement between MRI and histopathological data. Image quality 
was evaluated using a linear qualitative scale.
Results: Global sensitivities for T parameters were 56% and 64% for 2D and 
3D images, while N category lesion accuracy values were 53% and 56%, 
respectively. Accuracy in measuring the distance from pubo- rectal muscle to 
lesion border was 60% and 100% for 2D and 3D, respectively. Image quality 
was considered very good on 2D images, and good on 3D images.
Conclusion: No signiﬁcant differences between 2D and 3D images were 
observed for T and N staging. However, T2w FSE-Cube demonstrated higher 
accuracy than 2D in determining the distance between the lesion and the 
pubo-rectal muscle, which represents a key factor in planning surgical 
resection.
SS 7.05
MRI morphology after transanal endoscopic 
microsurgery for patients with rectal cancer
M.H. Martens1, M. Maas1, L. Heijnen1, D.M. Lambregts1, 
J.W.A. Leijtens2, F.C.H. Bakers1, V.C. Cappendijk1, G.L. 
Beets1, R.G.H. Beets-Tan1;  1Maastricht/NL, 2Roermond/NL
Purpose: Patients with early rectal cancer or a good response after 
chemoradiation (CRT) are sometimes treated with transanal endoscopic 
microsurgery (TEM). Follow-up of TEM-patients includes MRI. This study aims 
to describe the rectal wall MRI morphology during short-term and long-term 
follow-up after TEM.
Material and Methods: A total of 36 patients were included with at least one 
post-operative TEM. For 17 patients multiple consecutive MRIs were available; 
29 patients had a primary TEM and 7 had TEM after CRT.
Results: Three morphological patterns on MRI after TEM could be identiﬁed: (1) 
rectal wall thickening with or without ﬁbrosis, (2) a notch at the TEM location, and 
(3) irregular delineation of the rectal wall. In eight cases, edema was present 
during short-term follow-up and remained present during long-term follow-up in 
patients with TEM after CRT. Wall thickening with or without ﬁbrosis was 
observed in 24 patients and remaind consistent during long-term follow-up. A 
notch was observed in 15 patients and persisted during long-term follow-up in 
83%. Sixteen patients had irregular delineation of the rectal wall, only during 
short-term follow-up. Six luminal recurrences occured; three patients had wall 
thickening, two a notch, and ﬁve patients had an irregular rectal wall.
Conclusion: Three patterns on MRI were identiﬁed after TEM. Radiologists 
can monitor these patients more accurately, which is important at a time when 
minimal invasive techniques are emerging.
SS 7.06
High-resolution magnetic resonance imaging  versus 
computed tomography for preoperative local staging of 
colon cancer
E. Rollvén, T. Holm, E. Lörinc, B. Glimelius, L. Blomqvist; 
Stockholm/SE
Purpose: To study high-resolution T2-weighted MRI versus CT for preoperative 
local staging of colon cancer with surgery and histopathology as reference 
standard.
Material and Methods: Twenty-eight patients with a total of 29 tumours were 
included. Patients were examined on a 1.5 T MR unit using a phased array body 
coil. T2 turbo spin-echo high-resolution sequences were performed in three 
planes at the site of the tumour. CT was performed using a protocol for metastasis 
staging. The examinations were independently evaluated by two gastrointestinal 
radiologists using criteria adapted to imaging for prediction of T- and N-stages 
and extramural venous invasion. Based on the T-stage, tumours were divided 
into locally advanced (T3cd-T4) and not locally advanced (T1-T3ab). Surgical 
and histopathological ﬁndings served as reference standard.
Results: With MRI, T-stage, N-stage and extramural venous invasion were 
correctly predicted for each observer in 90 and 93%, 72 and 69%, 82 and 78% 
of cases, respectively. With CT, the corresponding results were 79 and 76%, 
72 and 72%, and 78 and 67%. For MRI, interobserver agreements were 0.79, 
0.10 and 0.76. For CT, the corresponding results were 0.64, 0.66 and 0.22.
Conclusion: Locally advanced colon cancer can be distinguished from not 
locally advanced by both high-resolution MRI and CT. MRI may have an 
advantage in identifying certain prognostic factors such as T-stage and 
extramural venous invasion.
SS 7.07
Gadofosveset-enhanced MRI for nodal staging in rectal 
cancer: pitfalls and learning curve
M.H. Martens, D.M.J. Lambregts, L. Heijnen, M. Maas,  
V.C. Cappendijk, F.C. Bakers, G.L. Beets, R.G.H. Beets-Tan; 
Maastricht/NL
Purpose: Nodal staging in rectal cancer remains a diagnostic challenge. In a 
recent pilot study, we have shown good performance for MRI using 
gadofosveset contrast in expert hands (sensitivity 80%, speciﬁcity 97%). The 
aim of the present study is to investigate whether the high accuracy will be 
sustained in clinical setting with non-expert radiologists.
Material and Methods: A total of 53 patients underwent standard MRI (T2W-
FSE) for treatment planning and gadofosveset-MRI. Sixteen underwent (5x5 
Gy+) immediate surgery, 37 underwent chemoradiation, a restaging MRI and 
surgery. Patients were scored as cN0/N+ based on the presence/absence of 
nodal gadofosveset enhancement on the pre-surgical MRI. Histology was the 
gold standard. In case of FP/FN ﬁndings, the scan was re-evaluated by an 
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SS 8.03
Single-energy low-voltage arterial phase scanning for 
the detection of adenocarcinoma of the pancreas.
M.C. Ambrosetti, G.A. Zamboni, E. Zivelonghi, C. Cavedon, 
R. Pozzi Mucelli; Verona/IT
Purpose: To test a single-energy low-voltage protocol for detecting pancreatic 
adenocarcinoma.
Material and Methods: A total of 26 patients with pathology-proven pancreatic 
adenocarcinoma underwent MDCT with arterial phase at 80 kV on a 64-row 
scanner and were compared to a similar group of 26 patients scanned with a 
120 kV arterial phase protocol. Except for tube voltage, all other scan 
parameters were constant. Scans were compared for quantitative image 
parameters (attenuation and standard deviation in liver, pancreas, aorta and 
tumour), CTDI and DLP using an unpaired t test. Image noise values for each 
protocol (SD of the HU from 3 ROIs drawn outside the body) were compared 
using an unpaired t test. Effective dose for each protocol was estimated with 
TLD measurements on an anthropomorphic phantom.
Results: The mean attenuation was signiﬁcantly higher at 80 kV in the aorta (525.6 
± 126.8 vs. 292.9 ± 87.4 HU), liver (94.4 ± 17.8 vs. 75.3 ± 14 HU) and normal 
pancreas (162.1 ± 42 vs. 89.9 ± 19.7 HU) (all p < 0.0001), while no signiﬁcant 
difference was observed for adenocarcinoma (67.8 ± 39.2 vs. 50.5 ± 20.5 HU; p = 
n.s.). CTDI and DLP were signiﬁcantly lower at 8 kV (6.0 ± 1 vs. 9.7 ± 2.8 mGy, and 
184.6 ± 40.3 vs. 369.6 ± 133.4 mGy x cm, respectively; all p < 0.0001). Tumour 
conspicuity (HUpancreas-HUtumour) was signiﬁcantly higher at 80 kV (94.2 ± 39.3 
vs. 39.5 ± 22HU; p < 0.0001). Mean image noise was signiﬁcantly higher at 80 kV 
(12.3 ± 3.6 vs. 9.5 ± 2.9 HU; p < 0.0001). Estimated effective dose was signiﬁcantly 
lower at 80 kV (0.157 vs. 0.201 mSv; p = 0.0083).
Conclusion: The use of 80 kV arterial-phase for abdominal CT increases the 
conspicuity of adenocarcinoma, thus potentially improving its identiﬁcation.
SS 8.04
Dual energy CT perfusion in pancreatic carcinoma
M. Klauß, W. Stiller, M. Kieser, J. Werner, H.U. Kauczor,  
L. Grenacher; Heidelberg/DE
Purpose: The purpose of this study was to evaluate the feasibility of dual-
energy (DE)-CT perfusion in pancreatic carcinoma.
Material and Methods: A total of 21 patients with histologically proven 
pancreatic carcinoma were examined prospectively with a 64-slice dual-
source CT using a dynamic sequence of 34 acquisitions (80/140 kV~p~; 
270/49 mAs; collimation of 14×1.2 mm) every 1.5 s after i.v. injection of 80 ml 
of iodinated contrast material (370 mg/ml, ﬂow rate 5 ml/s). Image data of 80 
kV~p~ and linearly blended 120 kV~p~-equivalent (M0.3) DE-perfusion 
acquisitions were evaluated with a body-perfusion CT tool (Siemens Medical 
Solutions, Erlangen, Germany) for estimating perfusion, permeability, and 
blood volume and parameter maps. These parameters were calculated to 
ROIs in carcinoma and healthy tissue.
Results: In all 21 patients, DE-CT perfusion was feasible, and tumor as well as 
healthy tissue was covered. All carcinomas could clearly be identiﬁed in the 
color-coded perfusion maps. Calculated values of perfusion, permeability and 
blood volume were lower in pancreatic carcinomas compared to healthy 
pancreatic tissue - 120 kV~p~-equivalent (M0.3): 0.23 ± 0.03 vs. 0.88 ± 0.04 
min[-1] (p < 0.0001); [0.49 ± 0.07] vs. [0.66 ± 0.06]*0.5 min[-1] (p = 0.06), and 
0.44 ± 0.06 vs. 1.22 ± 0.12 min[-1] (p < 0.0001); 80 kV~p~: 0.22 ± 0.04 vs. 0.81 
± 0.05 min[-1] (p < 0.0001), [0.37 ± 0.04] vs. [0.70 ± 0.05]*0.5 min[-1] (p < 
0.0001), and 0.51 ± 0.08 vs. 1.37 ± 0.18 min[-1] (p = 0.0001). There were no 
signiﬁcant differences between 120 kV~p~-equivalent and 80kV~p~-DE-
acquisition regarding the difference between healthy and carcinoma tissue 
(perfusion: 0.65 ± 0.05 vs. 0.59 ± 0.06 min[-1] (p = 0.47), permeability: [0.17 ± 
0.09] vs. [0.33 ± 0.08]*0.5 min[-1] (p = 0.21), blood volume 0.79 ± 0.13 vs. 0.86 
± 0.17 (p = 0.72).
Conclusion: DECT perfusion of the pancreas is feasible. Use of 120 kV~p~-
equivalent DECT perfusion image data combines the advantages of increased 
(iodine) contrast at low kV~p~ (80) with the low noise at high kV~p~ (140) and 
could improve the delineation of pancreatic carcinomas in clinical use.
SS 8.05
New CT ﬁndings in severe acute pancreatitis that 
correlate with clinical outcome
K. Sandrasegaran, B. Tahir, M. Tann, T. Howard; 
Indianapolis, IN/US
Purpose: Recently, new concepts of severe acute pancreatitis (SAP) have 
emerged, including disconnection of main pancreatic duct and peripancreatic 
fat necrosis. We wanted to determine which imaging criteria best predicted 
medium-term outcome (<6 months) in SAP.




Intraductal papillary mucinous neoplasm with an 
associated invasive carcinoma:   image ﬁndings and 
diagnostic performance of MDCT for important 
prognostic factors
J.H. Kim, H.W. Eun, J.Y. Lee, J.M. Lee, J.K. Han, B.I. Choi; 
Seoul/KR
Purpose: Approximately, 30% of Intraductal papillary mucinous neoplasm 
(IPMN) have an associated invasive carcinoma (IPMC). To investigate imaging 
ﬁndings and diagnostic accuracy of MDCT for important prognostic factors in 
surgically proven IPMC.
Material and Methods: During 10 years, 38 patients with surgically proven 
IPMC were included in the study. Two radiologists retrospectively accessed 
morphological types, tumor size, duct size and mural nodule. They also 
accessed T and N stage and graded perineural invasion focus on ﬁve routes: 
plexus pancreaticus capitalis-I,R1; PLX-II, R2; along gastroduodenal artery, 
R3; along splenic artery, R4; posterior of pancreatic body, R5. Statistical 
analyses were performed using ROC analysis, McNemar test and Fisher’s 
exact test. The  statistics was used for interobserver agreement.
Results: Morphological types included main duct (29%), combined (47%) and 
branch duct (24%). Tumor size (3.9 + 2 cm) on CT was not statistically different 
from pathologic size (3.8 + 2 cm, p = 0.582). The main duct was 11.5 + 6.2 mm. 
Mural nodule was detected in 74%. Accuracy for the T stage was 73.7% and 
68.4% and N stage was 68.4% and 76.3% with moderate agreement ( = 
0.636,  = 0.708). AUC (Az) for perineural invasion was 0.868 and 0.821. The 
sensitivity, speciﬁcity and positive predictive value were 100%, 71.4% and 
55.5%, and 90%, 71.4% and 52.9%. Interobserver agreement was moderate 
( = 0.659). Cancer located in the head commonly invades route 1 to 3, whereas 
cancer in the body and tail commonly invades route 4 or 5 (p = 0.002).
Conclusion: Main duct dilatation and mural nodule are common ﬁndings for 
IPMC. CT plays major roles in IPMN, not only in differentiating IPMC but also 
predicting important prognostic factors.
SS 8.02
Diagnostic performance of MDCT for prediction of 
important prognostic factors in resectable pancreatic 
cancer
J.H. Kim, S.H. Kim, H.W. Eun, J.Y. Lee, J.M. Lee, J.K. Han, 
B.I. Choi; Seoul/KR
Purpose: T-stage, N-stage, tumor size, vascular invasion and perineural 
invasion are most important prognostic factors for resectable pancreatic 
cancer. The purpose was to investigate the diagnostic accuracy of MDCT for 
these prognostic factors.
Material and Methods: This study group consisted of 111 patients with 
surgically resected pancreatic cancer who underwent preoperative dynamic 
CT during 10 years. Two radiologists retrospectively and independently 
accessed T-, N-stage, size, vascular invasion and graded perineural invasion 
using three-point scale focus on 5-routes; plexus pancreaticus capitalis I, R1; 
PLX-II, R2; along the gastroduodenal artery, R3; along the splenic artery, R4; 
posterior region of pancreatic body, R5. Statistical analyses were performed 
using the ROC analysis, McNemar test, paired T-test and Fisher’s exact test. p 
value < 0.05 was considered signiﬁcant. The  statistics was used to determine 
interobserver agreement.
Results: The accuracy for T-stage was 82.9% and 77.5% with moderate 
interobserver agreement (=0.732). The accuracy for node metastasis was 
59.5% and 55.0% with fair agreement (=0.597). Diagnostic accuracy for 
vascular invasion was 94% and 92%. The Az for diagnostic performance 
regarding perineural invasion was 0.733 and 0.66 with moderate agreement 
(=0.770). The cancer located in head commonly invade routes 1-3, whereas 
cancer located in body and tail commonly invade route 4 or 5 (p<0.0001). 
Tumor size on surgical specimen (3.4cm+1.46) is statistically larger than tumor 
size on CT (3.2cm +1.41, p=0.001). The nodular growth pattern was statistically 
larger than tumor size on CT (p=0.013).
Conclusion: CT is very useful for preoperative evaluation of T-stage, perineural 
invasion, and vascular invasion in pancreatic cancer, but limited evaluation for 
N-stage. CT, which plays a major role in patient with pancreatic cancer, not 
only accesses preoperative respectability by means of T-stage and vascular 
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Conclusion: Our study conﬁrms in a large series of patients that the previously 
described MDCT criteria are seen in most cases. Yet, conversely to pathological 
hypothesis, we have not shown a strong association between CDHP and 
minor papilla abnormalities.
SS 8.08
Can MDCT predict the resection status after 
pancreaticoduodenectomy   for pancreatic 
adenocarcinoma?
O. Zakharova, G.G. Karmazanovsky; Moscow/RU
Purpose: The completeness of resection for pancreatic cancer (PC) has a 
powerful prognostic signiﬁcance for recurrence and survival. 3D-CT is an 
accurate predictor of resectability for PC. The aim is to ﬁgure out whether it 
can prevent an R+ resection.
Material and Methods: Retrospective analysis of CT scans and 
pathohistological reports of 89 cases of PC after Whipple procedures was 
performed. We conducted a comparative analysis of demographic, clinical, 
intraoperative and pathologic characteristics of the two groups of patients: 
with R0 and R1 resections. The tested speciﬁcations included: sex, age, size 
of tumor (CT and morphology), TNM stage, evaluation of vessel involvement 
(using 3D reconstructions) and tumor grade.
Results: R0 resections were found in 76 (85.4%) patients (group A). R1 surgical 
margins were detected in 13 (14.6%) cases (group B). There were no R2 
resections in our study. The accuracy of 3D-CT in determining an R0 resection 
was 85%. Patients who underwent vascular resections were more likely to 
have had an R1 resection. In group B, the average size of tumor was 30.4 ± 3,7 
mm (p < 0.05); four (30.8%) patients had circumferential involvement of a 
major vessel of more than 180 degrees (p < 0.05).
Conclusion: MDCT is the most reliable method used for PC staging. In up to 
15%, irresectability is only seen during surgery. 3D-CT imaging increases the 
diagnostic accuracy of vascular invasion. To avoid unnecessary laparotomies, 
it is important to properly interpret CT data.
SS 8.09
Acute pancreatitis: evaluation by using diffusion-
weighted MR imaging with parallel imaging technique 
and multiple b gradient factor values
P. Boraschi, F. Donati, R. Gigoni, G. Gherarducci, F. Pacciardi, 
F. Falaschi, C. Bartolozzi; Pisa/IT
Purpose: To determine the usefulness of diffusion-weighted MR imaging (DW-
MRI) with parallel imaging technique and multiple b-gradient-factor values in 
patients with acute pancreatitis (AP).
Material and Methods: A series of 25 patients with clinical diagnosis of AP 
underwent MR imaging with 1.5 T device (Signa HDxt,GE Healthcare). After the 
acquisition of axial T1/T2w sequences and coronal MRCP, DW-MRI was 
performed using an axial breath-hold single-shot spin-echo echo-planar 
sequence (parallel imaging factor,3); the values of b-factor were set at 0, 300, 
500, 700 and 1000s/mm[2]. All DW images were blindly interpreted. Qualitative 
evaluation was performed by consensus reading of two reviewers who 
evaluated the presence or absence of AP and complications. Quantitative 
evaluation was performed by two other radiologists in conference who 
calculated mean ADC values for each patient using a b-value of 500s/mm[2].
Results: DWI could detect acute pancreatitis as persistent bright signal 
intensity at different b-gradient-factor values. The reviewers were able to 
differentiate inﬂammation from necrotic and hemorrhagic tissue and identiﬁed 
possible causes of AP (choledocholithiasis and pancreas divisum) on MR 
images in 11/25 cases. Furthermore, the mean pancreatic ADC value in the AP 
group was signiﬁcantly lower than in the normal control group (p less than 
0.05).
Conclusion: DW-MRI with parallel imaging technique and multiple b-gradient-
factor values can assess the manifestations of acute pancreatitis using no 
contrast material and has the potential of becoming a powerful tool for the 
evaluation and follow-up of these patients.
SS 8.10
Does image registration inﬂuence tumour perfusion 
values?
S. Kandel1, H. Meyer2, P. Rogalla1;  1Toronto, ON/CA, 2Berlin/DE
Purpose: To evaluate whether image registration in CT perfusion inﬂuences 
perfusion values in pancreatic cancer.
Material and Methods: A total of 23 patients with pancreatic cancer underwent 
perfusion CT imaging of the pancreas on a 320-slice dynamic volume CT 
scanner (Toshiba) using 16 cm detector coverage with 0.5 mm primary slice 
thickness. The dynamic CT protocol consisted of 17 low-dose volumetric scans, 
Material and Methods: A total of 61 patients with SAP were retrospectively 
evaluated for site, presence and % volume of pancreatic and peripancreatic 
fat necrosis and signs of infection. The imaging ﬁndings were correlated with 
the occurrence of mortality (n = 2), systemic morbidity (organ failure, DIC) (n = 
36), local morbidity (persistent pancreatic ﬁstula, colonic perforation) (n = 25), 
length of hospital stay and number of surgical operations required. Multivariate 
generalized linear model analysis was performed.
Results: The mean age was 48.1 years (range 18 to 81), and there were 37 
males and 24 females. Local morbidity was correlated signiﬁcantly with the 
presence of main duct disconnection (p = 0.04), peripancreatic fat necrosis (p 
= 0.02) and size of collection > 10 cm (p = 0.01). Initial length of stay correlated 
with necrosis of >30% of pancreas (p = 0.01), and presence of duct 
disconnection (p = 0.05). Number of operations required correlated with duct 
disconnection (p = 0.03). CT ﬁndings did not correlate with mortality or 
systemic morbidity.
Conclusion: The presence of peripancreatic fat necrosis >10 cm in the widest 
dimension and main duct disconnection signiﬁcantly affect medium-term 
morbidity and need to be included in radiology reports, in addition to the extent 
of glandular necrosis.
SS 8.06
Correlation of CT scores and acute kidney injury in 
severe acute pancreatitis
Z. Li, B. Song; Chengdu/CN
Purpose: To investigate the correlation between MDCT severity scores and 
the presence of acute kidney injury (AKI) in patients with severe acute 
pancreatitis (SAP).
Material and Methods: 119 SAP patients with conﬁrmed AKI in 42 were 
retrospectively included. Contrast-enhanced MDCT scan was performed for 
all patients and 75 had repeated CT scans. The imaging ﬁndings including 
pancreatic size, necrosis, retroperitoneal inﬂammatory exudation, and other 
organ involvements were observed, based on which Balthazar’s CT score, CT 
severity index (CTSI) and extrapancreatic inﬂammation on CT (EPIC) score 
were calculated. The correlation between CT Severity indexes, clinical scores 
(APACHE II and Ranson Score) and ﬁnal clinical outcomes were statistically 
analyzed.
Results: SAP patients with AKI were associated with markedly increased 
incidence of multiple organ dysfunction (88.1%) and high mortality (47.6%). 
Unclear delineation between renal cortex and medulla, and pancreatic/
peripancreatic hemorrhage suggested AKI. In SAP patients with AKI, the CT 
severity indexes showed signiﬁcantly closer correlation with APACHE II and 
Ranson scores than in patients without AKI. EPIC score showed the largest 
area under the ROC curve (AUC = 0.903) than CTSI (AUC = 0.721) and 
Balthazar scores (AUC = 0.571). CT ﬁndings of exudates reduction and 
encapsulation were predictive for AKI recovery.
Conclusion: EPIC score is better correlated with clinical scores in predicting 
the presence of AKI in SAP patients; however, it is signiﬁcantly less sensitive 
than APACHE II Score in reﬂecting the dynamic changes of AKI.
SS 8.07
Cystic dystrophy in heterotopic pancreas: MDCT 
ﬁndings in a large series and possible association with 
minor papilla abnormalities
M. Wagner, M. Vullierme, V. Rebours, P. Ruszniewski,  
V. Vilgrain; Clichy/FR
Purpose: Cystic dystrophy in the heterotopic pancreas (CDHP) is a 
complication of pancreatic heterotopia mostly associated with alcoholism. The 
purpose was to describe MDCT features of CHDP and to analyze its association 
with minor papilla abnormalities as described by Klöppel in 2007.
Material and Methods: A total of 82 patients, with a CDHP conﬁrmed on 
endoscopic ultrasonography and a triple-phase MDCT on the upper abdomen, 
were retrospectively included. The following imaging ﬁndings were recorded: 
size and location of cysts, duodenal wall thickness, pancreatic abnormalities 
and inﬂammatory changes.
Results: Typical ﬁndings of CDHP were observed in 95% (78/82). Among 
them, CDHP was mostly located in the second part of the duodenum (72/78, 
92%). Mean thickness of the duodenal wall was 22.6 mm. Cysts were multiple 
in 90%, (mean number 2.9) and measured between 2 and 60 mm. Pancreas 
abnormalities were depicted in 74.5% (58/78) (calciﬁcations: 10% (8/78), 
dilatation of main pancreatic duct in 15.5% (12/78) or both in 49% (38/78)). 
Santorini duct dilatation and/or calciﬁcation in minor papilla was present in 
35% (27/78). Calciﬁcations in the minor papilla without calciﬁcation in the 
major papilla were only observed in three patients (4%). Inﬂammatory changes 











SCIENTIFIC SESSIONS / THURSDAY, JUNE 14, 2012
 S478
Results: All examinations were technically feasible and well tolerated. The 
mean image quality for the automated processed examinations was rated 
higher for all categories and showed statistically signiﬁcant difference in 
assessment of image contrast (mean~automated~ 4.6 vs. mean~manual~ 4.1) 
and presentation of target organ (mean~automated~ 4.4 vs. mean~manual~ 
4.0) (p < 0.05). The diagnostic conﬁdence was 4.6/3.9 (p < 0.05), respectively. 
Mean examination time was 25.24 min in the automatically and 21.05 min in 
the manually processed examinations.
Conclusion: Despite higher examination time, the automated MR scanner 
user interface shows an increase in image quality and diagnostic conﬁdence. 
The innovation of new optimized MR sequences should carry the potential for 
time-saving strategies.
SS 9.03
Differentiating small I 1 cm) focal liver lesions as 
metastases or cysts by means of computed 
tomography: a case study to illustrate a fuzzy logic-
based method to quantify uncertainty in radiological 
diagnosis
R. Girometti1, F. Fabris2, A. Sgarro2, S. Pullini1, G. Zanella3, 
G. Como1, L. Cereser1, C. Zuiani1, M. Bazzocchi1;  1Udine/IT, 
2Trieste/IT, 3Palmanova/IT
Purpose: To illustrate a fuzzy logic-based method to quantify uncertainty in 
radiological diagnosis.
Material and Methods: We enrolled 22 oncologic patients with 50 focal liver 
lesions 1 cm detected at 64-row computed tomography (CT), proven to be 
cysts (n = 20) or metastases (n = 30). Two readers with 15 (R1) and 5 (R2) years 
of experience independently reviewed CT images. For each lesion, they 
expressed the diagnosis of metastasis as a certainty level (C) within the interval 
[0,1] (certainty in the alternative diagnosis of cyst was assumed to be 1-C). 
After cross-tabulating data according to the gold standard, table cells were 
considered as fuzzy subsets and complementary certainty values as their 
degrees of memberships. Accordingly, we estimated per-lesion diagnostic 
performance of readers both on usual crisp (C  0.51) and fuzzy basis.
Results: Uncertainty mainly increased the crisp subset of false-positive cases: 
from 0 to 0.8 (R1) and from 1 to 2.4 (R2). The difference between crisp and 
fuzzy diagnostic performance was larger for the less experienced reader: 
sensitivity, speciﬁcity, PPV, NPV and accuracy were 90.0, 100, 100, 87.0 and 
94.0% versus 90.0, 96.0, 97.1, 86.5 and 92.4% for R1 and 93.3, 95.0, 96.6, 
90.5 and 94% versus 94.0, 88.0, 92.1, 90.7 and 91.6% for R2, respectively.
Conclusion: Radiological diagnosis can be expressed as a fuzzy degree 
membership to weight the impact of readers’ uncertainty on crisp diagnostic 
performance. One potential application is to test the readers’ competency.
SS 9.04
In vivo and ex vivo intravoxel incoherent motion and 
dynamic contrast-enhanced MRI in pancreatic ductal 
adenocarcinoma: correlation with histologic parameters
P. Lucchesi, M.A. Bali, T. Metens, P. Demetter, L. Verset,  
C. Matos; Brussels/BE
Purpose: To quantify changes in dynamic contrast-enhanced (DCE)-MR 
perfusion and intravoxel incoherent motion-diffusion coefﬁcients obtained in 
pancreatic ductal adenocarcinoma (PDA) in vivo and IVIM-diffusion coefﬁcients 
ex vivo. To determine whether these quantitative parameters correlate to each 
other and if there is a correlation between IVIM-diffusion coefﬁcients and 
ﬁbrosis or microvascular density (MVD).
Material and Methods: DCE-MR perfusion and IVIM (9 b value) were performed 
at 1.5 T in ten patients with PDA. IVIM was repeated on specimens after surgery. 
The ADC, the perfusion fraction f and the pure diffusion D were calculated in vivo 
and ex vivo. The obtained values were tested for signiﬁcant differences between 
in vivo and ex vivo and were correlated with ﬁbrosis content and MVD counts. 
DCE-MR quantitative parameters derived from one-compartment (OC) and two-
compartment (TC) models were correlated with IVIM parameters.
Results: The in vivo signal decay was biexponential, whereas the ex vivo 
signal decay was monoexponential. In comparison to in vivo measurements, a 
signiﬁcant reduction of f, D and ADC was found in ex vivo PDA (p = 0,05). No 
correlation between DCE-MR perfusion and IVIM parameters was found. IVIM 
parameters were not signiﬁcantly correlated with ﬁbrosis and MVD.
Conclusion: In PAD, in vivo ADC values are strongly inﬂuenced by perfusion. 
Quantitative DCE-MR perfusion parameters and IVIM parameters most 
probably represent different physiological processes and in our series no 
signiﬁcant correlation with MVD or ﬁbrosis could be demonstrated.
acquired over 66 seconds during 3 breath-hold periods. Rigid image registration 
was performed by using the volume with the highest aortic attenuation as 
reference. All other volumes were visually matched with the pancreatic lesion 
serving as the volumetric region of interest. Following registration to correct for 
motion, maximum-slope and Patlak analysis technique were applied. Values for 
tumour perfusion and blood volume before and after volume registration were 
statistically compared using the paired T test.
Results: The average ROI used for analysis was 79 mm[2]. Tumour perfusion 
and blood volume were 0.37 ml x 100 ml[−1] x min[−1] (SD: 0.05) and 36.7 
ml/100 mg (SD: 22.9) without, and 0.33 ml x 100 ml[−1] x min[−1] (SD: 0.02) 
and 18.8 ml/100 mg (SD: 7.17) with image registration, the difference was 
statistically not signiﬁcant for maximum slope perfusion (10.8%), but signiﬁcant 
for blood volume (48.9%, p < 0.001).
Conclusion: Image registration inﬂuences perfusion results in pancreatic 
cancer dependent on the analysis technique and degree of volumetric 
misregistration from breathing motion, and thus may be recommended in 
upper abdominal perfusion imaging.
11:00 - 12:30 Tinto
Scientiﬁc Session 9
GI MRI & CT
SS 9.01
Preliminary study on the optimal acquisition time for 
hepatobiliary phase MR imaging enhanced with Gd-
BOPTA
F. Yuan, B. Song; Chengdu/CN
Purpose: The purpose of this study was to investigate the optimal acquisition 
time for Gd-BOPTA-enhanced hepatobiliary phase MR imaging in healthy 
volunteers with normal liver function.
Material and Methods: A total of 48 healthy volunteers (29 males, 19 females) 
were recruited. They were scanned using a 3.0 T MR system with gradient-
echo 3D fast acquisition sequence prior to and at 40 min, 60 min and 90 min, 
respectively, after injection of Gd-BOPTA. The SNR, CR, %Enhancement~SNR~ 
and %Enhancement~CR~ of liver, left/right hepatic duct, gallbladder and 
common bile duct were measured in each phase and statistically analyzed 
using repeated measures ANOVA.
Results: (1) The SNR and CR of liver and left hepatic duct showed the highest 
value at 60 min after Gd-BOPTA injection, while at 90 min for gallbladder and 
common bile duct (p < 0.05). There were no signiﬁcant differences for SNR and 
CR of right hepatic duct among the three delay times (p = 0.61 and p = 0.69), 
but the highest mean value still appeared at 60 min. (2) The %Enhancement~SNR~ 
and %Enhancement~CR~ of liver and left/right hepatic duct showed the 
highest value at 60 min after injection, while at 90 min for gallbladder and 
common bile duct. However, only %Enhancement~SNR~ and 
%Enhancement~CR~ of gallbladder and %Enhancement~SNR~ of common 
bile duct showed statistical signiﬁcance.
Conclusion: For individuals with normal liver function, the optimal acquisition 
time to obtain hepatobiliary phase images of liver and hepatic duct after 
injecting Gd-BOPTA is at 60 min, while that for gallbladder and common bile 
duct is at 90 min.
SS 9.02
Potential beneﬁts from a novel automated MR scanner 
software interface in liver MR imaging in terms of 
examination efﬁciency and image quality
C. Kloeters1, L. Umutlu1, C. Mönninghoff1, A. Sombetzki2,  
G. Antoch2, M. Schlamann1, M. Forsting1, T.C. Lauenstein1;  
1Essen/DE, 2Düsseldorf/DE
Purpose: To analyze an automated MRI algorithm in patients with contrast-
enhanced liver examinations in terms of examination efﬁciency and image 
quality.
Material and Methods: Seventy-eight patients (34-75 years, mean: 53.2 
years) were prospectively included in the study and randomized to one of the 
following scanners: 1.5 T MAGNETOM Aera including a completely automated 
user interface or a 1.5 T MAGNETOM Avanto with manually operated scanner 
software. Two blinded readers rated the image quality of the contrast-enhanced 
MR liver examination in terms of angulations/FOV, image contrast, image 
noise, artifacts and presentation of the target organ from “excellent” (5) to 
“insufﬁcient” (1). The degree of diagnostic conﬁdence to depict liver lesions 
was rated from “certain” (5) to “uncertain” (1). Additionally, total examination 
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responders (n = 12) compared with poor responders (n = 18) (25.90% ± 
25.58% vs. 9.99% ± 15.83%, P < 0.05), yielding AUC = 0.752 when ROC curve 
was drawn. The best cutoff value was 10% increase for early ADC change, and 
the sensitivity and speciﬁcity to ﬁnd good responders were 75% and 72.2%. 
8/9(88.9%) patients with decreased ADC value at the 1st week were poor 
responders. All four (100%) patients with early tumor wall thickness decreasing 
10% were good responders.
Conclusion: Change of ADC value as early as 1st week was found following 
treatment related with tumor regression at the end of short-term treatment in 
GI cancer patients. Early changes of ADC value and tumor wall thickness can 
help to pick up some good/poor responders. This project is supported by the 
National Natural Science Foundation of China, No. 81071129.
SS 9.08
Non-occlusive mesenteric ischemia: CT features and 
their prognostic values
M.A. Mazzei, F.G. Mazzei, G. Imbriaco, S. Guerrini,  
E. Foderà, M. Centra, D. Marrelli, L. Volterrani; Siena/IT
Purpose: Non-occlusive mesenteric ischemia (NOMI) is the most lethal form of 
acute mesenteric ischemia (58-70%) because of the poor understanding of its 
pathophysiology, its mild and nonspeciﬁc symptoms and signs at imaging, 
which often delay the diagnosis. The purpose of our work has been to evaluate 
CT appearances in 16 patients with NOMI, to recognize their CT characteristic 
features and their prognostic values.
Material and Methods: Twenty-two abdominal CT examinations of 16 patients 
(14 males and 2 females, mean age of 73 years, range 49-88) with a conﬁrmed 
diagnosis of NOMI were retrospectively reviewed , randomly and individually 
by two radiologists (with 9 and 3 years’ experience in abdominal imaging, 
respectively) to evaluate mesenteric ﬁndings (mesenteric vessel caliber: 
normal, increased, reduced; fat stranding; ﬂuid; pneumatosis), vessel features 
(diameter of superior mesenteric artery, superior mesenteric vein and inferior 
vena cava), loop ﬁndings (thickness and degree of attenuation of bowel wall; 
content: gasless or dilated; pneumatosis of bowel wall) and ﬁndings of 
peritoneal cavity (ﬂuid and air).
Results: Global mortality was 50% (8/16 patients). The reduction of caliber of 
mesenteric vessels and the paper thin appearance of bowel walls were signiﬁcantly 
associated with higher mortality (p = 0.05 and p = 0.084, respectively).
Conclusion: Considering its characteristic features, the CT evaluation of 
patients with a clinical suspicion of NOMI could be useful to provide possible 
prognostic information.
SS 9.09
MRI in the evaluation of acute abdominal pain
S. Byott1, I. Harris2;  1Manchester/UK, 2Preston/UK
Purpose: To analyse the diagnostic accuracy and efﬁcacy of MRI in the diagnosis 
of patients under the age of 60 years presenting with an acute abdomen.
Material and Methods: A 3-year prospective analysis from January 2009 to 
December 2011 was performed. Patients presenting with acute abdominal 
pain were imaged using MRI when ultrasound was inappropriate or non-
diagnostic. Non-contrast HASTE coronal and axial sequences were performed. 
Patients presenting with renal colic were excluded. A minimum of 6-week 
follow up was made, with correlation between MR ﬁndings and surgical data 
to ascertain diagnostic accuracy.
Results: A total of 92 cases were included in the study. MRI was positive for 
acute surgical pathology in 19 patients and negative in 65, while 8 scans 
demonstrated acute pathology not requiring surgery. In the MR-negative 
group, 59 were discharged without surgery, 6 had negative laparoscopy and 2 
had subsequent readmissions without requiring surgical intervention. In the 
MR-positive group, 17 patients had surgery conﬁrming MR ﬁndings, while 2 
patients were treated conservatively. Nine different types of pathology were 
diagnosed by MRI including appendicitis, abdominal collections, caecal 
volvulus, small bowel obstruction, large bowel obstruction, Crohn’s stricture, 
splenic injury, colitis and pancreatitis. MRI demonstrated a 100% efﬁcacy in 
terms of diagnosis of pathology requiring surgical intervention.
Conclusion: MRI is a safe, readily available and effective way to diagnose 
acute abdomen and should be the investigation of choice for patients of an 
age prone to radiation.
SS 9.05
Parenchymal enhancement in MDCT of the abdomen: 
iso-osmolar versus low-osmolar contrast media
M. Rengo, D. Caruso, D. Bellini, M. Maceroni, C.N. De Cecco, 
M. Osimani, A. Laghi; Latina/IT
Purpose: To evaluate if a noninferior liver and pancreas parenchymal 
enhancement can be obtained injecting an iso-osmolar contrast at a lower 
iodine dose than a low-osmolarity contrast medium.
Material and Methods: A total of 120 patients were prospectively randomized 
into two groups. Group A received 650 mgI/kg of (lean body weight) LBW of 
iodixanol [320]. Group B received 750 mgI/kg of LBW of iomeprol [400]. 
Attenuation values were measured at the level of the aorta, portal vein, liver 
and pancreas parenchyma on unenhanced, portal and equilibrium enhanced 
phases. A noninferiority analysis and analysis of variance (ANOVA) were 
performed to compare the two groups.
Results: A total of 56 patients were included in group A and 57 in group B. No 
signiﬁcant differences were found between the two groups for liver and 
pancreas parenchymal enhancement. Mean liver CEI values for group A and B 
were respectively 51.8 (± 7.8) and 50.4 (± 10.9), during portal phase, and 28.4 
(± 6.7) and 32.8 (± 7.5), during equilibrium phase. Mean pancreas CEIs were 
44.4 (± 7.3) / 42.7 (± 11.6) and 29.1 (± 3.2) / 31.2 (± 8.9), respectively, for portal 
and equilibrium phases. No inferiority, in terms of contrast enhancement, 
resulted for the iso-osmolar CM compared to the low-osmolar one.
Conclusion: According to these results, we assume that a lower amount of 
iso-osmolar CM may be injected to obtain an equal parenchymal enhancement 
of a low-osmolar CM.
SS 9.06
Visceral fat volume and its association with mesenteric 
panniculitis
T. Meulman, N. Van Putte-Katier, O. Elgersma, T.R. Hendriksz; 
Dordrecht/NL
Purpose: Recent studies have improved the understanding of adipose tissue 
and its active role in inﬂammatory mesenteric and intestinal disease. Little is 
known on the role of adipose tissue in the pathophysiology of mesenteric 
panniculitis. The purpose of this study was to determine whether increased 
mesenteric adipose tissue plays a role in mesenteric panniculitis.
Material and Methods: As part of a large hospital-based prevalence study on 
mesenteric panniculitis, a nested case-control study was conducted. A total of 
94 patients (70% male) with mesenteric panniculitis were compared to 94 
individuals matched by gender and age. Total, subcutaneous and visceral fat 
volumes were measured on 10 x 5 mm contiguous CT slices around the level 
of the umbilicus. A fat-density mask was constructed to include pixels with 
attenuation values ranging from -190 -to -30 Hounsﬁeld units.
Results: The mean age of individuals in both groups was 66,6 + 11,2 years. 
Persons with mesenteric panniculitis had a larger total fat volume (mean 2257 
ml vs. 2121 ml, p = 0.038), visceral fat volume (mean volume 1037 ml vs. 923 
ml, p = 0.024) and borderline signiﬁcant higher BMI (26,9 kg/m[2] vs. 26,2 kg/
m[2], p = 0.061). Subcutaneous fat volume was not signiﬁcantly different 
between groups.
Conclusion: Signiﬁcant higher levels of visceral fat exist in patient with 
mesenteric panniculitis compared to individuals without mesenteric 
panniculitis. Further research is necessary to correlate these ﬁndings to the 
endocrine and metabolic functions of visceral fat in mesenteric panniculitis.
SS 9.07
Apparent diffusion coefﬁcient and tumor wall thickness 
in short-term treatment evaluation of gastrointestinal 
cancers: value of early changes on MR imaging
K. Cao, L. Tang, N. Wang, X. Li, Y. Sun, Y. Li, X. Zhang; 
Beijing/CN
Purpose: To assess the early changes of apparent diffusion coefﬁcient (ADC) 
and tumor wall thickness on MRI during treatment of gastrointestinal (GI) 
tumors, and investigate their abilities in short-term treatment evaluation.
Material and Methods: A total of 30 newly diagnosed GI cancer patients who 
subsequently received chemotherapy or chemoradiation therapy were enrolled. 
MR scans were performed before, 1st week and 4-6th week after therapy 
started. Tumor wall thickness and ADC value were measured. Those with 
30% regression in tumor wall thickness post-treatment were regarded as 
good responders. ROC were used to evaluate the abilities of ADC and 
thickness in differentiating good/poor responders.
Results: ADC values increased signiﬁcantly at both early and post-treatment 
points (P < 0.05). Tumor wall thickness showed signiﬁcant decrease at the later 











SCIENTIFIC SESSIONS / THURSDAY, JUNE 14, 2012
 S480




The value of gadobenate dimeglumine-enhanced MR 
imaging with dynamic and hepatobiliary phases in the 
characterization of small (2cm) nodular hepatic arterial 
phase enhancing: only lesions identiﬁed at contrast-
enhanced CT in liver cirrhosis
E. Quaia, L. De Paoli, E. Pantano, B. Cabibbo, M.A. Cova; 
Trieste/IT
Purpose: The purpose of this study was to assess the value of gadobenate 
dimeglumine (Gd-BOPTA)-enhanced MR imaging in the characterization of 
small (2cm) nodular hepatic arterial phase enhancing (HAPE), only lesions 
identiﬁed at contrast-enhanced CT in patients with liver cirrhosis.
Material and Methods: This prospective study was approved by the ethics 
committee and informed consent was obtained from all patients. We recruited 
125 cirrhotic patients (age: 68 ±12.36 years) who revealed up to ﬁve HAPE, 
only nodular lesions (2cm) at contrast-enhanced CT. All patients were 
scanned by MR imaging before and after Gd-BOPTA injection during hepatic 
arterial (HAP), portal venous (PVP), equilibrium (EP), and hepatobiliary phase 
(HP). Lesion characterization was based on MR imaging features considered 
typical for hepatocellular carcinoma (HCC) (n=34), imaging follow-up (n=105), 
or histology (n=12). Two experienced radiologists (5 and 10 years) analyzed the 
MR images in consensus, and multivariable logistic regression was conducted 
to test the signiﬁcance of the MR image ﬁndings with HCC diagnosis.
Results: One hundred ﬁfty-one HAPE-only lesions were identiﬁed, including 
115 benign nodules and 36 HCCs. PVP-EP washout and HP hypointensity not 
combined (OR 263.48, 95% conﬁdence intervals, CIs: 25.14–2761.25; P<.05) 
or combined with T2 hyperintensity (OR 327.43; 95% CIs: 28.19–3802.23; 
P<.05) or HAP hyperintensity (OR 256.43; 95% CIs: 24.49–2685.65; P<.05) on 
multivariable analysis were related to malignancy diagnosis.
Conclusion: Small HAPE-only lesions in cirrhotic patients are mainly benign 
and may be characterized by Gd-BOPTA-enhanced MR imaging.
SS 10.02
C-arm CT tumour-to-liver contrast in patients with HCC: 
intraindividual comparison of three protocols
C. Koelblinger, W. Schima, V. Berger-Kulemann, J. Lammer; 
Vienna/AT
Purpose: The purpose of this study was to compare the effect of three different 
protocols on the tumour-to-liver contrast (TLC) of HCCs using C-arm CT 
(CACT).
Material and Methods: After signed informed consent, 16 patients (15 male, 1 
female; mean age 65 years), treated with TACE for HCC, were included in this 
prospective IRB approved study. Three different CACT protocols were acquired in 
each patient in random order. Therefore, a 5F catheter was placed in the common 
hepatic artery and diluted (100 mg iodine/ml) contrast medium (CM) was injected 
with a ﬂow of 4 ml/s. With the early acquisition, CACT protocol (EA) acquisition, 
which lasted 8 s, started 4 s after the start of contrast medium application (total CM: 
48 ml). With the intermediate acquisition, CACT protocol (IA) acquisition started with 
a delay of 8 s (total CM: 64 ml). With the late acquisition, CACT protocol (LA) 
acquisition started with a delay of 12 s (total CM: 80 ml). One experienced radiologist 
measured the TLC by placing ROIs within the liver parenchyma and the tumor. A 
total of 33 HCCs, which had been proven by pre-interventional MDCT or MRI, were 
evaluated. Univariate analysis of variance was used for statistical analysis.
Results: Mean TLC was 184 HU for EA, 254 HU for IA, and 245 HU for LA. IA 
and LA were signiﬁcantly superior to EA (p<.01).
Conclusion: Compared to 4 s delay, TLC of HCC using CACT is signiﬁcantly 
improved using 8 s or 12 s delay.
SS 10.03
Dual-energy CT for detection of hepatocellular 
carcinoma (HCC) incidentally diagnosed during 
pathological workup in patients with liver cirrhosis after 
liver transplantation
C.M. Sommer, J. Schmoee, T. Longerich, P. Schirmacher,  
M. Mieth, P. Schemmer, N. Bellemann, U. Stampﬂ,  
H.U. Kauczor, B. Radeleff, W. Stiller; Heidelberg/DE
Purpose: The purpose of this study was to quantitatively deﬁne image quality 
of contrast-enhanced dual-energy CT for detection of hepatocellular carcinoma 
(HCC) incidentally diagnosed during pathological workup in patients with liver 
cirrhosis after liver transplantation.
SS 9.10
Abdominal and soft tissue abscess: diagnostic ultility of 
diffusion-weighted MRI in children and young adults
H. Neubauer, I. Platzer, V. Mueller, T. Meyer, J. Liese,  
H. Koestler, D. Hahn, M. Beer; Wuerzburg/DE
Purpose: To evaluate detectability and imaging characteristics of abscess 
formations on diffusion-weighted MRI (DWI) in children and young adults.
Material and Methods: Seventeen patients (11 females, age 13 ± 6 years, 
range 1 - 21 years) with suspected abdominal or soft-tissue abscess underwent 
routine MRI including diffusion-weighted free-breathing single-shot echo 
planar imaging. Seventeen randomly chosen age-matched patients with non-
purulent abdominal free ﬂuid collections served as controls. Mean ADC values 
were measured for abscess, muscle, liver, spleen and kidney tissue as well as 
for various body ﬂuids.
Results: All abdominal (n = 9) and soft tissue (n = 8) ﬂuid collections were 
identiﬁed on diffusion-weighted images. Twelve of 13 conﬁrmed abscess 
formations showed an ADC < 1.0 ×10[-3] mm[2]/s with a mean value of 0.80 ± 
0.38 mm[2]/s. One tuberculous soft-tissue abscess had a higher ADC of 1.85 
×10[-3] mm[2]/s. There were no false-positive ﬁndings in the control group.
Conclusion: Diffusion-weighted MRI reliably detects ﬂuid collections in 
paediatric patients and distinguishes between abscess and non-purulent ﬂuid 
collections. DWI facilitates free-breathing rapid image acquisition without the 
need of i.v. contrast application and constitutes a particularly useful choice in 
paediatric imaging.
SS 9.11
Comparison between opaque and transparent 
distension of the colon in multidetectorCT enteroclysis 
in intestinal endometriosis detection
E. Biscaldi, S. Ferrero, V. Remorgida, G.A. Rollandi;  Genoa/IT
Purpose: To compare the effectiveness of two multidetectorCT enteroclysis 
(MDCTe) protocols, with opaque or transparent distension of the colon, in the 
assessment of nodule detection and in evaluation of intestinal inﬁltration.
Material and Methods: A total of 96 consecutive patients (mean age 28 years), 
with a strong suspicion of deep inﬁltrating endometriosis, were assigned 
alternatively to opaque (48)/transparent (48) colon distension.The intestinal 
preparation and CT protocol were standardised: contrast-enhanced MDCT (64 
rows), portal phase. The opaque distension was performed by retrograde enema 
of tap water (2000 cc) with 80 cc of iodinated contrast (to reach a density of 250-
300 HU), and the transparent distension was done with tap water alone.Two expert 
radiologists, blinded, investigated the intestinal nodule detectability (scoring 
nodules as ‘well’ or ‘not well’ detectable), and the colon (rectum/sigmoid/other 
segments) inﬁltration. The diagnosis of inﬁltration was made on consensus. All 
patients underwent surgery and the results were compared to MDCTe.
Results: Transparent MDCTe: the radiologists in 19/48 patients detected 17 
sigmoid and 10 rectal nodules, 1 sigmoid polyp and 1 cecal lesion. All inﬁltrating 
nodules were scored as ‘well detectable’. At surgery, in 21 positive patients, 
MDCTe missed (3) small serosal nodules not inﬁltrating. Opaque distension 
detected endometriosis in 18 patients, and 15 sigmoid and 9 rectal nodules. Three 
of 24 nodules scored as ‘not well detectable’ were misinterpreted, and 1 sigmoid 
nodule was missed. Sensibility, speciﬁcity, PPV and NPV were: in transparent 
distension 91, 100, 100 and 93%; in opaque distension 82, 100, 100 and 87%. 
The mean X-ray dose was similar in both protocols.
Conclusion: The transparent enteroclysis is more effective in parietal nodule 
detection: the window between hypodense lumen and hyperdense wall highlights 
the detectability of lesions. The hyperdense lumen in opaque distension limits 
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Conclusion: DWI is a useful imaging sequence for detection of HCC in 
cirrhosis. A correct prediction of the grade of HCC is not possible preoperatively 
because of the overlap of the ADC values.
SS 10.06
Single-energy low-voltage arterial phase scanning 
increases conspicuity of hypervascular lesions of the 
liver: an intra-patient study
G.A. Zamboni, M.C. Ambrosetti, E. Zivelonghi, C. Cavedon, 
R. Pozzi Mucelli; Verona/IT
Purpose: The purpose of this study was to compare a intra-patient single-
energy low-voltage arterial-phase protocol and a 120 kV protocol for detecting 
hypervascular focal liver lesions (hFLL).
Material and Methods: 27 patients with chronic liver disease and 1 hFLL 
underwent abdominal MDCT with 80 kV arterial phase (test group) on a 64-row 
scanner. This was compared to a previous 120 kV scan. Mean interscan 
interval was 139 days; lesions were not treated between exams. Scans were 
compared for attenuation and standard deviation in the liver, aorta and largest 
hFLL, image noise, CNR, CTDI and DLP (paired t-test). Effective dose for each 
protocol was estimated with TLD measurements on an anthropomorphic 
phantom.
Results: All scans were of diagnostic quality, according to the reporting 
radiologist. Mean attenuation was signiﬁcantly higher at 80 kV than at 120 kV 
in aorta (501.7±148.3 vs 273.6±82.9 HU), liver (78.5±14.3 vs 60.9±11.9 HU) 
and hFLL (160.0±32.2 vs 107.9±23.2 HU; all p<0.0001). CTDI and DLP were 
signiﬁcantly lower at 80 kV (6.4±0.4 vs 12.96±4.3 mGy and 194.3±27.5 vs 
405.4±117.4 mGy cm, respectively; all p<0.0001). Lesion conspicuity 
(HU~nodule~ -HU~liver~) was signiﬁcantly higher at 80 kV (83.8±35.5 vs 
48.8±21.5 HU; p=0.0008). Mean image noise was signiﬁcantly higher at 80 kV 
(12.3±3.6 vs 8.5±2.4 HU; p<0.0001). Lesion CNR was not signiﬁcantly different 
between the two protocols. Estimated effective dose was signiﬁcantly lower at 
80 kV (0.157 vs 0.201 mSv; p=0.0083).
Conclusion: The use of a 80-kV arterial phase protocol for abdominal CT 
increases conspicuity of hFLL, possibly improving identiﬁcation, while allowing 
signiﬁcant dose reduction.
SS 10.07
Validation of diagnostic criteria using gadoxetic acid-
enhanced and diffusion-weighted MR imaging for small 
HCC (2.0 cm)
S.H. Kim, W.J. Lee, M.J. Park, J. Hwang, M.H. Lee, J.H. Lim; 
Seoul/KR
Purpose: The purpose of this study was to validate usefulness of MRI criteria 
using combined gadoxetic acid-enhanced MRI and diffusion-weighted imaging 
(DWI) for diagnosis of small HCC 2 cm.
Material and Methods: One hundred and eight patients who had pathologically 
proven 102 HCCs and 23 benign nodules (21 dysplastic nodules and 2 
regenerative nodules, 2.0 cm) detected during surveillance with MDCT 
underwent liver MRI including the gadoxetic acid-enhanced imaging and DWI. 
Index MR criteria for HCC were: (1) arterial hyperenhancement and hypointensity 
on hepatobiliary phase (HBP) with/without hyperintensity on DWI; (2) 
hypovascular nodule with hyperintensity on DWI; (3) arterial hyperenhancement 
and either iso- or hyperintensity on HBP, with hyperintensity on DWI and (4) 
hyperintensity only on DWI. According to the MR criteria, MRI ﬁndings for 
HCCs and benign nodules were independently classiﬁed by two reviewers.
Results: On MDCT, 64 HCCs (62.7%) showed typical enhancement pattern for 
HCC. Eighty-three HCCs (82.4%) showed arterial hyperenhancement and 
hypointensity on HBP, and hyperintensity on DWI. For each observer, 101 
(99.0%) and 100 HCCs (98.0%) were discernible with MR criteria, respectively. 
Three dysplastic nodules also ﬁtted into MR criteria, thus speciﬁcity was 
90.9% for both observers. The remaining benign nodules were seen as 
hypointense only on HBP. The kappa value for two observers was 0.904 for 
lesion categorization, indicating excellent inter-observer agreement.
Conclusion: With the proposed HCC criteria based on combined gadoxetic 
acid-enhanced MRI and DWI, it is possible to reliably diagnose HCC  2.0 cm, 
including early hypovascular HCC.
Material and Methods: This prospective study had two inclusion criteria: (I) 
CT examination comprising dual-energy acquisition in the arterial phase (AP-
DEA), and non-enhanced, venous and late phase acquisitions each in single-
energy technique 24 h before liver transplantation, and (II) incidentally 
diagnosed HCCs in explanted livers with hyperdense correlates in AP-DEA. 
Nine patients (8 men; mean age 58.9±7.9 years) with 13 HCCs (mean diameter 
1.6±0.8 cm) were included. Mean MELD score was 10.0±1.3 and mean AFP 
level was 15.0±19.2 IU/ml. From AP-DEA, four datasets were evaluated: 
80kVp, 120kVp-equivalent, optimum-contrast and pure-iodine image datasets. 
Attenuation and image noise of liver parenchyma, HCC, and aorta as well as 
HCC-to-liver-parenchyma contrast-to-noise ratio (CNR) were compared.
Results: For HCC, highest attenuation and image noise was found in 80kVp 
datasets, and lowest in pure-iodine datasets (147.8±33.1 HU vs. 56.6±26.7 HU 
[P<0.001] and 21.6±6.2 HU vs. 9.0±4.3 HU [P<0.001]). For HCC, attenuation 
was signiﬁcantly higher in optimum-contrast compared to 120kVp-equivalent 
datasets (123.2±30.7 HU vs. 108.2±21.3 HU [P<0.001]). HCC-to-liver-
parenchyma CNR was signiﬁcantly higher in pure-iodine and optimum-contrast 
datasets compared to 80kVp datasets (5.2±3.2 and 4.0±2.3 vs. 2.6±1.4 [both 
P<0.001]). CNR was signiﬁcantly higher in pure-iodine compared to 120kVp-
equivalent datasets (5.2±3.2 vs. 3.3±1.9 [P<0.001]).
Conclusion: Combination of optimum-contrast and pure-iodine datasets 
demonstrated best quantitative image quality for detection of HCC.
SS 10.04
Differentiating mass-forming intrahepatic 
cholangiocarcinoma from atypical hepatocellular 
carcinoma using gadoxetic acid-enhanced MRI
Y. Chong, W.J. Lee, S.H. Kim, H. Rhim, M.J. Park, J.H. Lim, 
H.J. Park; Seoul/KR
Purpose: The purpose of this study was to examine the differential features of 
mass-forming intrahepatic cholangiocarcinoma (ICC) from atypical hypovascular 
hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MRI.
Material and Methods: IRB approved this retrospective study and waived 
informed consent. Seventy patients with pathologically proven ICCs (35) and 
hypovascular atypical HCCs (35) who had undergone preoperative gadoxetic 
acid-enhanced MRI were enrolled. Images were analyzed as to the shape of 
the lesions and the presence of hyperintensity on the T1-weighted image 
(T1WI) and hypo- or hyperintense areas on the T2-weighted image (T2WI). In 
addition, images were analyzed as to the presence of linear hyperintensity or 
multifocal tiny hyperintense foci on T2WI and the presence of rim enhancement 
during early dynamic phases and a central enhancement with hypointense rim 
(target appearance) on 10-min and 20-min hepatobiliary phase image. The 
signiﬁcance of these ﬁndings was determined by the X[2] test.
Results: Univariate analysis revealed that the following signiﬁcant parameters 
favor ICC or hypovascular HCC: Presence of T2 hypo- and hyperintense areas 
and target appearance on the 10-min hepatobiliary phase for ICC; presence of 
T2 linear hyperintensity and multifocal hyperintense foci for hypovascular HCC 
(P<0.05). Multivariate analysis revealed that only target appearance on 10-min 
hepatobiliary phase was predictive of ICC (P=0.002, 85.7%). However, the 
target appearance was also observed in all six scirrhous HCCs.
Conclusion: Target appearance on 10-min hepatobiliary phase is the best 
predictor for identifying mass-forming ICC on gadoxetic acid-enhanced MRI.
SS 10.05
Comparison of diffusion-weighted imaging with dynamic 
contrast enhanced MRI for detection of HCC in cirrhosis
N. Kalra, S. Shankar Mp, P. Singh, R. Srinivasan, A. Duseja, 
Y. Chawla, N. Khandelwal; Chandigarh/IN
Purpose: The purpose of this study was to compare diffusion-weighted 
imaging (DWI) with dynamic contrast-enhanced MRI (DCEMRI) for detection of 
HCC in cirrhosis using a 3-T MRI scanner.
Material and Methods: 20 consecutive cirrhotics with focal liver lesions on 
US were enrolled. Patients underwent MRI which included T1-, T2-weighted 
imaging, DCEMRI, and axial DWI (b values 0, 100, 500 and 1000 mm[2]/sec). 
Two radiologists independently evaluated the DWI and DCEMRI and were 
blinded to each other. Average apparent diffusion coefﬁcient (ADC) values 
were calculated from the lesions. Findings on DCEMRI were taken as the gold 
standard. FNA was taken from the lesions seen on DCEMRI.
Results: DWI had a sensitivity of 95% (CI 95%), accuracy of 95% and positive 
predictive value of 100%. There was high degree of agreement (kappa value= 
0.898) between DWI and DCEMRI. ADC values of well, moderately and poorly 
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SS 10.10
Usefulness of gadoxetic acid (Gd-EOB-DTPA, Primovist) 
in the detection and characterization of indeterminate 
liver nodules in cirrhotic patients studied with 
gadobutrol (Gd-DTPA, Gadovist)
E. Ballesteros, D. Gil-Bello, J. Martin, M.J. Prieto, M. Solà, 
A. Malet, J. Puig; Sabadell/ES
Purpose: The purpose of this study was to evaluate the usefulness of Gd-
EOB-DTPA (Primovist[R]) in the detection and characterization of indeterminate 
liver nodules in cirrhotic patients studied with Gd-DTPA (Gadovist[R]).
Material and Methods: 19 patients (13 men, 6 women; mean age: 65 years) 
with 28 liver nodules classiﬁed as indeterminate on gadobutrol-enhanced MRI 
studies underwent gadoxetic acid-enhanced MRI. The diagnosis was reached 
by biopsy (n=17) and/or by imaging characteristics (n=11). Nodules were 
classiﬁed as hypointense, isointense or hyperintense in the portal venous 
phase in gadobutrol-enhanced MRI studies and in the hepatobiliary phase in 
gadoxetic acid-enhanced MRI. We correlated the signal intensity in the 
hepatobiliary phase with the diagnosis and compared the number of nodules 
detected with the two techniques, both overall and in the portal venous phase 
in gadobutrol studies versus in the hepatobiliary phase in gadoxetic acid 
studies. Student’s t-tests and Chi-square tests were used for different 
variables, as appropriate.
Results: The nodules (mean size: 14 mm) were hepatocellular carcinomas 
(HCC, n=17), dysplastic nodules (DN, n=10) and an adenocarcinoma (n=1). We 
found no relation between the signal intensity of the nodules in the hepatobiliary 
phase in gadoxetic acid studies and the diagnosis. More lesions were detected 
in the hepatobiliary phase of gadoxetic acid studies (n=32) than in the portal 
venous phase of gadobutrol studies (n=9, p<0.05).
Conclusion: Gadoxetic acid-enhanced MRI does not differentiate between 
HCC and DN, but it detects more lesions than gadobutrol-enhanced MRI.
SS 10.08
Liver perfusion CT for noninvasive assessment of 
response to sorafenib therapy in patients with advanced 
HCC: preliminary ﬁndings
L. Faggioni, P. Vagli, F. Pancrazi, R. Sacco, E. Neri,  
C. Bartolozzi;  Pisa/IT
Purpose: The purpose of this study was to assess treatment response to 
sorafenib therapy in patients with advanced HCC by means of perfusion CT 
(pCT).
Material and Methods: Ten patients with a total of 16 previously diagnosed 
HCC underwent liver pCT immediately before the beginning of sorafenib 
therapy and one month thereafter. pCT was carried out on a 64-row CT scanner 
(LightSpeed VCT, GE Healthcare, Milwaukee, WI) with a 4-cm longitudinal 
coverage on the target lesion. Using dedicated software, regions of interest 
were traced inside the HCC and in the surrounding liver parenchyma, and the 
following perfusion parameters were computed: blood ﬂow (BF), blood volume 
(BV), mean transit time (MTT), hepatic arterial fraction (HAF), and permeability-
surface product (PS). Serum alpha-fetoprotein levels (FP) were also measured 
immediately prior to each pCT scan.
Results: Baseline BF, BV, HAF, and PS were signiﬁcantly higher, and MTT 
values were signiﬁcantly lower in HCC lesions than in the surrounding liver 
parenchyma (p<0.01). At 1-month pCT follow up, in all patients, FP was 
signiﬁcantly reduced at baseline, while MTT values were signiﬁcantly higher 
(8.98±2.86 vs 5.15±1.87 seconds, p=0.0097). A statistically signiﬁcant inverse 
correlation was also found between baseline MTT and post-treatment FP 
reduction (r=-0.6685, p=0.0125).
Conclusion: In patients with advanced HCC under sorafenib therapy, MTT 
prolongation at 1-month pCT follow up can be used as a marker of biochemical 
treatment response. Baseline MTT could predict treatment response in patients 
candidate to sorafenib therapy.
SS 10.09
Measurement of CT attenuation of various tumor 
portions in Lipiodol-retaining hepatocellular carcinomas 
on CT images of low and high tube voltages: usefulness 
of dual energy CT
W.J. Lee, S. Shin, S.B. Shin, J. Kim; Seoul/KR
Purpose: The purpose of this study was to determine usefulness of DECT in 
detecting viable tumor portion (VTP) in Lipiodol-retaining HCCs by measuring 
CT attenuation of various TPs including VTP, necrotic TP (NTP), and Lipiodol-
retaining TP (LTP) on CT images of low and high tube voltages.
Material and Methods: Thirty HCC patients treated with TACE, who had 
suspected VTP clinically and underwent follow-up DECT, formed our study 
population. Three-phase DECT was performed with Somatom Deﬁnition Flash, 
of which HAP was obtained 18 sec after peak aortic enhancement (300 mgI/
mL, 0.6 g/kg, 30 sec injection duration). HU of ﬁve groups (19 VTPs, 14 NTPs, 
22 LTPs, 30 livers, and 30 aortas) was measured on HAP images of 80 kVp and 
140 kVp. Attenuation ratio (AR=HUs of 80 kVp/HUs of 140 kVp) of these groups 
was calculated.
Results: HUs of LTP, aorta, VTP, liver, and NTP on HAP images of 80 versus 
140 kVps were 2328.35±574.31 versus 963.12±405.11, 516.65±70.63 versus 
206.95±24.75, 199.57±54.93 versus 99.07±18.03, 91.05±17.14 versus 
70.55±8.77, and 52.22±18.72 versus 44.89±14.97, and corresponding ARs 
were 2.56±0.41, 2.49±0.06, 1.99±0.25, 1.29±0.15, and 1.16±0.14. All ARs 
were different with statistical signiﬁcance (p<0.001) except two occasions (LTP 
vs. aorta and liver vs. NTP). All ARs of VTPs were above 1.54, while those of 
NTPs were below 1.41.
Conclusion: ARs were related to iodine contents of each group, and particularly 
VTP was successfully differentiated from NTP using AR. Accordingly, DECT 
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SS 11.03
Detection of colorectal cancer at CT colonography
P. Simons1, L. Van Steenbergen2, M. De Witte1,  
M. Janssen-Heijnen1;  1Venlo/NL, 2Eindhoven/NL
Purpose: CTC is a less burdensome alternative for colonoscopy in excluding 
colorectal cancer (CRC) in symptomatic patients. We evaluated the proportion 
of patients who underwent CTC in whom CRC was missed.
Material and Methods: Patients who underwent CTC in the VieCuri Medical 
Centre, Venlo, The Netherlands, in the period 1-1-2007 to 1-1-2011 were 
merged with all cases of CRC recorded in the population-based Eindhoven 
Cancer Registry between 1-1-2007 and 1-7-2011 to identify all patients who 
had undergone CTC less than 2 years before CRC has been diagnosed. A 
missed cancer was deﬁned as a patient being diagnosed with CRC, whereas 
suspicious colonic mass, indeterminate lesion or polyp >1 cm was not found 
in the CTC report.
Results: In 53 out of 1857 patients who underwent CTC, CRC was diagnosed. 
Of these, 40 patients were suspected for CRC and 5 patients were diagnosed 
with large polyps on CTC. In 5 patients with an indeterminate mass, further 
investigation conﬁrmed malignancy. One cancer in the coecum was missed 
because of poor distension. Two cancers, one located in the distal rectum and 
one in the ascending colon, were missed. Sensitivity of CTC for CRC was 94% 
(95% CI 88-100%). The true miss rate, excluding the inadequate distended 
study, was 2 out of 53 (3.8%).
Conclusion: This study shows that the miss rate for CTC is low, which means 
that CTC is accurate in excluding CRC.
SS 11.04
Comparison study of 2-day versus 4-day limited bowel 
preparation regimens for fecal-tagging CT colonography
K. Meric, N.U. Bakal, E. Yencilek, G. Kilicoglu, M.M. Simsek, 
O. Cakir;  Istanbul/TR
Purpose: The aim of this study was to compare tagging efﬁcacy and the 
amount of residual stool and residual ﬂuid in 2-day versus 4-day limited bowel 
preparation regimens using barium-based fecal-tagging agent in incomplete 
conventional colonoscopy patients.
Material and Methods: Sixty consecutive patients were prospectively enrolled 
and randomly divided into 2-day and 4-day low-residue diet groups. We used 
barium sulfate suspension for fecal tagging and Bisacodyl for stool softening. 
Two radiologists graded residual stool (5=< >=6 mm and 1:none/scattered to 
4:>50% circumference), residual ﬂuid (1:no ﬂuid to 4:>50% AP diameter) and 
tagging efﬁcacy for stool (1:untagged to 5:100% tagged) using a system 
adapted from Taylor et al. Following CTC, a questionnaire was administered for 
investigating patient experience of the reduced laxative tagging regimen. 
Statistical analysis was performed between 2 groups using the Mann-Whitney 
U test.
Results: There was no signiﬁcant difference between 2-day and 4-day 
preparation group for residual stool, residual ﬂuid and fecal tagging efﬁcacy. In 
all patients, there was statistically difference for residual stool and residual ﬂuid 
between right hemi-colon and left hemi-colon.The fecal tagging efﬁcacy was 
87.6% for >=6 mm residual stool in all colonic segments. Patient acceptability 
in 2-day preparation was higher than 4-day preparation.
Conclusion: Two-day limited bowel preparation regimen for fecal-tagging 
CTC offers the patient a well-tolerated preparation and improves high fecal-
tagging efﬁcacy.
SS 11.05
CTC after fecal tagging: comparison between supine-
only and prone/supine approach
D. Caruso1, M.M. Maceroni1, F. Vecchietti1, D. Bellini1,  
M. Rengo2, A. Laghi1;  1Latina/IT, 2Rome/IT
Purpose: The purpose of this study was to retrospectively compare double 
prone/supine scans and single supine scan in a population of patients prepared 
with fecal tagging and to evaluate the feasibility of performing CTC studies 
only on the supine scan.
Material and Methods: Two radiologists in consensus evaluated only the 
supine scans of 20 patients, with 30 endoscopically proved polyps (from 6mm 
to 12mm), chosen from our database. After one month, prone and supine 
scans of the same dataset were evaluated. All patients were prepared for CTC 
with a dedicated low-residue diet. Fecal tagging was performed by the oral 
administration of a ﬁxed amount of 200 ml of Gastrograﬁn at major meals 
starting three days before the examination. We evaluated sensitivity, speciﬁcity 
and mean reporting time for the two approaches.
11:00 - 12:30 Pentland
Scientiﬁc Session 11
CT Colonography 2 - Technical performance
SS 11.01
Detection of extracolonic pathology by CT colonography 
in symptomatic patients: clinical consequences and 
outcomes versus colonoscopy or barium enema: 
multicentre randomised controlled trial
S. Halligan1, K. Wooldrage1, E. Dadswell1, C. Von Wagner1, 
C. Kay2, J. Wardle1, R. Lilford3, W. Atkin1, T. Siggar 
Investigators1;  1London/UK, 2Bradford/UK, 3Birmingham/UK
Purpose: CT colonography (CTC) simultaneously examines the colorectum 
and extracolonic organs. We performed a multicentre randomised controlled 
trial to quantify the frequency and clinical consequences of extracolonic 
ﬁndings.
Material and Methods: 8484 symptomatic patients referred for barium enema 
or colonoscopy were registered at 21 centres. 5384 eligible patients were 
consented and randomised to CTC or default in a 1:2 ratio. We determined the 
frequency of extracolonic ﬁndings, number and nature of subsequent 
investigations, and ultimate diagnosis. Extracolonic cancers were matched 
with national registries.
Results: 1748 CTC examinations were analysed: 1042 (59.6%) had 1 
extracolonic ﬁnding (1,945 individual ﬁndings), rising with age (p<0.0001). 149 
patients (8.5%) underwent subsequent investigation, 52 of whom (34%) 
underwent multiple procedures, 32 (21.5%) underwent surgery. 79 extracolonic 
neoplasms were diagnosed, 29 malignant. Overall, neoplasia was diagnosed 
in 79 (4.5%) patients having CTC, malignant in 29 (1.7%). Positive predictive 
value of symptoms for extracolonic disease was low. The proportion of patients 
diagnosed with extracolonic cancers or dying did not differ signiﬁcantly 
between procedures within 3 years of randomisation. 14 (0.8%) patients had 
extracolonic abdomino-pelvic cancer diagnosed within 3 years of apparently 
normal CT colonography.
Conclusion: Most symptomatic patients have extracolonic ﬁndings on CTC, 
approximately 2% malignant. Surprisingly, offering CTC as a primary procedure 
does not signiﬁcantly increase the proportion of patients diagnosed with 
extracolonic malignancy at 3 years when compared with colonoscopy or 
barium enema.
SS 11.02
Preliminary 2D reading of CTC studies on the iPad2®: 
comparison with a conventional desktop workstation
L. Faggioni, E. Neri, P. Vagli, S. Angeli, L. Cini, E. Picano,  
D. Caramella, C. Bartolozzi; Pisa/IT
Purpose: The purpose of this study was to evaluate the effectiveness of the 
iPad2[®] as a mobile device for 2D reading of CTC datasets.
Material and Methods: We retrospectively reviewed 37 CTC examinations 
performed in a colorectal cancer screening setting, for a total of 68 polyps 
sized between 5 mm and 26 mm. All datasets were wirelessly imported in 
DICOM format on an iPad2[®] 64GB (Apple Inc, Cupertino, CA) running OsiriX 
HD[®] (www.osirix-viewer.com) from a Macintosh desktop computer (iMac[®] 
3.06GHz) connected to our hospital PACS and running OsiriX 4.0. Two 
experienced raters read CTC datasets independently on the iMac[®] and on 
the iPad2[®]. Detection rate and segmental localization of lesions were 
recorded for each CTC dataset as well as the time needed for complete 
reading of each CTC examination. Image quality was also visually assessed 
using a three-point scale (1=poor, 2=fair, 3=good).
Results: All lesions detected on the iMac[®] were also identiﬁed on the 
iPad2[®], and their segmental localization was correctly assessed in 100% of 
cases. Image quality was good with both devices, while image reading time 
was longer on the iPad2® than on the iMac[®] (6.24±2.32 vs 4.06±2.28 
minutes, respectively [mean±standard deviation], p<0.05).
Conclusion: The iPad2[®] allows to effectively display all colonic lesions 
detected on the iMac[®], at the expense of a longer image reading time, 
suggesting that the iPad2[®] is more suitable for preliminary 2D reading than 
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SS 11.08
Computer-aided detection (CAD) for CT colonography: 
incremental beneﬁt for inexperienced over experienced 
readers
D. Boone1, S. Halligan1, S. Mallett2, O. Hrydziuszko2,  
J. McQuillan1, S.A. Taylor1, D. Altman2;  1London/UK, 2Oxford/UK
Purpose: Computer-assisted detection (CAD) is known to be useful for both 
inexperienced and experienced readers of CT colonography (CTC). We aimed 
to quantify the incremental beneﬁt for inexperienced over experienced 
readers.
Material and Methods: 16 experienced (mean 264 validated cases) and 10 
inexperienced radiologists read 102 individual CTC cases (56 with polyps), 
with and without CAD assistance, with temporal separation between 
interpretations. Diagnostic accuracy was determined via comparison to a joint 
endoscopic/radiological reference standard. The primary outcome was a per-
patient analysis of the change in polyp sensitivity + speciﬁcity with/without 
CAD (all polyp diameters; weighted 3:1 in favour of sensitivity), adjusted for 
prevalence. Meta-analysis was used to average across the two reader groups. 
500 bootstraps were used to calculate 95% conﬁdence intervals for this 
abstract; 1999 will be presented.
Results: The difference between inexperienced and experienced readers was 
8.6 (95%CI 0.6, 16.9): % change in sensitivity with CAD was 14.3 (7.0, 20.8) for 
inexperienced, 4.7 (0.2, 9.4) for experienced. % change in speciﬁcity was -5.8 
(-11.3, -0.7) for inexperienced, -2.8 (-5.7, 0.4) for experienced. The incremental 
beneﬁt for inexperienced readers was greatest for 6mm+ polyps; 12.53 (5.07, 
19.7) versus experienced readers.
Conclusion: Both inexperienced and experienced readers beneﬁt signiﬁcantly 
from CAD. Overall, the incremental beneﬁt for inexperienced readers is 
approximately 4x that for experienced readers. This appears to be because 
inexperienced readers are relatively poorer at detecting polyps 6 mm or 
larger.
SS 11.09
Computer-aided detection (CAD) for CT colonoscopy: 
polyp size estimation and clinical patient categorization
G. Iussich1, L. Correale2, C. Senore2, N. Segnan2,  
D. Campanella1, C. Laudi1, G. Galatola1, D. Regge1;  
1Candiolo/IT, 2Turin/IT
Purpose: The purpose of this study was to compare polyp size measurement 
as determined by CAD-assisted CTC interpretation with endoscopic 
visualization.
Material and Methods: We performed a secondary analysis of a prospective 
trial comparing diagnostic performance of ﬁrst and second reader CAD (CAD1 
versus CAD2) where FOBT positive patients underwent both CTC and 
colonoscopy. Polyps size was measured on 2D images for CAD2 and CAD1, 
and at CC with open biopsy forceps. Agreement was evaluated using 
descriptive statistics and Bland-Altman methodology.
Results: Colonoscopy found 285 all size lesions in 125 patients (reference 
size: 2-100 mm). Of these, 145 were found by CAD2 and 129 by CAD1. There 
was no signiﬁcant difference between colonoscopy and CTC size estimation 
both for CAD2 (mean difference: -0.23 mm, P=0.4) and CAD1 (mean difference: 
-0.6 mm, P=0.2). Intervals of agreement between colonoscopy and CTC were 
(-6.5; 6.5-mm) for CAD2 and (-5.4; 5.4-mm) for CAD1. When simulating a 3-risk 
classes (polyps > 9 mm, referral to colonoscopy; polyps 6-9 mm, CTC 
surveillance and polyps < 6 mm, not reported), 10-18% of patients with 
advanced adenomas at colonosopy were placed into the surveillance class. 
Preview and ﬁnish
Conclusion: For both CAD reading modes, CTC polyp size was not different 
from colonoscopy reference size. However, stratifying patients into 3-risk 
classes, 10-18% of patients with advanced adenoma could have polypectomy 
delayed at least 3 years.
SS 11.10
Computed-aided detection software in CT 
colonography: effect in training of novice readers
D. Bellini, D. Caruso, M. Rengo, F. Vecchietti, M. Maceroni, 
A. Laghi; Latina/IT
Purpose: The purpose of this study was to evaluate the inﬂuence of computer-
aided detection (CAD) in the learning process of ﬁve inexperienced readers, 
using 3D ﬂy-through as ﬁrst approach.
Material and Methods: We retrospectively selected 50 patients, all positive 
for polypoid lesions, for a total of 150 polyps endoscopically conﬁrmed, with a 
diameter between 6 mm and 40 mm (mean diameter 8.6 mm). Five doctors 
with any previous experience in CT colonography reading were enrolled. 
Results: All patients with optimal distention and tagging on both supine and 
prone scans and negative for polyps could be evaluated on supine scans only. 
In the four patients positive for polyps at supine scan, the combined evaluation 
of prone scan was necessary in order to improve lesion conspicuity.
Conclusion: Performing CTC only on supine position seems to be a feasible 
approach, in patients prepared with fecal tagging and with good colonic 
distention and with negative ﬁndings. This will reduce the dose to the patients 
and the reporting time.
SS 11.06
The use of sodium picosulphate to prepare the patient 
for CT colonography
I. Lefere1, M. Lefere1, P. Lefere2, S. Gryspeerdt2, C. Silva3,  
A. Rodrigues3;  1Leuven/BE, 2Hooglede/BE, 3Funchal/PT
Purpose: The purpose of this study was to assess the efﬁcacy of a CTC 
preparation based on sodium picosulphate.
Material and Methods: 510 patients undergoing CTC and optical colonoscopy 
were prepared with 2 days of a low residue diet, augmented the day before 
CTC with a clear liquid diet, fecal tagging and cleansing with sodium 
picosulphate and bisacodyl. Quality of preparation was assigned a score 1-3: 
score 1, failed preparation with non-tagged stool hampering interpretation; 
score 2, non-tagged or inhomogeneous stool making primary 3D read difﬁcult, 
but not hampering 2D interpretation; score 3, clean colon with homogeneous 
tagging allowing primary 3D interpretation. Per-patient sensitivity, speciﬁcity, 
positive (ppv) and negative (npv) predictive values with 95% conﬁdence 
intervals (95%CI) were calculated for lesions  6 mm.
Results: This preparation enabled primary 3D read in the majority of patients. 
On the same day, optical colonoscopy was performed in all patients without 
additional preparation. Score 1 was assigned to 9 patients (1.8%), score 2 to 
40 patients (7.8%) and score 3 to 461 patients (90.4%). Non-tagged stool 
caused a false positive 6mm in 3 patients. For all lesions  6 mm, CTC 
obtained a per-patient sensitivity, speciﬁcity, ppv and npv of 95.6% (87-98.9% 
95%CI), 93.9% (91.1-95.9% 95%CI), 71.7% (61.2-80.4% 95%CI), and 99.3% 
(97.7-99.8% 95%CI), respectively. CTC diagnosed all patients with advanced 
neoplasia  6mm. There were no major side effects.
Conclusion: This preparation based on fecal tagging and sodium picosulphate 
proved successful for polyp detection.
SS 11.07
Effect of training, experience and computer-aided 
detection (CAD) on CT colonography interpretation
G. Iussich1, L. Correale2, P. Falco2, C. Senore2, N. Segnan2, 
D. Campanella1, F. Iafrate3, E. Neri4, A. Laghi5, D. Regge1;  
1Candiolo/IT, 2Turin/IT, 3Rome/IT, 4Pisa/IT, 5Latina/IT
Purpose: The purpose of this study was to assess performance of radiologists 
using a double reading with CAD as a ﬁrst reader (DR CAD-FR) after a 2-day 
speciﬁc training program and to correlate readers performance with their level 
of experience in CT colonography (CTC).
Material and Methods: 12 radiologists entering the educational training had 
different levels of experience (>300 studies, very experienced; 100-300, 
moderately experienced; <100, inexperienced). During the course, 46 training 
cases were interpreted and discussed by experts. Day 3 was dedicated to a 
ﬁnal test including 30 cases read using DR CAD-FR (only CAD-prompts 
evaluation followed by unassisted review for mass detection). Per-patient and 
per-polyp sensitivity and speciﬁcity were calculated. Receiver operating 
characteristic (ROC) curve was generated for each reader. Relationship 
between prior experience in CTC and correct case classiﬁcation were assessed 
using logistic regression statistics.
Results: 14/30 cases were positive. There were a total of 24 polyps6-mm. 
CAD sensitivity was 88% (21/24); there was an average of 11 false positives 
per scan. Across all readers, per-patient sensitivity was 75% (95% CI: 68-
81%). Reader speciﬁcity ranged from 75 to 100%. ROC curve values varied 
between 0.79 and 0.98. Average per-polyp sensitivity was 58% (range: 29-
75%). Per-polyp sensitivity of very experienced readers was signiﬁcantly 
greater than that of moderate experienced readers (P=0.04) and low 
experienced readers (P=0.03).
Conclusion: A 2-day structured training probably does not reduce performance 
gap between very experienced and less experienced readers. Additional 
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Conclusion: The increase of mean tumor ADCs correlates with good response 
to CRT; tumor response more likely occurs in pts who report higher LPI values 
on D-CE-MR analysis during treatment with respect to pre-treatment.
SS 12.03
Comparison of diffusion-weighted imaging MR and 
FDG-positron emission tomography for the prediction of 
pathologic response  to neoadjuvant therapy in patients 
with locally advanced rectal cancer
D. Ippolito, P.A. Bonafﬁni, L. Monguzzi, C. Trattenero,  
C. Capraro, S. Sironi; Monza/IT
Purpose: The purpose of this study was to evaluate the correlation between 
the changes of SUVmax and of apparent diffusion coefﬁcient (ADC) before and 
after neoadjuvant therapy, in order to predict therapy response in patients with 
locally advanced rectal cancer (LARC).
Material and Methods: Thirty patients with LARC who underwent CRT were 
recruited for our study. All patients underwent a whole body 18FDG-positron 
emission tomography (PET)/CT scan and a pelvic MR examination including 
diffusion-weighted imaging (DWI) for staging (PET/CT1RM1) and after the 
chemoradiation therapy (PET/CT2RM2). Histopathologic analysis of rectal 
specimen, according to Tumour Regression Grade (Mandard’s criteria), was 
used as standard reference. MR and PET-CT images were analyzed and 
measurements of ADC values and SUVmax were performed. Diagnostic 
performance for selection of complete responders (TRG 1-2) and overall 
diagnostic accuracy for each item were calculated.
Results: After neoadjuvant therapy, all patients were submitted to surgery. 
According to Mandard’s criteria, 21 tumors showed complete (TRG1) or 
subtotal regression (TRG2) and were classiﬁed as responders; 9 tumors were 
classiﬁed as non-responders (TRG 3, 4 and 5). In all patients, mean value of 
SUVmax in PET/CT1 was higher than those of PET/CT2 (p<0.001), whereas 
mean ADC value was lower in RM1 than RM2 (p<0.001) with a signiﬁcant 
percentage decrease of values after the treatment (p<0.005). The best 
predictors’ cut-off values for TRG response were: SUVmax of 4.4 and ADC of 
1.28x10[3]mm[2]/s, with sensitivity, speciﬁcity, accuracy, negative predictive 
value, and positive predictive value of 77.3%, 88.9%, 80.7%, 61.5%, and 
94.4%, respectively.
Conclusion: MR DWI and FDG-PET/CT have a complementary diagnostic role 
in follow up of patients with LARC who underwent chemoradiation therapy, by 
differentiating ﬁbrosis from viable tumor tissue.
SS 12.04
Comparison between diffusion-weighted-based 
volumetry and apparent diffusion coefﬁcient in the 
assessment of response in patients with rectal cancer 
treated with neo-adjuvant therapy
S.F. Carbone, M. Palumbo, V. Ricci, T. Carfagno, S. Lazzi,  
L. Pirtoli, L. Volterrani; Siena/IT
Purpose: The purpose of this study was to assess the diagnostic accuracy of 
volumetry based on diffusion-weighted imaging (VDWI) and apparent diffusion 
coefﬁcient (ADC) in the evaluation of response in patients with rectal cancer 
treated with chemoradiotherapy (CRT).
Material and Methods: We retrospectively examined 25 patients (mean age 
67.8 years) with rectal cancer, who have performed MRI before and after 45 ± 
15 days of the CRT after undergoing anterior resection of the rectum. After 
surgery, ypTN and tumor regression grading (TRG) according to Mandard 
classiﬁcation were obtained. We considered responders’ patients with TRG 
1-2 or with a negative follow-up recurrence in the next 6 months (only three 
cases). Two radiologists, in consensus and using commercial software, have 
extrapolated pre- and post-CRT VDWI of the lesions and calculated the ADC.
Results: ADC did not show signiﬁcant differences between responders and 
non-responders (p = 0.078 pre-CRT, p = 0.101 post-CRT); the VDWI of 
responders was signiﬁcantly lower in both pre-CRT (p = 0.0065) and in post-
CRT (p = 0.0058) compared to non-responders of VDWI. The accuracy in the 
evaluation of response was of 68% and 92%, respectively, for the ADC and 
VDWI.
Conclusion: The VDWI is more reliable than to assess the response to CRT in 
patients with rectal cancer.
Each reader examined the same case, at ﬁrst, without CAD, and after two 
months, to reduce the recall bias, assisted by the analysis software CAD. For 
each reader, either for the ﬁrst or the second reading, ﬁve testing sessions over 
2 weeks were set up, each one with 10 exams for a total of 30 polyps per 
session. For each polyp, readers expressed the degree of diagnostic 
conﬁdence. After all, we performed per-polyp analysis including calculation of 
detection and false-positive rates.
Results: Polyps detection rate calculated from all reader and for all analysis, 
race from 69% (without CAD) to 81% (with CAD, P value< 0.05). Using 
McNemar test to compare single analysis session, with and without CAD, no 
statistically signiﬁcant differences were found (P value >0.05).
Conclusion: CAD software increases polyp detection rate and, for novice 
readers, seems to reduce the number of false positives. However, the curves 
obtained from analysis with and without CAD show similar shape (CAD does 
not change the learning curve).
11:00 - 12:30 Fintry
Scientiﬁc Session 12
GI tract malignancy: treatment response
SS 12.01
The predictive value of ultrasound elastography to 
response in patients with rectal cancer treated with 
chemoradiation
S.R. Rafaelsen, C. Vagn-Hansen, T. Sørensen, J. Lindebjerg, 
J. Pløen, A. Jakobsen; Vejle/DK
Purpose: The current literature has described several predictive markers in rectal 
cancer patients treated with chemoradiation, but so far none have been validated 
for clinical use. The purpose of the present study was to compare quantitative 
elastography based on ultrasound measurements in the course of chemoradiation 
with tumour response based on the Mandard classiﬁcation (TRG).
Material and Methods: From April 2010 to October 2011, we prospectively 
examined 24 patients with rectal cancer planned for high-dose 
radiochemotherapy. Surgery was performed after the end of treatment. A 
baseline ultrasound elastography scan was performed prior to chemoradiation 
and followed by re-scan two and six weeks after initiation of the treatment. The 
elastography shear wave velocity was compared to the TRG score.
Results: The baseline mean tumour elasticity was 3.12 m/s (95% CI: 2.9–3.4). 
Two and six weeks after start of chemoradiation, the velocities were 2.21 m/s 
(95% CI: 1.9-2.5) and 1.97 m/s (95% CI: 1.7-2.2), respectively, p < 0.0001. 
Patients with a tumour TRG 1 response had a tumour elasticity of 2.37 m/s 
(95% CI: 1.8–2.9) after six weeks. In patients with TRG > 1, the velocity was 
1.76 m/s (95% CI: 1.3–2.2) after six weeks, p < 0.05.
Conclusion: Ultrasound elastography seems to hold predictive information as 
to response to chemoradiation. It also seems able to identify scar tissue after 
treatment.
SS 12.02
DW-MRI and D-CE-MR: evaluation of the response in 
rectal cancer before, during and after neoadjuvant 
treatment
R. Del Vescovo, R. Cazzato, F. Giurazza, R.F. Grasso,  
B. Beomonte Zobel; Rome/IT
Purpose: The purpose of this study was to evaluate the response of rectal 
adenocarcinoma to chemoradiation therapy (CRT) calculating changes of apparent 
diffusion coefﬁcients (ADCs) before, during and after treatment and to correlate 
with the changes of dynamic contrast-enhanced MR (D-CE-MR) values.
Material and Methods: We enrolled 25 patients (pts) with primary rectal 
carcinoma who were undergoing preoperative CRT. DWI and D-CE-MR were 
performed with a 1.5-T system in all patients before, during and after 
preoperative CRT. All patients underwent histopathologic postoperative 
staging. ADC values were calculated through the speciﬁc formula, while tumor 
perfusion was calculated by a semiquantitative perfusion software (DYCHO), 
developed on Matlab. We evaluated the changes of ADCs and D-CE-MR 
dividing patients into two groups: not-downstaged group (not-responders, NR) 
and downstaged group (responders, R) at histologic postoperative staging.
Results: 6 patients were NR while 19 patients were R. Pretreatment ADC 
values were signiﬁcantly low; we observed a progressive increasing of ADC 
values during treatment in R, while there was no signiﬁcant ADCs increase in 
the NR (p = 0.003). The R showed 48% increase of local peak intensity (LPI) 
with respect to LPI before treatment; on opposite, the NR showed 18% 
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Material and Methods: 40 patients with locally advanced rectal cancer who 
were treated with chemoradiation (CRT) and surgery were included. T2-
weighted images were acquired at 1.5 T before and 8 weeks after CRT. The 
calculated signal intensities in tumor voxels were normalized to the mean 
signal intensity of the obturator internus muscle. The relative T2-weighted 
signal intensity (rT2wSI) distribution in the tumor was characterized by the 
descriptive parameters. Receiver operating characteristic curves were used to 
determine the diagnostic performance. The tumor regression grade (TRG) was 
used as a reference standard.
Results: CRT induced a signiﬁcant decrease of circa 50% in all rT2wSI 
descriptives for complete responders (TRG1). This drop was signiﬁcantly 
higher compared to incomplete response groups (TRG2–TRG4). The highest 
diagnostic performance for identiﬁcation of complete responders was found 
for the 95[th] percentile, SD and mean of the rT2wSI with accuracies of 
92%, 90% and 82%, respectively.
Conclusion: Quantitative assessment of the CRT-induced changes in the 
tumor T2-weighted signal intensity can be of high diagnostic value for selection 
of complete responders after CRT for rectal cancer. With this additional 
information, a radiologist can select complete responders more accurately and 
this can facilitate less invasive treatment after CRT.
SS 12.09
Monitoring treatment response in oncology: does 
reshufﬂing of radiologist’s tasks to radiologist assistants 
impact diagnostic performance?
A.M.H. Sailer, D. Douwes, V.C. Cappendijk, F.C. Bakers,  
J.E. Wildberger, A.G. Kessels, R.G.H. Beets-Tan; Maastricht/NL
Purpose: Decision making whether or not cancer (chemo)therapy needs to be 
continued is based on precise but time consuming RECIST-measurements on 
consecutive CTs. The aim of our study was to evaluate whether it is feasible to 
free radiologist’s time by reshufﬂing the task to radiology assistants and 
whether it would reduce diagnostic performance.
Material and Methods: 177 measurements on baseline and 2 consecutive 
CTs in 20 patients were performed following RECIST1.1: (A) According to the 
standard practice where several radiologists read scans random of all patients; 
(B) According to the experimental setting where a technician with CT-unit 
experience of >10yrs reads all scans, based on the radiologist’s 1[st] 
measurements, blinded to their results. Measurements of arm A was taken as 
reference standard and compared with B. Intraclass correlation coefﬁcient was 
calculated as well as the coefﬁcient of determination based on a linear 
regression model.
Results: RECIST-measurements performed according to the single-reading of 
radiology assistant (B) showed a high correlation with standard clinical practice 
reading (A): ICC 0,961, R² 0,924; SD 4 mm for difference between A&B. 
Sensitivity and speciﬁcity for radiology assistant for assessing progressive 
disease was 100% and 94%, respectively.
Conclusion: RECIST-measurements by a single-reader radiology assistant is 
feasible and equal in performance to the radiologists’ measurements in 
standard practice. This could impact the way radiologists may work, opening 
ways to reshufﬂe important but time consuming tasks and free radiologists’ 
time.
SS 12.10
The change of 18FDG uptake in lymph nodes after 
neoadjuvant chemotherapy as a predictor of malignant 
involvement in patients with esophageal carcinoma: a 
PERCIST study
P. Fencl, T. Harustiak, M. Zemanova; Prague/CZ
Purpose: To determine whether metabolic activity, measured by PERCIST 
protocol before and after neoadjuvant chemotherapy, is able to predict the 
absence of malignant involvement in surgical specimens of lymph nodes.
Material and Methods: 51 patients (pts) with esophageal carcinoma or carcinoma 
of esophageal-gastric junction were prospectively investigated on High Deﬁnition 
PET/CT scanner by 18FDG-PET/CT at base line (BL) and after ﬁnishing three 
courses of therapy (ChT3). All pts underwent surgical treatment 113 days (median) 
after BL, i.e. 7.1 (median) weeks after ChT3. The ﬁndings in histological specimens 
of lymph nodes were correlated to 18FDG-PET/CT stage. For negative stage was 
taken all negative ﬁndings on BL and positive ones on BL, if neoadjuvant 
chemotherapy induced complete metabolic response (CMR) at ChT3.
Results: At ChT3, using maximal 18FDG uptake as response criterion, 
sensitivity (SE), speciﬁcity (SP), and accuracy (ACC) were 37.5%, 74.1%, and 
56.9%, respectively. Using total lesion glycolysis as response criterion, SE, SP, 
and ACC were 37.5%, 81.5%, and 60.8%, respectively. On both tests, there 
were 15 false negative ﬁndings (FN) at ChT3, but 11 out of 15 FN investigations 
were FN even at BL, representing 73.3% of all FN.
SS 12.05
Withdrawn by the authors
SS 12.06
Could the magnetic transfer ratio play a role to evaluate 
post-radiation ﬁbrosis in rectal cancer management?
M.H. Martens1, D.M.J. Lambregts1, N.K. Papanikolaou2, R.G. 
Riedl1, A. Zur Hausen1, L.A. Heijnen1, M. Maas1,  
G.L. Beets1, R.G.H. Beets-Tan1;  1Maastricht/NL,  
2Heraklion/GR
Purpose: Magnetization transfer is a MR technique that utilizes differences in 
the magnetization interaction of free, ‘unbound’ water protons and 
macromolecular-bound protons. The effect of magnetization transfer is 
quantiﬁed by determining the magnetization transfer ratio (MTR). The 
hypothesis is that ﬁbrosis shows a higher MTR than normal tissue and/or 
tumour. The aim of this study was to evaluate if MTR may be used to identify 
ﬁbrosis and differentiate it from normal rectal wall/tumour in rectal cancer 
patients treated with chemoradiotherapy.
Material and Methods: 11 patients who were treated with chemoradiotherapy 
received a standard axial T2W-MRI. A single axial MTR slice was obtained at the 
former tumour location. In two additional patients, MRI including MTR was obtained 
from the surgical resection specimens. Whole-mount histological sections with 
Sirius-red staining were used as the reference to determine the areas of ﬁbrosis.
Results: There was a good correlation between the areas of ﬁbrosis as 
visualized on the T2 images and the areas of increased MTR on the MTR 
maps. The normal rectal wall had an average MTR of 16.9% (0-35.6), as 
compared to 31.9% (15.1-40.5) for the areas of ﬁbrosis (p=0.001). The areas of 
ﬁbrosis on the whole-mount sections with Sirius-red staining correlated well 
with the MTR maps of the two surgical specimens.
Conclusion: Our preliminary results show that MTR discriminates ﬁbrosis from 
other tissue. This could be promising for the unsolved dilemma of interpreting 
post-radiation ﬁbrosis in rectal cancer.
SS 12.07
Accurate identiﬁcation of complete responders after 
CRT for rectal cancer with endoscopy and MRI
M. Maas1, D.M. Lambregts1, J.W. Leijtens2, M. Sosef3,  
K.W. Hulsewé4, G.L. Beets1, R.G. Beets-Tan1;  
1Maastricht/NL, 2Roermond/NL, 3Heerlen/NL, 4Sittard/NL
Purpose: Chemoradiation (CRT) for rectal cancer leads to complete tumor 
response (CR) in 15-25%. Accurate identiﬁcation of a CR is necessary to allow 
for less invasive treatment (e.g. local excision or wait&see). Standard imaging 
cannot accurately identify a CR. The aim was to evaluate the accuracy of 
endoscopy for identiﬁcation of a CR and compare it to T2W- and diffusion-
weighted MRI (DWI).
Material and Methods: 20 patients who underwent CRT and T2W-MRI+DWI and 
endoscopy 8 weeks after completion of CRT were included. One reader scored the 
T2W images followed by immediate evaluation of the DWI images with the T2W 
images at his disposal. A second reader scored the endoscopy images. Readers 
were blinded for histology and each others’ results. Scoring was performed with a 
conﬁdence level score (0=deﬁnitely residual tumour, 4=deﬁnitely CR).
Results: Of the 20 patients, 9 had residual tumour and 11 had CR. The AUCs 
for T2W-MRI, T2+DWI and endoscopy were 0.65, 0.65 and 0.91, respectively. 
Corresponding sensitivities and speciﬁcities were 36% and 78% for T2W, 46% 
and 89% for T2+DWI and 73% and 89% for endoscopy.
Conclusion: Endoscopy is more accurate in identifying a CR after CRT than 
MRI(+/-DWI), mainly because of a higher sensitivity, which corrects for 
understaging of a CR with MRI. MRI remains crucial to evaluate the presence 
of any extramural tumour/N+. A combination of endoscopy and MRI+DWI is 
therefore recommendable to identify patients with a CR post-CRT, making less 
invasive treatment after CRT feasible.
SS 12.08
Quantitative assessment of changes in the T2-weighted 
MR signal intensity in the tumor for detection of 
complete response after chemoradiation for rectal 
cancer
M. Maas, E. Kluza, E. Rozeboom, M.H. Martens, J. Slenter, 
D.M. Lambregts, G.L. Beets, R.G.H. Beets-Tan; Maastricht/NL
Purpose: The purpose of this study was to determine the diagnostic value of 
the change in signal intensity of the tumour on T2-weighted MR images after 
neoadjuvant chemoradiotherapy for identiﬁcation of complete response 
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SS 13.03
Apparent diffusion coefﬁcient (ADC) in discriminating 
between solid benign and malignant focal liver lesions 
(FLLs) with diffusion-weighted imaging (DWI): 
comparison of ADC thresholding versus normalized 
ADC thresholding and lesion-to-liver ADC ratio
S. Pullini, R. Girometti, L. Cereser, G. Como, C. Zuiani,  
M. Bazzocchi; Udine/IT
Purpose: The purpose of this study was to compare the diagnostic performance 
of three different methods of ADC estimation in differentiating solid benign and 
malignant FLLs.
Material and Methods: We included forty-ﬁve patients with 75 FLLs detected 
on a 1.5 T system, and proven to be malignant and benign in 55 and 20 cases, 
respectively (cysts/haemangiomas excluded). During separate reading 
sessions, two readers in consensus evaluated DWI images and the ADC map. 
FLLs were assessed as benign or malignant: (a) according to the threshold 
established by a receiver operating characteristic (ROC) analysis, without 
(ADC-T) and with (ADC-TS) normalization for the spleen, respectively; (b) by 
calculating the lesion-to-liver ADC ratio (ADC-R; cut-off <1). End-points for the 
three methods were the positive- and negative-predictive value (PPV, NPV) for 
malignancy and the area under the curve (AUC) values.
Results: ADC threshold for malignancy was 1.06 x10-³ mm²/sec for ADC-T 
and 1.27 x10-3 mm²/sec for ADC-TS. ADC-T, ADC-TS and ADC-R showed 
high PPV (89.2%, 84.6% and 78.1%, respectively), but low NPV (42.1%, 
38.9% and 30.2%, respectively). AUCs of ADC-T (0.70) and ADC-TS (0.65) 
were higher as compared to that of ADC-R (0.55), showing a signiﬁcant 
difference between ADC-T and ADC-R (p<0.01). Main source of false-negative 
cases was hepatocarcinoma (22-30/55).
Conclusion: Normalizing FLLs ADC for the spleen or providing the ADC-R did not 
improve the diagnostic performance of ADC-T, which is limited by a low NPV.
SS 13.04
Predictive value of liver MRI parameters in patients with 
liver  metastases of neuroendocrine tumors
W. Sommer, P.M. Paprottka, F. Ceelen, M.F. Reiser,  
D. Theisen; Munich/DE
Purpose: The aim of this study was to deﬁne pretherapeutic MRI predictors for 
treatment response of radioembolization in patients with hepatic metastases 
from neuroendocrine tumors.
Material and Methods: In 45 patients with proven hepatic metastases of 
neuroendocrine tumors (NET), MRI examinations were performed at baseline 
in all patients, consisting of standard T1w and T2w sequences as well as post-
contrast sequences. The following imaging predictors were deﬁned: patient 
age and gender, proliferation marker Ki-67, tumor load in the liver (%), 
vascularisation of metastases, tumor necrosis, hemorrhage and ﬂuid-ﬂuid 
levels. As primary endpoint, we deﬁned the progression-free survival (PFS) 
using RECIST criteria in MRI follow-up examinations. The effect of the 
predictors on the PFS has been analyzed using Kaplan-Meier statistics.
Results: The mean PFS was 699 days (95% CI 326-964). Hypovascular 
metastases showed signiﬁcant earlier progress (255 vs. 727 days; p<0.01). A 
proliferation marker <2% (G1) was signiﬁcantly associated with a longer PFS 
than a proliferation marker between 2 and 20% (G2) or >20% (G3) (p<0.001). 
Patient age, gender, tumor load in the liver, tumor necrosis, hemorrhage as well 
as radioreceptor status of pre-SIRT did not show any impact on PFS 
(p>0.05).
Conclusion: Selective internal radiation therapy in neuroendocrine tumors turns 
out to be most efﬁcient in hypervascular tumors with low proliferation index. 
Tumor-liver-ratio as well as radioreceptor status do not have inﬂuence on the 
progression-free survival in contrast to other therapeutic options in NETs.
SS 13.05
High sensitivity of diffusion-weighted MRI for the 
detection of liver metastases from neuroendocrine 
tumors compared with T2-weighted and dynamic 
gadolinium-enhanced MRI, using surgical and 
histological ﬁndings as a standard of reference
G. D’Assignies1, P. Fina2, O. Bruno1, M. Ronot1, M.P. Vullierme1, 
V. Paradis1, A. Sauvanet1, V. Vilgrain1;  1Clichy/FR, 2Rome/IT
Purpose: The purpose of this study was to assess and compare the sensitivity 
of diffusion-weighted (DW) MR imaging for the detection and characterization 
of liver metastases from neuroendocrine tumors (NET) to T2-weighted fast 
spin-echo (T2WFSE) and dynamic gadolinium-enhanced MRI, using surgical 
and histopathological ﬁndings as the standard of reference.
Conclusion: Despite using High Deﬁnition PET/CT scanner in all standardized 
investigations, 18FDG-PET/CT was not able to exclude malignant involvement 
of lymph nodes due to low sensitivity of the test even at BL and inability to 
prove residual malignancy when metabolic activity decreased to the CMR level 
on ChT3.
11:00 - 12:30 Sidlaw
Scientiﬁc Session 13
Focal Liver Lesions: Imaging assessment
SS 13.01
The spectrum of imaging and aetiological factors in 
focal nodular hyperplasia presenting in the paediatric 
population
A. Deganello, R. Inchingolo, M. Samyn, M. Sellars,  
P.A. Kane, J. Karani; London/UK
Purpose: Focal nodular hyperplasia (FNH) is a rare benign liver tumour in 
children. Previous studies have described an increased incidence of FNH in 
patients treated for cancer or in the presence of congenital or acquired vascular 
disorders. The aim of this study is to set a light on the risk factors and 
radiological features of FNH in a large paediatric population.
Material and Methods: Single-centre retrospective clinical, radiological and 
histopathological review of children diagnosed with FNH between January 
1990 and April 2011.
Results: A total of 25 children (52% females) with FNH were identiﬁed. Median 
age at presentation was 9 years. 36% had no associations and 12% had a 
previously treated extra-hepatic malignancy. A congenital portosystemic shunt 
was detected in 40%. One child had a surgical portocaval shunt created 
following acute Budd Chiari Syndrome. The lesion was unifocal in 60% and 
multifocal in 40%; a central scar was identiﬁed in 36% of the cases. All patients 
treated for cancer had multiple lesions; solitary lesions were found in all except 
one of the patients with sporadic FNH and in 54% of the patients with 
portosystemic shunts.
Conclusion: Portosystemic shunts and treated malignancy are recognised 
risk factors for the development of FNH in children, the underlying link being a 
congenital or acquired alteration of the portal venous ﬂow. Recognising the 
features of FNH and its predisposing factors leads to appropriate diagnosis 
and treatment.
SS 13.02
Added value of Gd-EOB-DTPA-enhanced hepatobiliary 
phase MRI of solid focal hepatic lesions: a ROC analysis
M. Haimerl1, I. Platzek2, C. Nießen1, A.G. Schreyer1, E.M. Jung1, 
C. Stroszczynski1, P. Wiggermann1;  1Regensburg/DE, 
2Dresden/DE
Purpose: The purpose of this study was to determine the added value of 
hepatobiliary phase images in the Gd-EOB-DTPA-enhanced MRI in the 
differentiation of solid focal hepatic lesions.
Material and Methods: 84 patients underwent Gd-EOB-DTPA-enhanced MR 
examinations. 64 patients had malignant focal hepatic lesions proven by 
histology (HCC: n= 34, metastases: n=30), 20 patients had benign liver lesions 
(FNH: n=14, hemangioma: n=3, adenoma: n=3). Five radiologists independently 
reviewed three sets of MR images using a score from 1 (benign) to 5 (malignant): 
set 1, unenhanced T1- and T2-weighted; set 2, unenhanced T1- and T2- 
weighted + gadoxetic acid-enhanced dynamic images; set 3, set 2 + 
hepatobiliary phase images.
Results: Diagnostic accuracy, compared using the area under the alternative 
free-response receiver operating characteristic curve (A~Z~), was signiﬁcantly 
improved by the addition of gadoxetic acid-enhanced dynamic images: A~Z~ 
in set 1 was 0.708, A~Z~ in set 2 was 0.833. With the addition of the 
hepatobiliary phase, A~Z~ value was 0.941 in set 3.
Conclusion: Hepatobiliary phase images obtained after Gd-EOB-DTPA-
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Conclusion: Regardless of the ADC evaluation method, NPV was low, while 
the PPV was high, especially by comparing lesion and parenchymal ADCs with 
ADC-R2. However, the use of an ADC threshold provided higher diagnostic 
performance in terms of AUC.
SS 13.08
Accuracy of visual assessment versus apparent 
diffusion coefﬁcient quantiﬁcation in differentiating 
malignant and solid benign focal liver lesions with 
diffusion-weighted imaging
R. Girometti, M. Del Pin, S. Pullini, L. Cereser, G. Como,  
M. Bazzocchi, C. Zuiani; Udine/IT
Purpose: The purpose of this study was to compare the accuracy of diffusion-
weighted imaging (DWI) visual analysis (VA) versus the apparent diffusion 
coefﬁcient quantiﬁcation (ADC-Q) in assessing malignancy of solid focal liver 
lesions (FLLs).
Material and Methods: Two radiologists in consensus retrospectively 
assessed as benign or malignant 50 FLLs (16 benign, 24 malignant) on 32 
patients examined on a 1.5 T. Two different methods were used in separate 
reading sessions: (a) VA of signal intensity on DWI images at b=800 sec/mm2 
and ADC-map; (b) lesion ADC measurement on the ADC-map. Reference 
standard included histology and follow-up conﬁrmation of a consensus panel 
diagnosis. We estimated the accuracy for malignancy of both methods and the 
ADC-Q threshold as assessed by a receiver operating characteristic (ROC) 
analysis.
Results: Because of 20 false-negative hepatocarcinoma, VA showed lower 
accuracy than ADC-Q (52.0% vs. 68.0%). However, stratiﬁed accuracy for 
metastases was higher than VA (75.0 vs. 66.7%). ADCs and signal features of 
malignant and benign FLLs largely overlapped.
Conclusion: VA performed worse than ADC-Q for hepatocarcinoma, and 
better for metastases, possibly in relation with the T2-shine-through 
phenomenon. Overall, the accuracy of both methods was limited because of 
the overlap in visual appearance and ADC values between solid benign and 
malignant FLLs.
SS 13.09
Hypervascular liver lesion at dual-energy CT: 
enhancement evaluation at different tube voltages
P. Cabassa, A. Colleoni, A. Scrimieri, R. Maroldi; Brescia/IT
Purpose: The purpose of this study was to compare attenuation values of 
hypervascular liver lesion with 80 kvp-images, 140 kvp-images and with 
weighted-average (WA) simulated 120 kvp-images, using dual energy CT 
(DECT).
Material and Methods: 58 patients (47 male) underwent (in a 6 months period) 
prospectively abdominal DECT for suspected or known hypervascular lesions. 
An arterial phase with DE technique (80Kvp, 140Kvp and WA) and a venous 
acquisition (120 kvp) were performed. Arterial images were obtained after a 
standard triggered threshold. The attenuation values were calculated using 
ROIs placed in arterial DE images on 6 different areas: lesion, aorta, psoas 
muscle, subcutaneous fat, healthy right and left liver. The LLR (lesion-to-liver 
ratio) and the CNR (contrast-to-noise ratio) were calculated independently by 
two radiologists: CNR by (ROI lesion - ROI healthy liver)/(SD subcutaneous fat) 
and LLR by mean value of the lesion/mean value of healthy liver. Student-t test 
was used for statistical analysis.
Results: Twenty lesions were detected. The mean attenuation values of the 
lesions were 157.19±55.26 HU for 80kv-images, 86.51±19.21 HU for 140Kv-
images, 109.51±26.69 HU in WA images. LLR was 2.48 in 80Kv-images, 1.55 
in 140Kv-images (p<0.005) and 1.89 in WA images (p=0.003). The mean CNR 
was 3.40 in 80Kv-images, 1.27 in 140Kv-images (p<0.005) and 2.51 in WA 
images (p=0.21).
Conclusion: 80 kvp images demonstrated a higher LLR than acquired images 
at 140kvp and at WA-120KvP. The 80KVp images could be used in clinical 
practice to better evaluate hypervascular liver lesions.
SS 13.10
Phase contrast computed tomography of focal liver 
lesions using a conventional X-ray source
A.A. Fingerle1, M. Willner2, J. Herzen2, P.B. Noël1, D. Hahn2, 
E. Drecoll1, D. Münzel1, E.J. Rummeny1, F. Pfeiffer2;  
1Munich/DE, 2Garching/DE
Purpose: The purpose of this study was to evaluate grating-based phase 
contrast computed tomography (PCCT) for the detection and characterization 
of ex vivo focal liver lesions in comparison to standard absorption-based 
computed tomography and histopathology.
Material and Methods: Forty-one patients with 162 liver metastases from 
NET underwent MR imaging including DW, T2WFSE, and dynamic gadolinium-
enhanced MR imaging. Images were retrospectively reviewed by two 
independent abdominal radiologists for the detection and characterization of 
liver metastases. MR ﬁndings were compared to histopathological and 
intraoperative ultrasound ﬁndings on a lesion-by-lesion basis to determine the 
sensitivity of each MR sequence, alone and combined.
Results: There was excellent agreement for lesion characterization between 
observers 1 and 2 for the per-lesion analysis. DW-MR was more sensitive 
(Se=71.6%; 95% CI: 64.2-78.0 and Se=71.0%; 95% CI: 63.6-77.4 for 
observers 1 and 2, respectively) than T2-weighted fast spin-echo, and dynamic 
gadolinium-enhanced MR (Se=55.6%; 95% CI: 47.9-63.0, and Se=47.5%; 
95% CI: 34.0-55.2 for observer 1 and Se=55.6%; 95% CI: 47.9-63.0 and 
Se=48.1%; 95% CI: 40.6-55.8 for observer 2). The sensitivity of the three types 
of sequences combined was 80.3% (95% CI: 73.2-85.8) for both observers.
Conclusion: DW-MR imaging was more sensitive for detecting and 
characterizing liver metastases from NET than T2WFSE and dynamic 
gadolinium-enhanced MR imaging. We, therefore, recommend performing this 
sequence in patients for preoperative disease staging.
SS 13.06
Enteric and pancreatic neuroendocrine liver metastasis: 
comparison of vascular behavior on triple-phase MDCT
G. D’Assignies, F. Cuccioli, M.P. Vullierme, M. Ronot,  
O. Bruno, V. Vilgrain; Clichy/FR
Purpose: The purpose of this study was to describe vascular behavior of liver 
metastases (LM) from enteropancreatic neuroendocrine tumor (EPNET) and to 
look for differences between enteric (ENLM) and pancreatic (PNLM) 
neuroendocrine liver metastases and to identify the best phase for their 
detection.
Material and Methods: 78 patients with pathologically proven EPNETs and 
untreated liver metastases were retrospectively analyzed. 559 LM were seen 
on triple-phase (non-contrast, arterial and portal) MDCT and characterised as 
hypo, iso or hyper-attenuating on each phase. Best phase for lesion depiction 
was evaluated per patient.
Results: 45 patients (58%) had LM from pancreatic origin and 33 (42%) from 
enteric origin. On non-contrast-enhanced phase, PNLM were hypoattenuating 
in 189 (72%), whereas 105 (34%) ENLM were hypoattenuating (p < 0.05). 385 
LM (69%) were hypervascular on arterial phase, including 201 ENLM (68.7%) 
and 184 PNLM (70%, ns). The classical pattern (hypervascularity on arterial 
phase and hypoattenuation on portal venous phase) was present in 50 patients 
(64%) including 31 patients (40%) with other vascular behaviors. Best phase 
for tumor depiction was portal venous phase for ENLM (19 patients, 58%) and 
arterial phase for PNLM (36 patients, 80%).
Conclusion: Neuroendocrine LM were hypervascular on arterial phase in only 2/3 
of cases. Nearly half of patients with hypervascular LM also had other CT patterns. 
Both portal venous and arterial phases are important for LM depiction.
SS 13.07
Comparison of three methods of apparent diffusion 
coefﬁcient evaluation in assessing solid focal liver 
lesions with diffusion-weighted imaging (DWI)
R. Girometti, S. Pullini, L. Cereser, M. Del Pin, G. Como,  
M. Bazzocchi, C. Zuiani; Udine/IT
Purpose: The purpose of this study was to compare the performance in 
diagnosing focal liver lesions (FLLs) malignancy of the apparent diffusion 
coefﬁcient thresholding (ADC-T) method versus two variants of the lesion-to-
liver ADC ratio (ADC-R).
Material and Methods: Examinations were performed on a 1.5 T system. 
Analysis was applied to 50 FLLs proven to be malignant and benign in 34 and 
16 cases, respectively. Cysts and haemangiomas were excluded from the 
analysis. We estimated the positive-predictive value (PPV) and negative-
predictive value (NPV) for malignancy of ADC-T and two variants of the ADC-R, 
calculated without (ADC-R1) and with (ADC-R2) the inclusion of the 
parenchymal ADC standard deviation value, respectively. An ADC-R < 1 was 
considered as malignant. A receiver operating characteristic (ROC) analysis 
was performed to establish ADC-T threshold for malignancy and to compare 
the areas under the curve (AUC).
Results: The ADC-T threshold for malignancy was 1.09x10-3 mm2/sec. PPV 
and NPV were 87.5% (95%C.I.: 74.4-94.7) and 50.0% (95%C.I.: 35.7-64.3) for 
ADC-T versus 75.0% (95%C.I.: 60.4-85.7) and 36.7% (95%C.I.: 23.9-51.5) for 
ADC-R1 versus 90.9% (95%C.I.: 78.5-96.8) and 38.5% (95%C.I.: 25.4-53.3) 
for ADC-R2, respectively. Most false-negative FLLs were represented by 
hepatocellular carcinoma. ADC-T showed an AUC (0.71) signiﬁcantly higher 
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intensity in the liver parenchyma were observed in 14/22 ITBL patients. Fitted 
ADC values of liver parenchyma in ITBL group were signiﬁcantly lower than 
those in normal control group (p-less-than-0.05).
Conclusion: In liver recipients with ITBLs, MRC and DW-MRI at 3T reveal 
characteristic features that may allow differentiation from other complications 
after liver transplantation.
SS 14.03
Contrast-enhanced MR perfusion of solid pancreatic 
lesions: utility of time-signal intensity curves
F. Donati, P. Boraschi, R. Gigoni, G. Gherarducci, F. Pacciardi, 
F. Falaschi, C. Bartolozzi; Pisa/IT
Purpose: The purpose of this study was to evaluate the usefulness of time-
signal intensity curve (TSIC) using dynamic contrast-enhanced MR perfusion 
of solid focal pancreatic lesions.
Material and Methods: Twenty patients without pancreatic disease and forty-ﬁve 
with pathologically conﬁrmed pancreatic lesions (ductal adenocarcinoma, n=23; 
endocrine tumor, n=6 with 9 lesions; focal chronic pancreatitis, n=13; autoimmune 
pancreatitis, n=3) underwent MRI at 1.5T device. Dynamic contrast-enhanced MR 
perfusion consisted of a 3D axial free-breathing LAVA sequence (TR/TE, 2.28 ms/1.05 
ms; 10.0 mm thk/-0.0 mmsp; matrix, 128x128; 0.75 NEX; 1 second) repeated up to 5 
minutes. A dose of 7 mL gadobenate-dimeglumine (Gd-BOPTA; MultiHance) with 20 
mL saline ﬂush was injected at 4 mL/sec. MR perfusion images were processed by 
two radiologists in conference that classiﬁed ﬁve TSIC shapes: type 1 (quick 
enhancement and quick decay followed by slowly decaying); type 2 (slow enhancement 
followed by slow constant enhancement); type 3 (fast enhancement followed by signal 
plateau); type 4 (fast enhancement followed by slowly decaying plateau); type 5 (quick 
and marked enhancement followed by slow constant decay).
Results: All 20 patients with normal pancreas presented a TSIC-type 1. TSIC-type 2 
was observed in all 23 ductal adenocarcinomas and in 1 endocrine tumor; TSIC-type 
3 was recognized in 13 patients with focal chronic pancreatitis and in 16 post-
obstructive chronic pancreatitis; TSIC-type 4 was identiﬁed in all cases of autoimmune 
pancreatitis, and TSIC-type 5 in the 8 lesions of 5 patients with endocrine 
neoplasms.
Conclusion: Dynamic contrast-enhanced MR perfusion using TSIC could 
improve the diagnosis of solid focal pancreatic lesions.
SS 14.04
Improved detection of cholesterol gallstones using dual 
energy CT: results in an anthropomorphic phantom 
model
R.W. Bauer, S. Hohertz, J. Schulz, M.C. Larson, T. Vogl; 
Frankfurt am Main/DE
Purpose: Cholesterol gallstones elude detection on regular 120 kV CT scans. 
The potential of dual energy CT (DECT) post-processing for the correct 
classiﬁcation of gallstones in an anthropomorphic phantom model was 
assessed.
Material and Methods: 34 gallstones with known chemical composition (11 
pure cholesterol, 12 non-cholesterol, 11 cholesterol core and non-cholesterol 
shell) were put into a standard plastic specimen container functioning as 
artiﬁcial gallbladder and then into a water-ﬁlled cylindrical acrylic glass 
phantom with a diameter of 32 cm that contained porcine organs and spine to 
simulate noise levels of a human abdomen. DECT scans were performed with 
a ﬁrst-generation Dual Source scanner (Deﬁnition, Siemens). DECT prototype 
post-processing software was used to selectively highlight cholesterol 
information by color overlay. 80 kV, 140 kV grayscale images and color-coded 
images were analyzed for the presence and characteristics of gallstones.
Results: Pure cholesterol stones were not visible at 140 kV, 6/11 were not 
detected at 80 kV, but all were detected on post-processed color-coded DE 
images. Non-cholesterol stones appeared hyperdense on grayscale images 
and were visible on both the 140 kV and 80 kV series. The appearance of core/
shell stones was best deﬁned at 80 kV; however, the conspicuity of cholesterol 
parts was more pronounced on color-coded images.
Conclusion: DECT post-processing allowed for reliable identiﬁcation of 
cholesterol gallstones in this anthropomorphic phantom simulating a human 
abdomen. This may be beneﬁcial in patients with abdominal pain and no 
primary ﬁnding on regular abdominal CT.
Material and Methods: Formalin-ﬁxed liver specimens with benign and 
malignant focal liver lesions were scanned with an experimental grating-based 
PCCT setup using a conventional X-ray tube (ENRAF Nonius rotating anode 
X-ray tube, single photon counting detector Pilatus II, Dectris). Tube voltage 
was 35 pkV, tube current 70 mAs. Phase contrast and conventional absorption 
CT data were obtained. The reconstructed images were correlated with 
hematoxylin and eosin staining of the specimens and compared for imaging 
features like contrast, lesion delineation and depiction of internal structures.
Results: Grating-based PCCT images of ex vivo focal liver lesions show a 
marked improvement of soft-tissue contrast compared to standard absorption 
CT. In PCCT images, lesion delineation is signiﬁcantly improved and internal 
structures are visible.
Conclusion: When introduced to the clinic, grating-based phase contrast 
computed tomography has the potential to be a valuable tool for the 
characterization of structural information of focal liver lesions.




Ultra-high-ﬁeld imaging of the biliary tract at 7 Tesla: 
initial results of Gd-EOB-DTPA-enhanced MRCP
A. Fischer, O. Kraff, S. Orzada, M.E. Ladd, L. Umutlu,  
T.C. Lauenstein; Essen/DE
Purpose: The aim of this study was to assess the feasibility and diagnostic 
potential of imaging of the biliary tract using biliary secreted Gadoxetic acid at 
7 Tesla in comparison to T2-weighted MRCP at 3 Tesla.
Material and Methods: 10 healthy volunteers were examined on a 7T whole-
body MR system using a custom-built 8-channel body coil. The following 
sequences were included: T1w 3D FLASH VIBE, 3D FLASH with inversion 
recovery, and T2w TSE in coronal orientation. For dynamic imaging, Gadoxetic 
acid was administrated with a clinical standard dosage. Acquisition of a 
dynamic series started after 20, 70, and 120 seconds with additional 
acquisitions performed at 5, 10, 15, 20, 25 and 30 minutes after injection. All 
volunteers underwent a non-enhanced T2-weighted MRCP on a 3T MR 
system.
Results: Dynamic contrast-based MRCP at 7T showed a homogeneous 
depiction of the intra- and extrahepatic biliary tract. While T1w 3D VIBE 
imaging provided a moderate delineation of the biliary tract, it also yielded near 
isointense liver tissue and vasculature. In contrast, 3D FLASH imaging with 
inversion recovery enabled a high-quality assessment of the biliary duct due to 
a strong saturation of hepatic tissue and vessels. T2w TSE showed only poor 
to moderate image quality.
Conclusion: Our results demonstrate the feasibility of contrast-enhanced 
imaging of the biliary tract at 7 Tesla. In particular, 3D FLASH MRI with inversion 
recovery enabled high-quality assessment of the biliary tract.
SS 14.02
Ischemic-type biliary lesions after orthotopic liver 
transplantation: evaluation with MR cholangiography 
and diffusion-weighted MR imaging at 3T
P. Boraschi, F. Donati, R. Gigoni, F. Filipponi, F. Falaschi,  
C. Bartolozzi; Pisa/IT
Purpose: The purpose of this study was to determine the usefulness of MR 
cholangiography (MRC) and diffusion-weighted MR imaging (DW-MRI) at 3T for 
evaluating ischemic-type biliary lesions (ITBLs) in liver transplant recipients.
Material and Methods: Twenty-two liver transplant patients with ischemic 
changes of the biliary tree at ERCP/PTC underwent MRI at 3T device (GE-
DISCOVERY MR750;GE-Healthcare). After acquisition of T1w/T2w images, 
MRC was performed through thin-slab 3D-FRFSE and thick-slab SSFSE T2w 
sequences. DW-MRI of the liver was performed using an axial respiratory-
triggered spin-echo echo-planar sequence with multiple b-values (150, 500, 
1000, 1500 s/mm2) in all diffusion directions. Two blinded observers reviewed 
all images in consensus and recorded the presence of biliary and liver 
abnormalities. ADC values of liver parenchyma in ITBL group and normal 
control group (n=10) were, respectively, calculated using a dedicated software 
ﬁtting the curve obtained from the corresponding ADC for each b-value.
Results: Abnormal ﬁndings of bile ducts were observed in all patients; the 
most common ﬁndings were intrahepatic bile duct dilatation (22/22), strictures 
involving hepatic bifurcation (20/22), extrahepatic biliary wall thickening (20/22) 
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Results: There was no difference in incidence of chronic pancreatitis or 
divisum between the SOD (n=43) and non-SOD (n=27) groups. MRCPS 
parameters of maximum PD caliber, time to maximum PD caliber, maximum 
DFC, and time to maximal DFC did not correlate with the presence of SOD or 
severity of elevation of manometric pressure (all p>0.05).
Conclusion: Previous reports had suggested a correlation between MRCPS 
parameters and SOD. We did not ﬁnd such a correlation.
SS 14.08
Radiological features of malignancy combined with 
inﬂammation in pancreatobiliary system
K. Jee, S.A. Lee, M. Park; Cheonan/KR
Purpose: The purpose of this system was to evaluate the radiological features 
and clinical ﬁndings of chronic inﬂammation combined with malignancy in 
pancreatobiliary systems.
Material and Methods: For 10 years, pathologically and clinically conﬁrmed 
chronic inﬂammation combined with malignancy in pancreatic (n = 6) and 
biliary (n = 20) systems were evaluated about radiological and clinical ﬁndings. 
Mean age was 63.8 and male to female ratio was 21 to 5. Radiological 
examinations of CT (n = 26), ERCP (n = 19), MRCP (n = 19) and EUS (n = 6) 
were done. Clinical records were evaluated.
Results: Biliary cases were RPC with cholangioca (n = 12) and biliary 
intraepithelial neoplasm (n = 5), IPMT with stones (n = 2), cholangioca with 
clonorchis infestation (n = 1). 70% of RPC were in left lobe. Radiological tumor 
detectability was 55% with six bile ductal wall thickening and ﬁve mass-forming 
patterns. CA 19-9 was elevated in 52.9 %. Pancreatic cases were carcinoma 
(n = 5) and pancreatic intraepithelial neoplasm (n = 1) with chronic pancreatitis. 
P-duct dilatation showed all, parenchymal atrophy in ﬁve and calciﬁcation/
stones in three. Tumor detectability was 83%. Lymph node enlargement in 68% 
but all were pathologically negative. CA 19-9 was elevated in 80%.
Conclusion: Pancreatobiliary ductal malignancy could have combined chronic 
inﬂammation and reveals multistep process of malignant change. Serial 
imaging and tumor marker follow-up can be helpful for early diagnosis of 
pancreatobiliary malignancy in underlying chronic inﬂammation.
SS 14.09
The role of diffusion-weighted imaging and ADC values 
in the evaluation of hilar strictures
M. Alkhouri1, J. James2, L. Brits3, A. Sanderson1, A. Milson1, 
J.V. Macpherson1;  1Devon/UK, 2Plymouth/UK, 3Milton Keynes/UK
Purpose: The purpose of this study was to assess the role of diffusion-weighted 
imaging (DWI) in the evaluation of hilar strictures and to correlate the apparent 
diffusion coefﬁcient (ADC) values of the obstructing lesion with the ﬁnal diagnosis.
Material and Methods: Patients who had an MRCP with DWI showing a hilar 
structure were included. The area of bile duct obstruction was assessed for 
high signal on b=800 DWI. If identiﬁed, the ADC value for that area was derived 
from the ADC map in x10-³mm²/s by two observers. Statistical analysis was 
performed. The ﬁnal diagnosis was reached by tissue diagnosis, follow-up 
imaging of appropriate clinical course. Correlation was made between the ﬁnal 
diagnosis and the ADC value.
Results: 19 patients with hilar stricture were identiﬁed from 2009 to 2011 with 
follow up of 4-26 months: 16 with malignancy and 3 with benign disease. 
There were 8 cholangiocarcinomas, 3 gallbladder carcinomas, 5 liver 
metastases, 2 benign anastomotic strictures and 1 Mirizzi’s. 10 patients had a 
tissue diagnosis. Two observers derived the ADC value and it ranged from 
0.774 to 1.256 in the cholangiocarcinoma, 0.736-1.290 for gallbladder 
carcinoma and 0.470-1.281 for metastases. The one case of small cell 
carcinoma had the lowest ADC values at 0.470 and 0.481. No high signal 
causing obstruction on b=800 DWI compared to adjacent normal structures 
was seen in the benign cases.
Conclusion: DWI is useful in the evaluation of hilar strictures, by differentiating 
benign from malignant strictures.
SS 14.10
Attenuation value of gall bladder ﬂuid on multidetector 
computed tomography in acute unspeciﬁed pancreatitis: 
comparison with normal control group
C.S. Choi, S.H. Bae, E.J. Yun, D.Y. Yoon, Y.L. Seo, K.J. Lim, 
S. Baik, A. Han; Seoul/KR
Purpose: The purpose of this study was to retrospectively compare the 
computed tomography (CT) attenuation value (HU) of gall bladder (GB) ﬂuid in 
patients with acute unspeciﬁed pancreatitis with those of normal control group.
Material and Methods: From January 2009 to April 2011, 59 consecutive 
patients with acute unspeciﬁed pancreatitis and 59 normal control subjects 
SS 14.05
Dual energy CT in patients with acute RUQ pain: is it 
possible for virtual non-enhanced images to replace 
true non-enhanced images?
Y.H. Lee, S.N. Moon, D.M. Kang, S.H. Wee, S.W. Im; Iksan/KR
Purpose: The purpose of this study was to determine whether virtual non-
enhanced (VNE) images derived from dual energy computed tomography (DECT) 
replace true non-enhanced (TNE) images in patients with acute RUQ pain.
Material and Methods: Among the 93 patients who had acute RUQ pain 
underwent MDCT including non-enhanced scan and dual phases enhanced 
scans. Total 58 patients with surgically and ultrasonographically proven gallstones 
or bile duct stones were selected. Portal phase enhanced CT images were 
obtained using DE technique. For quantitative analysis, CT numbers were 
measured on the stone, liver and GB. Contrast to noise ratio (CNR) of stone to liver 
and stone to bile was tested with a Student’s t-test. Effective radiation doses were 
calculated. For qualitative analysis, two blinded readers independently compared 
the image qualities and artifact for VNE and TNE images.
Results: TNE images showed signiﬁcantly higher mean CT numbers (p<0.05) than 
VNE images. CNR of stone to bile was signiﬁcantly higher in VNE images than TNE 
images (p<0.05). Stone size was not signiﬁcantly different between the TNE and VNE 
images (p<0.05). By skipping the TNE images, we could reduce the radiation dose 
about 30%. The image quality and artifacts of VNE were not signiﬁcantly different from 
that of TNE (P<0.05) images. Interobserver agreement of showed good (k=0.687).
Conclusion: DECT provides high-quality VNE images, which can be used as 
reasonable alternative to TNE images, in patient with gallstones or radioopaque 
bile duct stones.
SS 14.06
Early biliary decompression prior to preoperative 
staging of hilar and extrahepatic cholangiocarcinomas: 
What happens?
E.S. Lee, J.Y. Lee, S.H. Kim, J.M. Lee, J.K. Han, B.I. Choi; 
Seoul/KR
Purpose: The purpose of this study was to compare the accuracy of 
preoperative CT before and after biliary decompression in the evaluation of 
local tumor extent and resectability of hilar and extrahepatic cholangiocarcinomas 
using surgery and histological results as the reference standard.
Material and Methods: Thirty-six patients who had undergone surgery due to 
hilar or extrahepatic cholangiocarcinomas from June 2006 to December 2009 
were included in this study. All of them underwent triple-phase before and after 
endoscopic or percutaneous biliary decompression prior to the surgery. Three 
experienced radiologists independently and blindly evaluated the pre-
decompression and post-decompression CT images separately in terms of 
Bismuth type of tumor, the presence of involvement of second order branch of 
intrahepatic ducts, the presence of intrapancreatic CBD involvement, lymph 
node metastasis, and tumor resectability. Diagnostic accuracy was calculated 
and compared between pre- and post-decompression CT scans. For statistical 
analysis, the McNemar test was used.
Results: Mean diagnostic accuracies were signiﬁcantly lowered after biliary 
decompression for Bismuth type (P=0.01), second-order branch involvement 
of IHD (P=0.007), and intrapancreatic CBD involvement (P=0.001). However, 
mean accuracies were not signiﬁcantly changed after biliary decompression 
for lymph node metastasis (P > 0.05) and resectability (P > 0.05).
Conclusion: Early biliary decompression prior to preoperative staging CT inﬂuenced 
on the evaluation of local tumor extent of hilar or extrahepatic cholangiocarcinomas. 
However, it did not inﬂuence on the determination of resectability.
SS 14.07
The utility of secretin-enhanced MRCP in diagnosing 
pancreatic sphincter of Oddi dysfunction
K. Sandrasegaran, M. Tann, F. Akisik; Indianapolis, IN/US
Purpose: The purpose of this study was to assess the usefulness of secretin-
enhanced MRCP in diagnosing sphincter of Oddi dysfunction (SOD), deﬁned as 
basal sphincteric pressure of > 40 mmHg. Theoretically, the presence of SOD should 
result in persistently distended main pancreatic duct and reduced rate of entry of 
exocrine ﬂuid into the duodenum, following intravenous secretin stimulation.
Material and Methods: Retrospective review found 70 patients with SMRCP and 
ERCP manometric measurements, without intervening sphincteric therapy. MRCP 
was performed using 1.5 T MRI (Magnetom Harmony or Avanto, Siemens, Erlangen, 
Germany) using previously published protocol (Sandrasegaran et al. AJR 2010;195:42). 
All patients had 300 mL of oral ferumoxsil (GastroMark, Mallinckrodt Inc, St Louis) prior 
to MRCP, ensuring a dark duodenal luminal signal at baseline. Studies were 
anonymized and independently reviewed by two reviewers for the dynamic changes 
in pancreatic duct (PD) caliber and semiquantitative measurement of duodenal ﬂuid 
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Conclusion: Our results demonstrate the beneﬁts and the limitations of an 
increase of magnetic ﬁeld strength from 1.5 T to 3 T to 7 T, offering improved 
and highly detailed delineation of anatomical and vascular structures in T1w 
imaging.
SS 15.03
Role of diffusion-weighted MR imaging in detection of 
hepatic abscesses and their differentiation from non-
infected ﬂuid collections in the liver
C. Schmid-Tannwald1, R. Neumann1, C. Schmid-Tannwald1, 
A. Oto2, M.F. Reiser1, K. Nikolaou1, C. Rist1;  1Munich/DE, 
2Chicago, IL/US
Purpose: The purpose of this study was to evaluate the role of diffusion-
weighted MRI (DW-MRI) in differentiation between hepatic abscesses versus 
biloma.
Material and Methods: In this retrospective study, 22 abscesses and 27 
bilioma in 27 patients who underwent abdominal MRI including DW-MRI were 
included. Two independent observers reviewed T2-weighted (T2w) images 
alone, T2w images with DW-MR images and T2w images together with 
contrast enhanced T1-weighted (CET1w) images at three different sessions to 
detect liver abscesses and biloma based on a conﬁdence scale. Sensitivity, 
conﬁdence level and mean ADC values of abscesses and biloma were 
calculated and compared.
Results: Detection of abscesses improved signiﬁcantly by combining T2w images 
with DW-MRI [both observer: 21/22 (95.5%), p<0.01] or with T1CE images 
[observer 1: 21/22 (95.5%), observer 2: 22/22 (100%), p<0.01] in comparison to 
T2w images alone [observer 1: 11/22 (50%) and observer 2: 12/22 (54.4%)]. 20/27 
(74.0%) and 18/27 (66.6%) biloma were dected on T2w images by observer 1 and 
2, respectively. Observer 1 and observer 2 detected more biloma on their review 
of T2w+DW-MRI [observer 1: 23/27 (85.2%), p=0.006, observer 2: 24/27 (88.9%), 
p=0.008]. The detection rate signiﬁcantly improved by combining T2w images 
with CET1w images [both observer: 26/27 (96.3%), p<0.001]. Mean ADC of 
abscesses was signiﬁcantly lower (0.83±0.24x10[-3]mm²/s) compared to mean 
ADC of biloma (2.25±0.6x10[-3]mm²/s, p<0.001).
Conclusion: DW-MRI is a valuable adjunct to T2w images to detect and differentiate 
hepatic abscesses from non-infected ﬂuid collections in the liver. Furthermore, ADC 
measurements may help to distinguish liver abscesses from biloma.
SS 15.04
Diffusion-weighted imaging of the liver: value of 
apparent diffusion coefﬁcient and inﬂuence of region of 
interest
J.P. Filipe, L. Curvo-Semedo, C. Marques, F. Caseiro-Alves; 
Coimbra/PT
Purpose: The purpose of this study was to investigate the usefulness of 
diffusion-weighted imaging (DWI) in the differential diagnosis of hepatic 
disease, by measuring apparent diffusion coefﬁcient (ADC) of hepatic 
parenchyma and focal liver lesions (FLL), and the inﬂuence of region of interest 
(ROI) characteristics in the results.
Material and Methods: Ninety-three patients were retrospectively evaluated 
and 90 lesions were analyzed: 14 hepatocellular carcinomas (HCC), 18 
metastases, 10 focal nodular hyperplasias (FNH), 4 adenomas, 30 hemangiomas 
and 14 cysts. ADC was measured in liver parenchyma with ROIs in four 
segments and in FLL, using three circular centimetric ROIs and one ROI 
encompassing the full lesion area (b-values of 50 and 700 s/mm[2]). Reference 
standard was the histopathological data or, alternatively, a consensus between 
imaging methods, follow-up and clinical history. ADCs were statistically 
compared, with P<0.05 being signiﬁcant.
Results: Mean ADCs (×10[−3]mm[2]/s) were 1.45, 1.28, 1.25 (normal, cirrhotic, 
steatotic parenchyma) and 1.16, 1.18, 1.30, 1.64, 1.89, 2.77 (metastases, 
HCCs, adenomas, FNHs, hemangiomas, cysts). ADCs of malignant lesions 
were signiﬁcantly lower than all benign lesions but with overlap between 
malignant and solid benign lesions. The AUC for malignancy determination 
was 0.94 (89.7% sensitivity, 90.6% speciﬁcity), for a cut-off ADC of 1.43. No 
signiﬁcant differences were found between ROI sampling methods in 
homogeneous lesions.
Conclusion: ADC measurements are useful in differentiating normal from 
pathological liver parenchyma and in the characterization of FHLs. The ROI 
size does not inﬂuence ADC measurements in homogeneous lesions.
were enrolled in this study. The control group was consisted of normal healthy 
population. Disease patients were 43 males and 16 females with average age 
of 44.8 years. Normal control subjects were 33 males and 26 females with 
average age of 49.8 years. The CT scanner was 16 channel multidetector 
Mx8000 (Phillips, Haifa, Israel) with automated modulation of mAs with ﬁxed 
120 kVp. We measured HU in the central portion of GB with region of interest 
(ROI) of 2cm[2] in portal phase on DICOM images. Student t-test and Chi-
square test were employed as statistical methods. p-value less than 0.05 was 
considered as statistically signiﬁcant.
Results: HU of GB ﬂuid in disease patients was 23.74 ±10.44 and that in 
control group was 17.66 ± 8.19 ( p= 0.001 ). HU over 30 was observed in 15 in 
acute pancreatitis compared with 3 in control group. No difference between 
two groups in age and sex distribution was observed.
Conclusion: GB ﬂuid attenuation of disease patients was higher than those of 
control group. Probably, calcium bilirubinate crystal juice might be one of 
causes of acute unspeciﬁed pancreatitis.




Does diffusion-weighted imaging contribute to 
differentiation of benign and malignant portal vein 
thrombus?
K. Sandrasegaran, B. Tahir, F. Akisik, M. Tann;  
Indianapolis, IN/US
Purpose: The purpose of this study was to determine whether diffusion-
weighted imaging (DWI) adds to the differentiation of benign from malignant 
portal vein thrombus (PVT) in cirrhotic patients.
Material and Methods: Retrospective review of MRI examinations was 
performed for reports containing phrase “portal vein thrombus”. PVT was 
considered tumor thrombus (n=15) if it progressed in distribution in <3 months 
in the presence of HCC, or there was tumor thrombus on portal vein cytology. 
Bland thrombus was diagnosed if PVT remained stable for >12 months follow 
up (n=19). Images were analyzed by two radiologists, blinded to follow up, for 
signal intensity on DWI of PVT compared to liver (hypo, iso or hyperintense) 
and ADC measurements of PVT, HCC and unaffected liver.
Results: MRI parameters that were signiﬁcant on logistic regression analysis 
were distance of thrombus from HCC (p<0.01), arterial enhancement of PVT 
(p<0.01), venous enhancement of PVT (p=0.04), and size of HCC (p<0.01). 
Signal characteristics of PVT on DWI, ADC measurements of PVT, ADC ratios 
of PVT to liver were not signiﬁcant. The presence of at least two of three MRI 
ﬁndings, (a) distance from tumor to PVT of < 5 cm, (b) HCC size of > 10 cm, 
and (c) arterial enhancement of PVT, had a sensitivity of 100% (95% CI 78-
100%) and speciﬁcity of 90% (95% CI 55-98%) for malignant PVT.
Conclusion: DWI does not add to the differentiation of malignant and benign 
PVT.
SS 15.02
1.5 Tesla versus 3 Tesla versus 7 Tesla abdominal MRI: 
the more Tesla, the better?
L. Umutlu, S. Maderwald, A. Fischer, M. Forsting,  
M.E. Ladd, O. Kraff, T.C. Lauenstein; Essen/DE
Purpose: The aim of this study was to investigate and to compare the 
diagnostic ability of 1.5, 3 and 7 Tesla in vivo abdominal MRI.
Material and Methods: 12 volunteers were examined on a 1.5 T, 3 T and 7 T 
MR system with equivalent FOV and acquisition times including: (1) T1w fs 2D 
and (2) 3D FLASH, (3) T1w fs VIBE, (4) T1w 2D i.-and-op. phase, (5) True-FISP 
and (6) T2w TSE. Qualitative image analysis was performed regarding (1) 
overall image quality, (2) delineation of abdominal vasculature, (3) delineation 
of the biliary duct system and (4) image impairment. For correlation of signal 
intensities, regions-of-interest were assessed in parenchymatous organs.
Results: Overall image quality was rated comparably high for T1w imaging in 
all three ﬁeld strengths, with 7T T1w MRI showing its superiority in the 
assessment of non-enhanced abdominal vasculature due to a hyperintense 
vessel-signal (mean1.5T 1.2, mean3T 1.2, mean7T 3.6). T2w TSE showed a 
statistical signiﬁcant strong impairment in 7 T MRI (mean1.5T 3.4, mean3T 3.5, 
mean7T 1.5). Quantitative image analysis revealed an increase in the mean 
organ signal from 1.5 T to 3 T of 1.45 on average (p=0.04) with a mild further 
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evaluated liver image quality. Signal intensity (SI) of the right and left liver lobe were 
measured for unenhanced and enhanced images using a a 1-cm2 manual ROI. A 
Student’s t-test was used to demonstrate signiﬁcant difference.
Results: No signiﬁcant difference in mean image quality was observed 
(p>0.05). Liver SI on enhanced images was signiﬁcantly lower (p<0.05) than on 
unenhanced images.
Conclusion: Gd-EOB-DTPA affects DWI at low b values resulting in a SI 
reduction. The SI modiﬁcation could inﬂuence the perfusion fraction quantiﬁcation 
applying intravoxel incoherent motion (IVIM)-based biexponential analysis.
SS 15.08
Low-tube-voltage, intermediate-tube-current 
multidetector liver CT with sinogram afﬁrmed iterative 
reconstruction (SAFIRE) algorithm for detection of 
hypervascular hepatocellular carcinoma
M.H. Yu, J.M. Lee, J. Yoon, J.H. Baek, J.K. Han, B.I. Choi; 
Seoul/KR
Purpose: The purpose of this study was to assess the image quality, lesion 
conspicuity and radiation dose of sinogram afﬁrmed iterative reconstruction 
(SAFIRE) compared with ﬁltered back projection (FBP) for low-tube-voltage 
(80-kVp), intermediate-tube-current (300-mA) liver CT for detection of 
hypervascular hepatocelluar carcinoma (HCC).
Material and Methods: 126 patients suspected of having HCCs who 
underwent multiphasic liver CT using dual-energy scanning (300 mAs for each 
80-kVp tube) were included. The late arterial scans of one tube (half-dose) 
were reconstructed with FBP, iterative reconstruction in image space (IRIS) 
and 5 difference SAFIRE percentage sets (S1-S5), respectively, and then 
compared with corresponding full-dose virtual scans (mixed ratio of 0.5: 
600mA) with FBP. Quantitatively, image noise; contrast-to-noise ratio (CNR) 
relative to muscle for the liver, aorta, portal vein; CNR of lesion- to-liver were 
assessed. Qualitatively, two abdominal radiologists scored image noise, vessel 
sharpness, lesion conspicuity and overall image quality in consensus. The 
results of image assessment were compared among FBP, IRIS and SAFIRE.
Results: The image noise on SAFIRE was signiﬁcantly lower and CNRs on 
SAFIRE were signiﬁcantly higher than on FBP (p<0.001). CNR of lesion-to-liver 
on SAFIRE (S5) was signiﬁcantly higher than on both IRIS and full-dose FBP 
(p<0.05). For all qualitative analysis, half-dose SAFIRE acquired higher score 
than FBP and similar score to full-dose FBP. Mean CTDI~vol~ for half-dose 
late arterial scans was 2.63 mGy.
Conclusion: Half-dose 80-kVp liver CT protocol with SAFIRE may increase 
image quality and maintain diagnostic accuracy at reduced radiation dose, 
compared with full-dose protocol with FBP.
SS 15.09
Radiation dose in multiphasic CT of the liver using 
ﬁltered back projection and iterative reconstruction: 
how low can we go while preserving diagnostic 
accuracy?
S.T. Schindera, D. Odedra, H. Mehrez, P. Rogalla;  
Toronto, ON/CA
Purpose: The purpose of this study was to compare image quality and diagnostic 
accuracy at different radiation dose levels with ﬁltered back projection (FBP) and 
iterative reconstruction (IR) for multiphasic CT of the liver.
Material and Methods: Two liver phantoms with simulated HCC during the 
arterial and portal-venous phase were designed. Both phantoms contained 12 
tumors with four diameters (5, 10, 15 and 20 mm) and three tumor-to-liver contrast 
values (±10, ±20 and ±40HU). A fat ring was added to the phantoms to mimic a 
medium size patient (total diameter, 30 cm). The phantoms were scanned using 
standard abdominal imaging protocol [120 kVp; standard deviation (SD) value 15]. 
Low dose protocols were acquired at 70, 60, 50, 40, 30 and 20% of the standard 
protocol. CT data sets were reconstructed with FBP and IR (AIDR 3D, Toshiba). 
Image noise was measured and contrast-to-noise ratio (CNR) of the tumors was 
calculated. Tumor detection was performed by two readers.
Results: IR reduces image noise by 45-66% and increases CNR by 82-204% 
compared to FBP depending on the dose level and enhancement phase. 
Sensitivity for tumor detection of the standard protocol was maintained while 
lowering the dose to 70% with FBP and to 40% with iterative reconstruction in 
both simulated phases.
Conclusion: The radiation dose of arterial and portal-venous hepatic CT can 
be reduced up to 30% with FBP and up to 60% with IR technique while 
preserving diagnostic accuracy.
SS 15.05
Is a liver size measurement as accurate as automated 
volumetry for predicting hepatomegaly? Preliminary 
results on liver transplant patients
S. Nougaret1, H. Addley2, S. Al Sharif3, S. Fujii4, B.P. Gallix1, 
C. Reinhold3;  1Montpellier/FR, 2Cambridge/UK,  
3Montreal, QC/CA, 4Tottori/JP
Purpose: The aim of our study was to compare several liver length 
measurements and liver automated volumetry on CT to liver weight in order to 
ﬁnd an easy and accurate method to assess hepatomegaly on CT. Indeed, 
automated volumetry needs trained users and dedicated software. In clinical 
practice, it may be desirable to have a simple method for rapid estimation of 
hepatomegaly.
Material and Methods: We compared, in forty liver pretransplant patients, 
automated CT volumetry to liver weight on pathology to describe the correlation 
between weight and automated volumetry. For each patient, we measured on 
CT craniocaudal, maximal transverse, midclavicular, oblique craniocaudal at 
the level of the hepatic veins and maximal oblique craniocaudal lengths and 
compared these results liver weight on pathology.
Results: There was a statistically excellent positive correlation (r[2]= 0.95[0.90-
0.98], p<.0001) between liver volume and liver weight. The regression line was 
y = 0.94x+40, where x and y indicate the measured weight and volume, 
respectively. 14 patient presented hepatomegaly on pathology predicted on 
every cases on automated volumetry. Using liver size measurements, the 
maximal oblique craniocaudal length was best correlated to liver weight 
(r2=0.80[0.72-0.85], p<.0001). According to ROC curve, a maximal oblique 
craniocaudal length of over 175 mm was associated with hepatomegaly 
(sensitivity 90%, speciﬁcity 87%, AUC= 0.91[0.85-0.95], p=0.0001).
Conclusion: Automated volumetry is a reliable method to predict liver weight. 
However, in clinical practice, maximal oblique craniocaudal could be used to 
easily predict hepatomegaly.
SS 15.06
Gadoxetate-enhanced MRI after liver resection for 
hepatocyte damage quantiﬁcation
S. Bickelhaupt1, C. Kim-Fuchs2, D. Candinas2, P. Studer2, 
J.M. Froehlich1, M.A. Patak1;  1Zurich/CH, 2Bern/CH
Purpose: Intraoperative handling procedures during liver resection may 
inevitably result in damaged liver tissue slightly larger than the usual resection 
surface. Its assessment and quantiﬁcation might be crucial in patients with 
preoperatively calculated borderline liver volumes. The aim was to determine 
the feasibility of evaluating hepatocyte damage using hepatocyte-speciﬁc 
contrast (Primovist®, Gd-EOB, Schering, Berlin, Germany) as an MRI marker 
for viable hepatocytes after liver resection.
Material and Methods: 15 patients were prospectively included in this study 
prior to elective liver resection. Gadoxetate-enhanced MRI (3T, Verio, Siemens, 
Erlangen Germany) was performed 3-7 days after surgery. T1-w GRE (Vibe) 
series were acquired after contrast administration. SNR of the resection border 
was compared to healthy liver rim and the area of non-viable tissue was 
compared with a standardized intraoperative area measurement. The paired 
Student’s t-test was used statistically.
Results: 2 patients dropped out, 12 of the remaining 13 patients showed 
sufﬁcient image quality for measurement. Mean MRI resection surface was 
75.65cm[2] (±28.65, depending on resection modality). Mean contrast 
enhancement was signiﬁcantly reduced (p<0.05) in the tissue next to the 
resection surface (mean SNR: 67.95 ±29.05) compared to healthy liver rim 
(mean SNR: 81.79 ±35.96).
Conclusion: After liver resection, contrast enhancement at the resection 
border was signiﬁcantly reduced suggesting an intraoperative affection of 
remaining liver tissue. Gadoxetate as a surrogate marker of tissue viability thus 
seems a promising approach.
SS 15.07
Liver diffusion-weighted imaging (DWI) on 3-T MRI: 
Gd-EOB-DTPA effects on low b value images
C.N. De Cecco1, M. Rengo1, M. Maceroni2, P. Lucchesi1,  
G. Muscogiuri1, A. Laghi2;  1Rome/IT, 2Latina/IT
Purpose: The purpose of this study was to evaluate Gd-EOB-DTPA effects on 
low b value diffusion-weighted imaging (DWI) of the liver.
Material and Methods: Twenty consecutive patients were studied with a 3 T MRI 
(Discovery MR750, General Electrics). A multi-b DWI sequence (b-values: 0, 10, 20, 
30, 50, 70, 100 s/mm2) was acquired with respiratory trigger before and after the 
administration of Gd-EOB-DTPA (0.025 mmol/kg) using the following parameters: 
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Material and Methods: 23 patients underwent ultrasound-navigated biopsies 
or interventions using V Nav image fusion of live fundamental ultrasound with 
ceCT, ceMRI or CEUS, which were acquired before the intervention. A CEUS 
data set was acquired in all patients. An image fusion was established for 
CEUS and CT or CEUS and MRI using anatomical landmarks in the area of the 
targeted lesion. The deﬁnition of a virtual biopsy line with navigational axes 
targeting the lesion was achieved by the usage of sterile trocar with a magnetic 
sensor embedded in its distal tip employing a dedicated navigation software 
for real-time needle tracking.
Results: In all 10 biopsies of suspect lesions of the liver, a histological 
conﬁrmation was achieved with a puncture from extrahepatic subcostal. We 
also used V Nav, a biopsy of the abdominal wall (metastasis) and for 
radiofrequency ablations (4 ablations). In 8 cases of inﬂammatory abdominal 
lesions, 9 percutaneous drainages were successfully inserted.
Conclusion: Percutaneous biopsies and drainages, even of small lesions 
involving complex access ways, can be accomplished with high success rate 
using 3D real-time image fusion together with real-time needle tracking.
SS 16.03
The diagnostic value of small bowel wall vascularity 
after sulfur hexaﬂuoride-ﬁlled microbubble injection in 
the differentiation of inﬂammatory and ﬁbrotic stenoses 
in patients with Crohn’s disease
E. Quaia, B. Cabibbo, T. Stocca, E. Pantano, M.A. Cova; 
Trieste/IT
Purpose: The purpose of this study was to assess the value of small bowel 
wall vascularity on contrast-enhanced US to differentiate inﬂammatory from 
ﬁbrotic stenoses in patients with Crohn’s disease (CD).
Material and Methods: Twenty-two patients (10 male and 12 female; mean 
age ± SD, 45.12 ± 13.25 years; range 23-63) with a biopsy-proven diagnosis of 
CD involving at least one ileal loop (wall thickness >5mm) were included. In 
each patient, the thickest ileal loop segment was scanned by contrast-
enhanced US after sulfur hexaﬂuoride-ﬁlled microbubble injection, and digital 
cine-clips (60 secs) were stored. Echo signal was quantiﬁed in grey-scale 
levels (0-255) by a manually drawn ROI encompassing the bowel wall. The 
percentage of enhancement compared to baseline, time to peak enhancement, 
and area under curve were quantiﬁed.
Results: All patients revealed diffuse transparietal contrast enhancement, 
except for 5 patients with ﬁbrotic stenosis who revealed contrast enhancement 
limited to the submucosa (n=3) or absent enhancement (n=2). Inﬂammatory 
versus ﬁbrotic stenoses did not differ in the percentage of enhancement (46.43 
± 5.67 36.81 ± 17.38 vs 43.25 ± 4.99%; P>.05) and in the time to peak 
enhancement (9.28 ± 4.42 vs 14.5 ± 7.33 secs; P>.05), while differed in the area 
under the enhancement curve (1148.51 ± 474.15 vs 680.69 ± 274.36; P<.05).
Conclusion: Bowel wall vascularity quantitation on contrast-enhanced US 
may differentiate inﬂammatory from ﬁbrotic stenoses in patients with CD based 
on the area under the enhancement curve.
SS 16.04
Contrast-enhanced ultrasound for differential diagnosis 
of suspected GvHD in patients after allogeneic 
transplantation
L.M. Dendl, G. Schill, C. Stroszczynski, E. Jung, A.G. Schreyer; 
Regensburg/DE
Purpose: GvHD is a serious complication in patients after allogeneic 
transplantation presenting with unspeciﬁc symptoms. Early differential 
diagnosis of GvHD (vs. viral or bacterial enteritis) is highly important. Recently, 
we detected penetration of microbubbles through the bowel wall as a 
diagnostic indicator for GvHD. In this study, we evaluate contrast-enhanced 
ultrasound (CEUS) as a new differential diagnostic tool in GvHD.
Material and Methods: We examined 23 patients with abdominal symptoms 
after allo-SCT. All patients underwent CEUS with particular attention to 
penetration of the intravenously applied microbubbles in the bowel lumen. The 
resulting examinations were documented digitally.
Results: Out of 17 patients with conﬁrmed GvHD of the GI tract, 14 showed 
penetration of the intravenously applied microbubbles into the bowel lumen, 
leading to a sensitivity and speciﬁcity of 82% and 100% for transmural bubble 
penetration for GvHD of the GI-Tract, since the patients without GvHD of the 
GI tract showed no transmural bubble penetration. In patients with viral or 
bacterial infections of the GI tract, no transmural penetration of the 
microbubbles into the bowel lumen was observed.
Conclusion: Using CEUS showing microbubble penetration as a criterion for 
GvHD of the GI-Tract, a negative predictive value of 67%, and a positive 
predicative value of 100% was calculated. Therefore, we consider CEUS as an 
excellent differential diagnostic tool in patients with the suspicion of GvHD.
SS 15.10
Comprehensive evaluation of liver changes in primary 
sclerosing hepatitis using MRI
J. Kovac, B. Banko, G. Lilic, M. Kratovac Dunjic,  
R. Milenkovic, R. Jesic, R. Maksimovic; Belgrade/RS
Purpose: The purpose of this study was to evaluate magnetic resonance 
imaging (MRI) ﬁndings in the patients with primary sclerosing cholangitis (PSC) 
and to determine the value of diffusion-weighted imaging in the assessment of 
liver ﬁbrosis.
Material and Methods: The following MRI ﬁndings were reviewed in 32 
patients: periportal hyperintensity (T2-weighted hyperintensity around portal 
venous branches), lymphadenopathy, splenomegaly, ascites, morphological 
liver changes and magnetic resonance cholangiopancreatography (MRCP) 
ﬁndings. Apparent diffusion coefﬁcient (ADC) was calculated for six locations 
in the liver for b=800 s/mm[2].
Results: Periportal hyperintensity was observed in 10 patients (31.2%). 
Lymphadenopathy was noted in 31% and signs of portal hypertension in 55.5% of 
patients. The most common morphological liver change was left lobe hypertrophy 
(30.8%), while spherical liver shape was observed in 2 patients. 78.6% of patients 
had bile duct irregularities, with left and right hepatic stenoses occurring most 
frequently (67.8%). The mean ADCs (x10[-3]mm[2]/s) were signiﬁcantly different at 
stages II versus III. There was signiﬁcant negative correlation between ADCs and 
histological stage (=- 0.749, p<0.001). Areas under receiver operating characteristic 
curves were 0.899 (stageII) and 0.936 (stageIII).
Conclusion: MRI should be used as a part of standard diagnostic protocol in 
the evaluation of disease progression in PSC patients.




Intraoperative high-resolution linear contrast-enhanced 
ultrasound (IOUS) for the detection of 
microvascularization of malignant liver lesions before 
surgery or radiofrequeny ablation
E. Jung, A. Agha, J. Rennert; Regensburg/DE
Purpose: The aim of this study was to evaluate the value of linear contrast-
enhanced intraoperative ultrasound (CE-IOUS) to improve detection of 
malignant liver lesions before surgery or radiofrequency ablation (RFA).
Material and Methods: 50 patients were included for surgery of malignant 
liver tumors [mean age 61 years (19-80); male n=35, female n=15], suffering 
from HCC (n=15), colorectal liver metastasis (n=28), CCC (n=2) or other malign 
liver lesions (n=5). Preoperative CE-CT (n=38), CE-MRI (n=23) or PET-CT (n=8) 
conﬁrmed hepatic tumor manifestation. Before undergoing surgery, 
intraoperative conventional (IOUS) as well as CE-IOUS was performed by one 
experienced examiner in all cases using multifrequency linear probes (6-9 
MHz, 6-15 MHz). CE-IOUS was performed after bolus injection of 5 ml up to 
15 ml SonoVue® (Bracco, Italy). Digitally stored images of CE-IOUS were 
compared with fundamental B-Scan and preoperative imaging (CE-CT, CE-
MRI and PET-CET).
Results: In 28 of 50 patients (56%), additional lesions were found using CE-
IOUS (mean tumor size 8 mm, range 4-12 mm). This required a change of 
surgical strategy or an intraoperative RFA in 27 patients (54%). Modiﬁcation of 
therapy due to additionally found liver lesions was statistically signiﬁcant.
Conclusion: This is the ﬁrst study using contrast-enhanced ultrasound with high 
resolution linear probes for intraoperative detection of malignant liver lesions. 
Compared to preoperative imaging and also conventional IOUS, more than 40% 
additional lesions were found leading to therapeutic consequences of patients.
SS 16.02
Volume navigation with contrast-enhanced ultrasound 
and image fusion for percutaneous interventions: ﬁrst 
results
L.M. Dendl, E. Jung, C. Stroszczynski, A.G. Schreyer; 
Regensburg/DE
Purpose: The purpose of this study was to assess the feasibility and efﬁciency 
of biopsies and interventions using ultrasound (US) volume navigation (V Nav) 
with real-time needle tracking and real-time image fusion with contrast-
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SS 16.07
Ultrasound in clinically equivocal appendicitis: the real 
world experience
N.D. Grunshaw1, P.L.S. Cheong2;  1Barrow in Furness/UK, 
2Darlington/UK
Purpose: Whilst imaging can reduce the negative appendicectomy rate, a 
variety of strategies exist. Much of the available data relates to CT and comes 
from specialist centres. In our institution, clinical review remains the primary 
assessment, imaging reserved for clinically equivocal cases. The purpose of 
this study is to review the value of ultrasound in reducing negative 
appendicectomy in clinically equivocal cases in a District General Hospital 
setting.
Material and Methods: Review of 8 years ultrasound in clinically equivocal 
appendicitis was performed. CT was used as secondary test. Final outcome 
was determined by case note review and operative histology. All examinations 
were performed by one operator, appendicitis was diagnosed on the basis of 
appendiceal thickening (>6mm) and periappendiceal inﬂammatory change. 
Review was performed of histology of non-imaged appendicectomies during 
the same period.
Results: 265 cases were identiﬁed. Ultrasound sensitivity was 83%, speciﬁcity 
92%, PPV 75%, NPV 95%, LR+ 10.3, LR- 0.19. The normal appendix was 
visualised in 25% of negatives. In 16%, ultrasound suggested signiﬁcant 
alternative diagnoses. This strategy together with clinical re-evaluation resulted 
in only 7 (3%) normal appendices being removed compared with 19% in the 
non-imaged group. Overall CT usage was 14%.
Conclusion: Primary ultrasound can signiﬁcantly reduce the negative 
appendicectomy rate and necessity for CT scanning in clinically equivalent 
appendicitis. The reduction in false negative appendicetomy rate is such that 
wider use of a primary ultrasound imaging strategy should be considered.
SS 16.08
Pretherapeutic histological evaluation of gastric 
submucosal tumour by endoscopic ultrasound-guided 
ﬁne needle aspiration
K. Akahoshi, M. Oya, Y. Motomura, M. Kubokawa, S. Itaba, 
J. Gibo, K. Komori, N. Nakama, M. Yamada, Y. Minoda,  
K. Tokumaru; Iizuka/JP
Purpose: Diagnosis of gastric submucosal tumour (SMT) using EUS imaging 
alone is very difﬁcult. EUS-guided ﬁne needle aspiration (EUS-FNA) is a 
promising technique to obtain tissue samples with minimal risks. The aim of 
this study was to evaluate the efﬁcacy and accuracy of EUS-FNA in the 
diagnosis of gastric SMT.
Material and Methods: From September 2002 to November 2011, 165 
consecutive EUS-FNAs of gastric hypoechoic solid SMT diagnosed by 
standard EUS were evaluated prospectively. The reference standards for the 
ﬁnal diagnosis were surgery (n=98), or clinical follow-up (n=67). Additionally, 
immunophenotyping of specimens obtained by EUS-FNA and surgical 
resection specimens were compared.
Results: In 5 cases, puncture was not performed because of anatomical 
problems. The diagnostic rate of the gastric hypoechoic solid SMT was 86% 
(137/160). The diagnostic rate according to the tumour size and location was 
75% (59/79) in less than 2 cm, 97% (66/68) in 2-5 cm, and 92% (12/13) in 5 cm 
or more, 79% (23/29) in the lower portion, 86% (77/90) in the middle portion, 
and 90% (37/41) in the upper portion. In 92 surgically resected cases, the 
diagnostic accuracy of EUS-FNA using immunohistochemical analysis of 
gastric hypoechoic solid SMT was 96% (88/92). No major complications were 
encountered.
Conclusion: EUS-FNA with immunohistochemical analysis is an effective and 
accurate method in the pretherapeutic diagnosis of gastric SMT, irrespective 
of tumor size and location.
SS 16.05
Wash out of hypervascular malignant lesions on CEUS: 
quantiﬁcation using a semiquantitative index
L. Sottocornola, P. Cabassa, M. Ravanelli, A. Giardini,  
R. Maroldi; Brescia/IT
Purpose: The purpose of this study was to quantify the wash out of malignant 
liver lesions at CEUS, using a semiquantitative index.
Material and Methods: From the institutional database of focal liver lesions 
studied with CEUS 103 hypervascular lesions were retrospectively analysed. 
Inclusion criteria were: histologically proven malignant lesions; at least 12 
months of follow up for benign lesions (with adequate imaging); no previous 
(<3 months) treatments with chemotherapy or TACE/RF. CEUS was performed 
with 2.4 ml of SonoVue with dedicated software (contrast coherent imaging). 
One signiﬁcant frame (in bitmap format) of portal phase was chosen for each 
lesion and analysed by software (AdobePhotoshop 7.0). Two circular deﬁned 
regions of interest (ROI) for each image were drawn encompassing the lesion 
and the adjacent normal parenchyma. Sonography videotape intensity (VI) was 
measured in gray-scale levels (0-255) through histogram analysis for each ROI. 
Background VI was set at the same level for each image. A semiquantitative 
index (VItumor–VIliver/VIliver) was calculated. Results were compared with the 
ﬁnal diagnosis and statistically analysed.
Results: Final diagnosis was: 54 HCCs, 10 cholangiocarcinomas, 19 
metastasis and 20 benign lesions (mainly FNH). A statistically signiﬁcant 
different index was found between benign and malignant lesions (p<0.005). 
Among malignant lesions, the index was signiﬁcant different between HCCs 
and CCCs/metastasis (p<0.005) but not between CCCs and metastases.
Conclusion: CCCs and metastasis shows a different quantiﬁable wash out 
than HCCs. This could help in the discrimination among focal liver lesions in 
different scenarios.
SS 16.06
Should sonographers or radiologists perform ultrasound 
scans of the gallbladder?
H.Y. Leung, Z. Toumi, K.G. Pursnani; Lanchashire/UK
Purpose: The purpose of this study was to evaluate the reliability of ultrasound 
scan (USS) performed by sonographers and radiologist in detecting 
gallstones.
Material and Methods: Patients were identiﬁed by retrieving all 
cholecystectomies operation notes of a single surgeon (May 2005-November 
2011). The accuracy, sensitivity and speciﬁcity of USS performed by 
sonographers and radiologists in identifying gallstones were evaluated by 
comparing with histology and operative report.
Results: Among 515 patients identiﬁed (393 female, 76%), 444 were included 
(91 have insufﬁcient data available). Median age was 51 (range 16-90). 
Sonographers performed 339 USS (76%). The overall sensitivity, speciﬁcity 
and accuracy were 97.2% (95% conﬁdence interval, CI, 95.6-99.8%), 25.0% 
(95% CI 12.8–37.3%) and 89.4%, respectively. Positive and negative predictive 
values were 91.4% and 52.2%, respectively. Positive and negative likelihood 
ratios were 1.30 and 0.11, respectively. The prevalence of gallstone in our 
study population was 89.2%. Radiologists and sonographers have no 
signiﬁcantly different (p>0.05) sensitivity (97.0% vs. 97.3%), speciﬁcity (40.2% 
vs.18.2%) and accuracy (89.7% vs. 89.3%). Radiologists had signiﬁcantly 
higher speciﬁcity than sonographers among female patients (50.0% vs. 11.8%, 
p<0.01), while sensitivity and accuracy were similar and not signiﬁcantly 
different. No signiﬁcant difference was observed in male patients. The 
sensitivity and positive predictive value of detecting gallbladder polyp were 
66.7% and 40%, respectively (n=6).
Conclusion: Sensitivity and accuracy in this study were comparable, but 
speciﬁcity was lower than previous reports. Recommendation: Radiologist 
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SS 16.09
Diagnostic performance of  contrast-enhanced 
ultrasound and MDCT in the characterization of focal 
liver lesions: comparison between readers with different 
levels of experience
R. Basilico, E. Rodolﬁno, V. Calamita, A.R. Ferri,  
A.R. Cotroneo;  Chieti/IT
Purpose: The purpose of this study was to assess the diagnostic performance 
of contrast-enhanced ultrasound (CEUS) and MDCT in the diagnosis of focal 
liver lesions by comparing readers with different levels of experience.
Material and Methods: 130 focal liver lesions, studied by means of CEUS and 
MDCT, were randomly reviewed by two readers with 10 and 3 years of 
experience in both CEUS and MDCT studies. They scored the lesions as 
benign, malignant or uncertain and gave the most likely etiologic diagnosis on 
each imaging modality, being unaware of the clinical history of the patients. 
Final diagnosis was based on pathology, conﬁrmatory imaging and on at least 
6-month imaging follow up.
Results: Final diagnoses were 40 benign lesions (20 hemangiomas, 9 FNHs, 4 
focal steatosis areas, 4 focal fatty sparing, 1 abscess, 1 adenoma, 1 
regenerative nodule) and 90 malignancies (73 metastases, 15 HCCs, 2 
cholangiocarcinomas). For both readers, CEUS showed higher diagnostic 
performance than MDCT in differentiating benign from malignant lesions. The 
most experienced reader correctly characterized 125/130 lesions on CEUS 
and 128/130 on MDCT; the less experienced reader correctly characterized 
110/130 on CEUS and 105/130 on MDCT.
Conclusion: The diagnostic performance of CEUS and MDCT in the 
characterization of focal liver lesions depends on the observer’s level of 
experience. Less experienced reader better characterized liver lesions by 
means of CEUS than MDCT due to the capability of CEUS to easily differentiate 
benign from malignant lesions.
SS 16.10
Low dose CT for renal calculi: detection rate of 
gastrointestinal ﬁndings
J. Sammon, P. McLaughlin, M. Twomey, S. O’Neill, S.A. Hayes, 
O.J. Flanagan, M. Maher; Cork/IE
Purpose: Unenhanced helical CT of the abdomen and pelvis (CT KUB) is the 
diagnostic test of choice in patients with suspected renal tract calculi. The 
purpose of this study is to assess the impact of a mean dose reduction of 83% 
(p<0.0001) on the ability to detect additional abdominal ﬁndings.
Material and Methods: Following ethical approval, 30 patients referred for 
clinically indicated CT KUB (57% male) consented to undergo an additional 
low-dose (LD) CT KUB as well as a conventional dose (CD) CT KUB. The LD 
CT KUB protocol was designed to have an effective dose of 0.5 mSv (mean 
dose 0.49±0.12mSv), the equivalent of an abdominal radiograph. All LD images 
were reconstructed with 70% adaptive statistical iterative reconstruction 
(ASIR). The CD and LD images were reviewed by two radiologists who recorded 
additional gastrointestinal ﬁndings as well as the presence or absence of 
calculi on both sets of images.
Results: There were 23 additional ﬁndings on CD imaging (n=4 were clinically 
important). Only 13 (56%) of the additional ﬁndings were detected on LD 
imaging (P<0.0019); sensitivity 56.5% (95%CI 0.36-0.76). None of the 4 
clinically important ﬁndings were detected.
Conclusion: LD CT KUB imaging using ASIR may allow adequate detection of 
renal calculi; however, our study demonstrates a signiﬁcant difference in the 
identiﬁcation of relevant abdominal ﬁndings and the failure to diagnose 
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Jung E.: SS 2.09, SS 13.02, SS 16.01,  
SS 16.02, SS 16.04
Jung S.: SS 3.06
K
Kalra N.: SS 10.05
Kandel S.: SS 8.10
Kane P.: SS 13.01
Kang D.: SS 14.05
Karani J.: SS 13.01
Karmazanovsky G.: SS 4.10, SS 8.08
Kauczor H.: SS 8.04, SS 10.03
Kauffmann C.: SS 5.10
Kay C.: SS 1.04, SS 2.10, SS 11.01
Kellati P.: SS 2.04
Kerr S.: SS 1.07
Kessels A.: SS 12.09
Khandelwal N.: SS 10.05
Kiefer B.: SS 5.08
Kieser M.: SS 8.04
Kilicoglu G.: SS 11.04
Kim-Fuchs C.: SS 15.06
Kim J.: SS 8.01, SS 8.02, SS 10.09
Kim S.: SS 8.02, SS 10.04, SS 10.07,  
SS 14.06
Kim Y.: SS 3.06
Kinner S.: SS 3.09
Klauß M.: SS 8.04
Kloeters C.: SS 9.02
Kluza E.: SS 12.08
Koelblinger C.: SS 10.02
Koestler H.: SS 9.10
Komori K.: SS 16.08
Kovac J.: SS 15.10
Kraff O.: SS 14.01, SS 15.02
Kratovac Dunjic M.: SS 15.10
Kubokawa M.: SS 16.08
Kuk D.: SS 7.01
Kupcsulik P.: SS 2.08
L
Lörinc E.: SS 7.06
Löwenberg M.: SS 6.10
Laasch H.: SS 2.04, SS 2.10
Ladd M.: SS 14.01, SS 15.02
Laghi A.: SS 1.03, SS 1.08, SS 9.05,  
SS 11.05, SS 11.07, SS 11.10, SS 15.07
Lambregts D.: SS 7.05, SS 7.07,  
SS 12.06, SS 12.07, SS 12.08
Lammer J.: SS 10.02
Lannoo M.: SS 3.03
Larson M.: SS 14.04
Lastoria S.: SS 2.06
Laudi C.: SS 11.09
Lauenstein T.: SS 3.09, SS 9.02, SS 14.01, 
SS 15.02
Lazzi S.: SS 12.04
Lebigot J.: SS 5.04
Lee E.: SS 14.06
Lee J.: SS 5.07, SS 8.01, SS 8.02, SS 14.06, 
SS 15.08
Lee J.: SS 8.01, SS 8.02, SS 14.06
Lee M.: SS 10.07
Lee S.: SS 14.08
Lee W.: SS 10.04, SS 10.07, SS 10.09
Lee Y.: SS 14.05
Lefere I.: SS 11.06
Lefere M.: SS 11.06
Lefere P.: SS 11.06
Leijtens J.: SS 7.05, SS 12.07
Leslie M.: SS 7.03
Leung H.: SS 16.06
Li X.: SS 9.07
Li Y.: SS 9.07
Li Z.: SS 8.06
Liese J.: SS 9.10
Lilford R.: SS 1.02, SS 1.05, SS 11.01
Lilic G.: SS 15.10
Lim J.: SS 10.04, SS 10.07
Lim K.: SS 14.10
Lindebjerg J.: SS 12.01
Longerich T.: SS 10.03
Lorenzoni G.: SS 2.07
Loss M.: SS 2.09













Lucchesi P.: SS 9.04, SS 15.07
M
Mönninghoff C.: SS 9.02
Münzel D.: SS 13.10
Maas M.: SS 5.05, SS 7.05, SS 7.07,  
SS 12.06, SS 12.07, SS 12.08
Maceroni M.: SS 9.05, SS 11.05,  
SS 11.10, SS 15.07
Macpherson J.: SS 14.09
Maderwald S.: SS 15.02
Maher M.: SS 16.10
Makanyanga J.: SS 6.01, SS 6.08
Maksimovic R.: SS 15.10
Malet A.: SS 10.10
Mallett S.: SS 1.05, SS 11.08
Manfredi R.: SS 4.07, SS 4.08, SS 4.09
Mantarro A.: SS 1.01, SS 7.10
Maresch J.: SS 5.02, SS 5.03
Maroldi R.: SS 5.01, SS 13.09, SS 16.05
Marques C.: SS 15.04
Marrelli D.: SS 3.02, SS 9.08
Martens M.: SS 7.05, SS 7.07, SS 12.06, 
SS 12.08
Martin J.: SS 10.10
Mateus Marques R.: SS 7.08
Matos C.: SS 4.01, SS 9.04
Mazzei F.: SS 9.08
Mazzei M.: SS 3.02, SS 9.08
McCartney S.: SS 6.08
McLaughlin P.: SS 16.10
McQuillan J.: SS 11.08
Mehrez H.: SS 15.09
Mendonça P.: SS 7.08
Menys A.: SS 6.01, SS 6.05, SS 6.08
Mercuri P.: SS 3.02
Meric K.: SS 11.04
Merz F.: SS 6.04
Metens T.: SS 9.04
Meulman T.: SS 9.06
Meyer H.: SS 8.10
Meyer T.: SS 9.10
Mezzanzanica M.: SS 7.04
Michalak S.: SS 5.04
Mieth M.: SS 10.03
Milenkovic R.: SS 15.10
Milson A.: SS 14.09
Minoda Y.: SS 16.08
Monguzzi L.: SS 12.03
Moon S.: SS 14.05
Motomura Y.: SS 16.08
Mueller V.: SS 9.10
Mullan D.: SS 2.04
Muscogiuri G.: SS 15.07
N
N’Kontchou G.: SS 2.02
Nakama N.: SS 16.08
Nederveen A.: SS 5.05, SS 5.06
Negrelli R.: SS 4.07, SS 4.08
Nensey R.: SS 3.08
Neri E.: SS 1.01, SS 6.03, SS 7.10,  
SS 10.08, SS 11.02, SS 11.07
Neubauer H.: SS 9.10
Neumann R.: SS 4.04, SS 15.03
Nießen C.: SS 13.02
Nikolaou K.: SS 15.03
Noël P.: SS 13.10
Nolz R.: SS 5.02, SS 5.03
Nougaret S.: SS 15.05
Novelli M.: SS 6.05
O
O’Neill S.: SS 16.10
Odedra D.: SS 15.09
Odille F.: SS 6.05
Oliveira M.: SS 7.08
Orzada S.: SS 14.01
Osimani M.: SS 1.08, SS 9.05
Oto A.: SS 15.03
Oya M.: SS 16.08
P
Pacciardi F.: SS 8.09, SS 14.08
Pajor P.: SS 2.08
Palumbo M.: SS 12.04
Pancrazi F.: SS 10.08
Pantano E.: SS 10.01, SS 16.03
Papagrigoriadis S.: SS 3.04
Papanikolaou N.: SS 12.06
Paprottka P.: SS 13.04
Paradis V.: SS 13.05
Parikh J.: SS 7.03
Park H.: SS 3.06, SS 10.04
Park M.: SS 10.04, SS 10.07, SS 14.08
Park S.: SS 3.06
Park U.: SS 3.06
Patak M.: SS 3.01, SS 6.02, SS 6.04,  
SS 6.06, SS 15.06
Patel P.: SS 2.03
Paty P.: SS 7.01
Peddu P.: SS 3.04
Pendse D.: SS 6.08
Perez R.: SS 1.06
Peri M.: SS 7.04
Pfeiffer F.: SS 13.10
Phillips R.: SS 3.05
Picano E.: SS 11.02
Pichi A.: SS 1.03
Pina F.: SS 7.08
Pirtoli L.: SS 12.04
Pløen J.: SS 7.02, SS 12.01
Platzek I.: SS 13.02
Platzer I.: SS 9.10
Poitou V.: SS 5.10
Ponsioen C.: SS 6.10
Pozzi Mucelli R.: SS 4.07, SS 4.08, SS 
4.09, SS 8.03, SS 10.06
Prasad D.: SS 1.04
Prieto M.: SS 10.10
Princivalle M.: SS 1.10
Proctor I.: SS 6.05
Proscurshim I.: SS 1.06
Puckett M.: SS 6.09
Puig J.: SS 10.10
Pullini S.: SS 9.03, SS 13.03, SS 13.07, 
SS 13.08
Punekar S.: SS 1.04
Punwani S.: SS 6.05, SS 6.08
Pursnani K.: SS 16.06
Q
Quaia E.: SS 10.01, SS 16.03
R
Radeleff B.: SS 10.03
Rafaelsen S.: SS 7.02, SS 12.01
Raible S.: SS 3.01, SS 6.02, SS 6.04,  
SS 6.06
Ravanelli M.: SS 5.01, SS 16.05
Rebours V.: SS 8.07
Regge D.: SS 1.03, SS 11.07, SS 11.09
Regini F.: SS 7.03
Reinhold C.: SS 15.05
Reiser M.: SS 4.03, SS 4.04, SS 13.04, 
SS 15.03
Reiter G.: SS 5.08
Remorgida V.: SS 9.11
Rengo M.: SS 1.08, SS 9.05, SS 11.05, 
SS 11.10, SS 15.07
Rennert J.: SS 16.01
Rhim H.: SS 10.04
Ricci V.: SS 12.04
Riedl R.: SS 12.06
Rigamonti P.: SS 7.04
Righi R.: SS 1.10
Rist C.: SS 4.04, SS 15.03
Rizzati R.: SS 1.10, SS 3.10
Rodolﬁno E.: SS 16.09
Rodrigues A.: SS 11.06
Rodrigues Duarte H.: SS 4.01
Rodrigues J.: SS 1.06
Rodriguez-Justo M.: SS 6.05
Rogalla P.: SS 8.10, SS 15.09
Rollandi G.: SS 9.11
Rollvén E.: SS 7.06
Ronot M.: SS 13.05, SS 13.06
Rossini A.: SS 5.01
Rottenberg G.: SS 7.03
Rozeboom E.: SS 12.08
Rummeny E.: SS 13.10
Ruszniewski P.: SS 8.07
Ryan S.: SS 3.04
S
Sørensen T.: SS 7.02, SS 12.01
Sacco R.: SS 10.08
Sailer A.: SS 12.09
Salvini N.: SS 3.02
Sammon J.: SS 16.10
Samyn M.: SS 13.01
Sanderson A.: SS 14.09
Sandrasegaran K.: SS 4.02, SS 4.06,  
SS 8.05, SS 14.07, SS 15.01
Santos P.: SS 7.08
Sardanelli F.: SS 7.04
Sauvanet A.: SS 13.05
Scagliarini L.: SS 3.10













Schemmer P.: SS 10.03
Schill G.: SS 6.07, SS 16.04
Schima W.: SS 10.02
Schindera S.: SS 15.09
Schirmacher P.: SS 10.03
Schlamann M.: SS 9.02
Schmid-Tannwald C.: SS 4.04, SS 15.03,
Schmid-Tannwald C.: SS 4.04, SS 15.03,
Schmidt G.: SS 4.04
Schmoee J.: SS 10.03
Schramm N.: SS 4.03, SS 4.04
Schreyer A.: SS 2.09, SS 6.07, SS 13.02, 
SS 16.02, SS 16.04
Schulz J.: SS 14.04
Schwartz L.: SS 7.01
Scrimieri A.: SS 13.09
Segnan N.: SS 11.07, SS 11.09
Sellars M.: SS 13.01
Sellier N.: SS 2.02
Senore C.: SS 11.07, SS 11.09
Seo Y.: SS 14.10
Seror O.: SS 2.02
Sgarro A.: SS 9.03
Shankar Mp S.: SS 10.05
Sheikh H.: SS 2.04
Sheridan M.: SS 1.07
Shin S.: SS 10.09, SS 10.09
Siddiqui M.: SS 3.05
Sidhu H.: SS 3.07, SS 3.08, SS 6.09
Siggar Investigators T.: SS 1.02, SS 11.01
Silva C.: SS 11.06
Simons P.: SS 11.03
Simsek M.: SS 11.04
Singh P.: SS 10.05
Sinkus R.: SS 5.05, SS 5.06
Sironi S.: SS 2.01, SS 12.03
Slenter J.: SS 12.08
Sogaro F.: SS 5.01
Sohn M.: SS 7.01
Solà M.: SS 10.10
Sombetzki A.: SS 9.02
Sommer C.: SS 10.03
Sommer W.: SS 13.04
Song B.: SS 5.09, SS 8.06, SS 9.01
Sosef M.: SS 12.07
Sottocornola L.: SS 5.01, SS 16.05
Soulez G.: SS 5.10
Srinivasan R.: SS 10.05
Stampﬂ U.: SS 10.03
Stedman B.: SS 2.03
Stephenson S.: SS 1.04, SS 2.10
Stiller W.: SS 8.04, SS 10.03
Stocca T.: SS 16.03
Stoker J.: SS 5.05, SS 5.06, SS 6.10
Stroszczynski C.: SS 2.09, SS 6.07,  
SS 13.02, SS 16.02, SS 16.04
Studer P.: SS 15.06
Sulkin T.: SS 3.08
Sun Y.: SS 9.07
T
Tahir B.: SS 4.02, SS 4.06, SS 8.05,  
SS 15.01
Talei Franzesi C.: SS 2.01
Tang A.: SS 5.10
Tang L.: SS 9.07
Tann M.: SS 4.02, SS 4.06, SS 8.05,  
SS 14.07, SS 15.01
Tartari S.: SS 1.10, SS 3.10
Taylor S.: SS 1.05, SS 6.01, SS 6.05,  
SS 6.08, SS 11.08
Theisen D.: SS 13.04
Tielbeek J.: SS 6.10
Tiferes D.: SS 1.06
Tokumaru K.: SS 16.08
Tolan D.: SS 1.07
Toumi Z.: SS 16.06
Tozer P.: SS 3.05
Trattenero C.: SS 12.03
Trinchet J.: SS 2.02
Twomey M.: SS 16.10
U
Umutlu L.: SS 9.02, SS 14.01, SS 15.02
V
Vagli P.: SS 1.01, SS 10.08, SS 11.02
Vagn-Hansen C.: SS 7.02, SS 12.01
Van Beers B.: SS 5.10
Van Dussen L.: SS 5.05
Van Muylder L.: SS 3.03
Van Putte-Katier N.: SS 9.06
Van Steenbergen L.: SS 11.03
Vanbeckevoort D.: SS 3.03
Vecchietti F.: SS 1.08, SS 11.05, SS 11.10
Verset L.: SS 9.04
Vilgrain V.: SS 5.10, SS 8.07, SS 13.05, 
SS 13.06
Vindigni C.: SS 3.02
Vogl T.: SS 14.04
Volterrani L.: SS 3.02, SS 9.08, SS 12.04
von Wagner C.: SS 1.05, SS 11.01
Vullierme M.: SS 8.07, SS 13.05, SS 13.06
W
Wagner M.: SS 8.07
Walton I.: SS 2.05
Wang N.: SS 9.07
Wardle J.: SS 11.01
Wee S.: SS 14.05
Werner J.: SS 8.04
Wiggermann P.: SS 2.09, SS 13.02
Wildberger J.: SS 12.09
Williams P.: SS 2.05
Willner M.: SS 13.10
Wilson I.: SS 2.03
Winternitz T.: SS 2.08
Witoszynskyj S.: SS 5.08
Wohlgemuth W.: SS 2.09
Wooldrage K.: SS 1.02, SS 11.01
Woolson K.: SS 6.09
Y
Yamada M.: SS 16.08
Yao G.: SS 1.02
Yencilek E.: SS 11.04
Yoon D.: SS 14.10
Yoon J.: SS 5.07, SS 15.08
Yu M.: SS 15.08
Yuan F.: SS 5.09, SS 9.01
Yun E.: SS 14.10
Z
Zakharova O.: SS 4.10, SS 8.08
Zamboni G.: SS 8.03, SS 10.06
Zanella G.: SS 9.03
Zech C.: SS 4.03
Zemanova M.: SS 12.10
Zhang X.: SS 9.07
Zhu S.: SS 1.02, SS 1.05
Zivelonghi E.: SS 8.03, SS 10.06
Zsirka A.: SS 2.08
Zuiani C.: SS 9.03, SS 13.03, SS 13.07, 
SS 13.08
Zur Hausen A.: SS 12.06
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